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ABSTRACT OF THE DISSERTATION 
 
Hedonics, Reward Prediction, and Reinforcement Learning in Schizophrenia: Relationships to Anhedonia 
and Avolition 
by 
Erin Connor Dowd 
Doctor of Philosophy in Biology & Biomedical Sciences 
Neurosciences 
Washington University in St. Louis, 2014 
Professor Deanna M. Barch, Chairperson 
 
 
 Anhedonia (a reduced experience of pleasure) and avolition (a reduction in goal-directed activity) 
are common features of schizophrenia that have substantial effects on functional outcome, but are poorly 
understood and treated. Here, we examine the potential contributions of three processes involved in the 
translation of reward information in the environment into goal-directed action among medicated 
individuals with schizophrenia.  The first process, hedonics, or the enjoyment of pleasant experiences, 
was examined using an fMRI study of emotional experience in response to affective stimuli.  Results were 
similar between patients and controls at a group level, but patients with greater anhedonia/avolition 
demonstrated reduced self-reports and brain activity in response to positive stimuli in ventral striatum and 
amygdala, regions associated with salience and reward.  The second process we examined was reward 
prediction, which describes anticipatory responses to cues that predict reward. This process is thought to 
be mediated by the mesolimbic dopamine system, which shows evidence of dysregulation in 
schizophrenia.  We examined reward prediction using a Pavlovian paradigm with monetary reward, using 
fMRI to examine brain responses during reward anticipation and receipt.  Responses to reward receipt 
were largely intact in schizophrenia, while anticipation responses in ventral striatum, a major target of 
dopaminergic afferents, were reduced in those patients who were higher in anhedonia/avolition.  The final 
process we examined was reinforcement learning, or the process by which positive and negative 
  vii 
feedback influences trial-and-error choice behavior.  Participants underwent fMRI during a reinforcement 
learning task with probabilistic feedback.  Evidence from behavior and computational modeling suggested 
impairment in learning from positive feedback.  However, neuroimaging data revealed largely intact 
striatal activation during both choice and feedback, a surprising result given the role of dopaminergic 
influence on corticostriatal circuits in mediating reinforcement learning.  Instead, there was some 
evidence for reduced cortical responses to choice execution among patients, and to positive feedback 
among those patients higher in anhedonia/avolition. Together, these studies suggest that impairments in 
hedonics, reward prediction, and reinforcement learning may play a role in anhedonia/avolition in 
schizophrenia, but that these impairments are not sufficient causes of these symptoms; impairments in 
other higher-level cognitive processes are also likely to contribute. 
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Chapter 1. 
 
Reward Processes and Negative Symptoms in Schizophrenia 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter were published in the September, 2010 issue of Schizophrenia Bulletin, to which I 
contributed conceptual input, literature review, and writing of some sections. 
 
Reference: Barch DM & Dowd EC. Goal representations and motivational drive in schizophrenia: the role 
of prefrontal-striatal interactions. Schizophrenia Bulletin (2010) vol. 36 (5) pp. 919-34. 
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Schizophrenia and Negative Symptoms 
 
Schizophrenia is a severe psychiatric illness with a complex and heterogeneous presentation. 
Among neuropsychiatric illnesses, schizophrenia is one of the most disabling, and renders heavy 
personal, economic, and social burdens (Knapp et al 2004) that place it among the top ten causes of 
long-term disability worldwide (Mueser and McGurk 2004).  While schizophrenia is most commonly 
associated with positive symptoms such as hallucinations and delusions, clinicians have long recognized 
that cognitive deficits and negative symptoms – such as affective flattening and reduced motivation – are 
important symptoms that contribute substantially to disability and poor quality of life in this illness 
(Kirkpatrick et al 2006; Leifker et al 2009; Milev et al 2005; Nuechterlein et al 2012). In fact, negative 
symptoms may have a greater impact on functional outcome than positive symptoms (Rabinowitz et al 
2012), but currently available treatments are often ineffective in reducing them (Kirkpatrick et al 2006).  
As revealed by factor-analysis studies of negative symptom scales such as the Scale for the Assessment 
of Negative Symptoms (SANS), negative symptoms consist of two major factors: expressive deficits, and 
anhedonia/avolition (Messinger et al 2011). The expressive deficits factor includes impairments in 
emotional expression such as flat affect and alogia (poverty of speech), and the anhedonia/avolition 
factor, on which I focus here, includes anhedonia (a reduction in the ability to experience pleasure) and 
avolition (a reduction in the motivation to initiate or persist in goal-directed behavior).  The work described 
here strives to examine the anhedonia/avolition symptom domain by using a perspective grounded in 
affective and computational neuroscience to identify and systematically examine several potential 
contributors to these symptoms among individuals with schizophrenia.  
In order to study the etiology of anhedonia and avolition in schizophrenia, it is helpful to outline 
several component processes that are required for the translation of information about rewarding 
experiences into behavioral responses designed to obtain these rewards again in the future (Wallis 2007).  
These processes represent major elements of reward processing and decision making as identified in 
basic animal and human studies (Berridge 2007; Wallis 2007), and while they are certainly an 
oversimplification, these processes provide a useful set of organizing principles for studying reductions in 
goal-directed behavior among individuals with schizophrenia.  The first of these components is hedonics 
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or “liking”, which reflects the enjoyment that results from experiencing a pleasurable stimulus or event.  
Impairments in hedonics/“liking” would yield anhedonia by definition, but may also yield avolition if the 
reduction in pleasure causes a lack of motivation to seek out similar events in the future. The possibility 
that hedonic processes are impaired in schizophrenia is examined in Chapter 2: Anhedonia and 
Emotional Experience in Schizophrenia. The second component process is reward prediction and 
“wanting”, which describes the ability of cues that predict rewards to trigger anticipatory responses in 
expectation of reward.  Impairment in this system would be expected to yield avolition by reducing the 
salience of reward-predictive cues in the environment, thus reducing the motivational drive to seek out the 
associated rewards.  I ask whether reward prediction is impaired in schizophrenia in Chapter 3: Pavlovian 
Reward Prediction in Schizophrenia.  The third component, which is closely related to reward prediction 
and wanting, is reinforcement learning, or the conditioning process by which choices are shaped by 
feedback over time to maximize reward.  If this process is impaired, subjects would have difficulty making 
choices that are likely to yield rewards even if they are motivated to obtain the rewards and enjoy them 
when they occur. This possibility is examined in Chapter 4: Probabilistic Reinforcement Learning in 
Schizophrenia.  In addition to these three components, which address the contribution of basic reward 
processing to goal-directed behavior, several additional computations must be performed on the reward 
information before a behavioral response is carried out.  These include the integration and updating of 
value information, effort computation, cost-benefit analysis, and finally generation of an action plan to 
obtain a valued outcome. While these processes were not examined in the studies conducted here, 
impairment in any of these domains would also be expected to yield reductions in goal-directed behavior, 
a possibility I return to in Chapter 5: Conclusions and Future Directions. 
 
Hedonics or “liking” in schizophrenia 
Hedonic or “liking” responses to pleasurable stimuli were long thought to be mediated by the 
mesolimbic dopamine (DA) system, primarily due to evidence that lesions to this system decreased 
reward-seeking behaviors in rats (Wise 1982). Since this time, however, work by Berridge and colleagues 
has shown that dopamine depletion does not reduce pleasure responses that do not depend upon 
motivational drive, such as orofacial reactions to sweet tastes (Berridge 2004). Accordingly, more recent 
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work suggests that hedonic responses are mediated not by DA, but by opioid- and GABA-dependent 
mechanisms in the ventral striatum, amygdala, and orbitofrontal cortex (Burgdorf and Panksepp 2006), 
while DA is associated with the related, but dissociable, functions of “wanting” (Berridge and Kringelbach 
2008) and learning (Schultz 2007). 
In the schizophrenia literature, current laboratory data on hedonics is somewhat at odds with the 
historical clinical picture.  Anhedonia has long been considered a core clinical feature of schizophrenia 
(Bleuler 1911; Kraepelin 1971), but a large body of literature has shown that individuals with 
schizophrenia report experiencing similar levels of pleasure as controls when describing their feelings “in-
the-moment” (see (Cohen and Minor 2008; Kring and Moran 2008) for reviews). In numerous laboratory-
based experiments of emotional experience, self-reported valence and arousal responses to emotion-
eliciting stimuli such as pictures, words, faces, and sounds have been found to be similar between 
patients and controls. Similarly, naturalistic experience-sampling studies examining emotional responses 
to everyday events have shown that individuals with schizophrenia and controls experience comparable 
increases in positive emotion when engaging in pleasurable activities (Gard et al 2007; Oorschot et al 
2011), although patients do experience less positive affect overall, perhaps due to having fewer 
pleasurable events in their every day lives (Myin-Germeys et al 2000). In addition to these self-report 
measures of emotion, intact hedonic responses in schizophrenia may also be inferred from the effects of 
positive emotion on other psychological processes. For example, startle responses are similarly reduced 
in both individuals with schizophrenia and controls following presentation of pleasant stimuli (Curtis et al 
1999; Schlenker et al 1995), and memory is enhanced for positively valenced emotional stimuli among 
both patients and controls (Hall et al 2007; Mathews and Barch 2004); although one study did find a 
failure of memory enhancement for positive, but not negative, stimuli (Herbener et al 2007). 
A similar pattern of intact responses to rewarding stimuli among patients with schizophrenia is 
also seen in neuroimaging studies that examine striatal responses to receipt of monetary reward in 
monetary incentive delay (MID) tasks. A number of such studies have reported intact ventral striatal 
responses in patients treated with either typical or atypical antipsychotics (Kirsch et al 2007; 
Schlagenhauf et al 2009; Simon et al 2010; Walter et al 2009). One of these studies did show reduced 
striatal responses to loss-avoidance among the individuals with schizophrenia, although group differences 
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in ventral striatal responses to reward receipt were not significant (Schlagenhauf et al 2009). However, 
while striatal responses to receipt of money seem to be largely intact in schizophrenia, some of these 
studies did report abnormal cortical responses. Specifically, reduced reward-related responses in patients 
as compared to controls have been reported in ventromedial prefrontal cortex (VMPFC) (Schlagenhauf et 
al 2009), rostral anterior cingulate cortex (rACC), inferior frontal gyrus, and amygdala (Waltz et al 2010), 
and reduced salience coding in has been reported in right ventrolateral prefrontal cortex (Walter et al 
2010; Walter et al 2009). 
Of note, a somewhat more mixed picture has arisen from functional neuroimaging studies that 
have examined brain responses to other types of pleasurable or rewarding stimuli in schizophrenia. A 
study of juice rewards revealed reduced activation upon juice delivery in a number of regions including 
bilateral putamen, insula, precentral gyrus, and postcentral gyrus (Waltz et al 2009). Studies using 
positive emotional pictures have revealed evidence for reduced ventral striatal activation in a mixed 
sample of medicated and unmedicated patients (Taylor et al 2005).  In unmedicated patients, reduced 
responses to pleasant pictures have been identified in medial frontal cortex, dorsolateral prefrontal cortex 
(DLPFC), orbitofrontal cortex (OFC), and insula (Paradiso et al 2003).  Studies of pleasant olfactory 
stimuli have revealed reduced activation in thalamus (Schneider et al 2007), insula, and OFC (Plailly et al 
2006) among patients as compared to controls.  However, a recent meta-analyses of studies of emotion 
perception and experience in schizophrenia failed to reveal evidence for systematic differences in 
activation patterns between patients and controls for positive stimuli (Taylor et al 2012), suggesting that 
the abnormal patterns of activity in these studies of emotional pictures and odors are not particularly 
robust.  The studies of odors may also have been influenced by factors such as smoking status, which 
can alter olfactory and gustatory processing. 
The abundance of evidence suggesting that hedonic experience may be intact in schizophrenia is 
puzzling given the long history of clinically documented anhedonia among these patients.  Studies of 
anhedonia using self-report questionnaires nearly unequivocally report elevated anhedonia in patients as 
compared to controls (Trémeau 2006).  The source of this discrepancy, referred to as the “emotion 
paradox” in schizophrenia, is as yet unresolved in the literature, but the most prominent hypotheses 
emphasize interactions between cognition and emotion.  Some authors have suggested that the emotion 
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paradox may result from impairments in the ability to remember or generalize emotion experienced in the 
past, yielding the appearance of emotion deficits on self-report measures with retrospective, abstracted, 
or hypothetical foci (Burbridge and Barch 2007; Strauss and Gold 2012).  Others (Gard et al 2007) have 
emphasized the differences between consummatory pleasure (hedonics) and anticipatory pleasure 
(pleasure resulting from reward prediction/wanting), pointing out that while these constructs have been 
shown to rely on physiologically dissociable systems, traditional self-report measures of anhedonia do not 
distinguish between them (Horan 2005).  In an experience-sampling study designed to address this 
question, it was found that patients experienced significantly less anticipatory, but not consummatory, 
pleasure than controls, particularly for goal-directed activities (Gard et al 2007). 
It is also important to note that given the heterogeneity of symptoms among individuals with a 
schizophrenia diagnosis, there may be important individual differences in anhedonia severity that relate to 
individual experiences of pleasure.  In several studies of emotional stimuli including pictures, words, 
sounds, faces, and films, higher anhedonia scores were associated with reduced positive affect in 
response to positive stimuli among patients (Blanchard et al 1994), or with blunted emotional responses 
to both positive and negative stimuli in both patients and controls (Burbridge and Barch 2007; Herbener et 
al 2007). In the neuroimaging literature, there is evidence that the magnitude of the reduction in striatal 
responses to the receipt of juice among patients is associated with the severity of anhedonia scores 
(Waltz et al 2009). In addition, Walter and colleagues report that salience coding in ventrolateral 
prefrontal cortex, which is reduced in patients, is correlated with negative symptom severity (Walter et al 
2009) or anhedonia (Walter et al 2010).  Interestingly, one study found that the magnitude of the reward 
receipt response in the ventral striatum was inversely associated with severity of depression, but not with 
anhedonia (Simon et al 2010), raising questions about the specificity of these effects.  This evidence 
suggests that hedonic experience and its associated BOLD activation may vary with individual differences 
in anhedonia; however, interpretation of these results is complicated by the fact that the “anhedonia” 
measures here may have been influenced by anticipatory and motivational processes as well as by 
hedonics per se. 
In sum, the self-report literature provides fairly consistent evidence for intact in-the-moment 
hedonic experience in schizophrenia, though there is evidence that greater self-reports of anhedonia are 
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associated with reduced hedonic experience. In addition, the neuroimaging literature on the receipt of 
monetary rewards shows relatively consistent evidence for intact striatal responses to the receipt of such 
rewards. Cortical responses to reward receipt are more variable, particularly for rewarding or pleasant 
stimuli other than money.  These studies have identified abnormal responses among patients in striatal 
regions as well as ventrolateral prefrontal cortex, insula, OFC, and VMPFC; however, the patterns 
identified have been inconsistent across studies.   Further, studies that have examined individual 
differences in negative symptoms suggest an important relationship between anhedonia (or motivational 
disturbances that may influence anhedonia questionnaires) and self-reports of hedonic experience.  
There are also hints of a relationship between anhedonia and reduced reward responses in striatum and 
VLPFC, but too few studies have been appropriately powered for individual difference analyses to draw 
strong conclusions about these relationships.  Chapter 2 aims to address some of the open questions in 
this domain by examining functional activation during the experience of several types of non-monetary 
emotional stimuli in schizophrenia, and its relationship to self-reported anhedonia, in a large sample of 
patients and community controls. 
  
Reward Prediction and “Wanting” in Schizophrenia 
A second process required for translating reward information into goal-directed behavior is reward 
prediction and “wanting”.  An extensive body of literature has revealed that this process is mediated by 
the midbrain dopamine system and its projections to dorsal and ventral striatum (Berridge 2004; Schultz 
2007). Converging data from animal, human, and computational studies suggests that phasic 
dopaminergic activity in the ventral tegmental area and substantia nigra mediates the acquisition of 
stimulus-reward associations over repeated pairings. A prominent theory holds that this phasic 
dopaminergic activity codes reward prediction errors that serve as teaching signals, guiding the formation 
of associations between rewards and the cues that predict them (Schultz et al 1997). A closely related, 
though slightly different, theory emphasizes the role of the dopamine-mediated learning process in 
transferring incentive salience from the reward itself to reward-predicting cues, thus imbuing these cues 
with motivational properties themselves (i.e., a “wanting” response (Berridge 2004)).  We do not aim to 
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adjudicate between these theories here, but instead point out that both involve a role of dopamine in 
establishing anticipatory and approach motivational responses to reward-predictive cues.  In support of 
both theories, during the process of learning, dopaminergic neurons in the ventral tegmental area initially 
fire in response to unexpected rewards, but after repeated cue-reward pairings, begin to fire upon cue 
presentation instead (Schultz et al 1993). When a cued reward is then omitted, dopaminergic firing 
momentarily drops below its basal level. This behavior is consistent with a role of phasic dopaminergic 
activity in coding prediction errors, or the difference between the magnitudes of rewards that were 
expected, and those that were actually received.  This difference may be used to update reward 
predictions on each trial until prediction is optimized, thereby driving learning. This iterative process is 
formalized in computational algorithms such as temporal difference models (Sutton 1988), whose 
simulations show considerable agreement with experimental data from dopaminergic neurons in animal 
studies (Montague et al 1996; Schultz 2007). Studies of reward prediction in humans have also shown 
functional activity consistent with dopaminergic coding of prediction errors (O'Doherty 2004). Studies 
examining BOLD responses to reward-predictive cues have revealed anticipatory activation in regions 
including dorsal and ventral striatum, which are major targets of dopaminergic projections from the 
midbrain (Knutson et al 2001; Knutson et al 2000). Further, during Pavlovian conditioning, regions 
including striatum and orbitofrontal cortex have shown evidence of activation that correlates with 
prediction errors derived from temporal difference models fit to the behavioral data (McClure et al 2003; 
O'Doherty et al 2003b).  
 In schizophrenia, there is robust evidence for altered striatal dopaminergic function, which raises 
a particular interest in reward prediction in this disorder. The specifics of dopaminergic pathophysiology in 
schizophrenia are as yet unknown, but recent meta-analyses of PET studies in schizophrenia indicate 
that striatal dopaminergic disturbances in schizophrenia are primarily presynaptic (Fusar-Poli and Meyer-
Lindenberg 2012; Howes et al 2012). These studies have revealed that striatal dopamine synthesis 
capacity, as assessed with [18F]/[11C]-DOPA, is elevated in schizophrenia (Fusar-Poli and Meyer-
Lindenberg 2012), as are dopamine release as measured with [11C]raclopride or [123I]IBZM binding 
following acute amphetamine challenge (Howes et al 2009; Howes et al 2012) and synaptic dopamine 
levels as assessed by raclopride binding before and after pharmacologic dopamine depletion (Howes et 
  9 
al 2012; Kegeles et al 2010). These presynaptic abnormalities may result in spurious DA release (Howes 
et al 2009) that could increase the noise in the system, reducing the effectiveness of environmentally 
relevant phasic dopamine signals and yielding impaired reward prediction mechanisms. 
In the fMRI literature, the main approach to studying reward prediction has been to examine 
reward anticipation responses, or activation in response to stimuli that have been associated with reward 
during pre-scan conditioning or explicit instruction. The monetary incentive delay (MID) task is commonly 
used in these studies, and involves presentation of a cue that indicates potential monetary gain or loss for 
the trial, followed by a reaction time task, then feedback on whether the money was won.  In healthy 
adults, such studies have shown reward anticipation responses upon presentation of the incentive cues in 
regions including dorsal and ventral striatum (Knutson et al 2001; Knutson et al 2000). In individuals with 
schizophrenia, a number of studies using the MID task have reported reduced ventral striatal activation to 
reward-predicting cues among patients as compared to controls. This result has been seen in 
unmedicated individuals with schizophrenia (Juckel et al 2006b), as well as in individuals taking typical 
antipsychotics (Juckel et al 2006a), but not in individuals treated with atypicals (Juckel et al 2006a; Walter 
et al 2009; Waltz et al 2010), nor in prodromal individuals (Juckel et al 2012). Studies focusing on 
medication have shown reduced ventral striatal responses to incentive cues in individuals with 
schizophrenia taking typical compared to atypical antipsychotics (Kirsch et al 2007), as well as reductions 
in anticipatory ventral striatal responses in antipsychotic-naive patients that improved following treatment 
with amisulpride (Nielsen et al 2012). Reduced striatal responses to appetitive food cues have also been 
reported among individuals with schizophrenia as compared to controls (Grimm et al 2012). 
Importantly, a number of these studies also showed a relationship between deficits in anticipatory 
ventral striatal activity and individual differences in negative symptom severity. In unmedicated (Juckel et 
al 2006b), typically medicated (Juckel et al 2006a), and primarily atypically medicated (Waltz et al 2010) 
patients, the severity of negative symptoms has been shown to predict the reduction in ventral striatal 
responses to anticipated monetary gains. Similarly, Simon and colleagues showed that the magnitude of 
the ventral striatal anticipatory response was inversely correlated with apathy (avolition) ratings among 
atypically medicated individuals with schizophrenia. 
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To summarize, a growing number of studies in the imaging literature suggests reduced ventral 
striatal reward prediction/”wanting” responses in unmedicated and typically medicated individuals with 
schizophrenia, while responses in patients taking atypical antipsychotics are more frequently intact. 
However, there is evidence that the magnitude of these striatal impairments may be related to the 
severity of negative symptoms even among atypically treated patients.  It is important to note, however, 
that the vast majority of these results were derived from a single task.  The MID task is a good choice for 
studies of reward prediction because of its consistently demonstrated ability to elicit robust striatal 
anticipatory responses, but it also requires subjects to execute speeded responses in order to obtain 
rewards, which may confound the ability to predict rewards with the ability to execute the actions required 
to earn them.  Chapter 3 addresses this problem by examining reward prediction during a Pavlovian task, 
where anticipatory responses to reward-predictive cues are examined in a context wherein outcomes 
depend only on the cues presented and are not contingent upon the execution of a behavioral response. 
 
Reinforcement Learning in Schizophrenia 
The term Reinforcement Learning (RL) is derived from the artificial intelligence literature, and 
describes algorithms that solve trial-and-error learning problems by using positive and negative feedback 
to optimize choice behavior with the goal of maximizing reward rate.  In the past two decades, interaction 
between the fields of neurophysiology, psychology and computational neuroscience has allowed the 
development of physiologically and behaviorally informed RL models, alongside neurophysiology and 
neuroimaging studies designed from information-processing standpoints influenced by RL (Cohen and 
Frank 2009; Dayan and Balleine 2002). Current data suggests that the same dopaminergic prediction 
error mechanisms underlying reward prediction and “wanting” also contribute to reinforcement learning. 
Phasic dopaminergic activity has been shown to modulate synaptic plasticity in the corticostriatal circuits 
associated with action selection (Calabresi et al 1997), thereby facilitating the strengthening of stimulus-
response associations for actions that yield positive outcomes, and the weakening of those that do not 
(Frank et al 2004).  Recent work in computational modeling suggests that the basal ganglia may be 
responsible for implicit forms of learning involving the gradual integration of reward information over 
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several trials, while top-down information from frontal cortex, OFC and amygdala is required for more 
rapid and explicit forms of learning such as those required in conditions of changing response 
contingencies (Frank and Claus 2006). 
Despite the evidence of alterations in striatal dopamine function in schizophrenia, numerous 
studies have suggested that reinforcement learning is intact in this population when learning is relatively 
easy or implicit (Ceaser et al 2008; Elliott et al 1995; Heerey et al 2008; Hutton et al 1998; Jazbec et al 
2007; Joyce et al 2002; Somlai et al 2011; Turner et al 2004; Tyson et al 2004; Weiler et al 2009), though 
with some exceptions (Oades 1997; Pantelis et al 1999). However, when the learning paradigms are 
more difficult and/or require the explicit use of representations about stimulus-reward contingencies, there 
is more consistent evidence of impaired reinforcement learning in patients (Gold et al 2012; Koch et al 
2010; Morris et al 2008; Waltz et al 2007; Yilmaz et al 2012). This pattern has given rise to the theory that 
the striatum-mediated gradual reinforcement learning system may be intact in schizophrenia, while the 
more rapid, on-line, cortically-mediated learning systems are impaired (Gold et al 2008; Weickert et al 
2002). In support of this theory, two studies of probabilistic reversal learning in schizophrenia showed that 
while reversal learning (which is thought to rely on rapid cortical mechanisms) was impaired, patients 
were able to acquire the initial probabilistic reward contingencies that may in part reflect striatally-
mediated implicit learning (Waltz and Gold 2007; Weiler et al 2009).  Additional evidence for this theory 
comes from the Weather Prediction Task, a probabilistic category-learning task on which performance is 
influenced by both implicit and explicit learning mechanisms Gluck, 2002 #145}. Several studies using 
this task have shown a relatively intact learning rate, but impaired asymptotic performance, in individuals 
with schizophrenia (Beninger et al 2003; Keri et al 2000; Keri et al 2005; Weickert et al 2002).  This 
finding is consistent with the possibility that the normal learning curve reflects relatively intact striatal 
learning mechanisms, while the impaired overall performance reflects relatively impaired cortically-
supported explicit learning mechanisms. However, more recent studies, including one with a much larger 
sample size than others in the literature (108 patients), found lower learning rates in patients than 
controls, suggesting impairments in striatal learning as well (Weickert et al 2010).  There is some 
evidence that performance on this task may be influenced by medication status, with greater impairments 
in patients taking typical than atypical antipsychotics (Beninger et al 2003), though performance does not 
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appear to be influenced by antipsychotic dose (Weickert et al 2010). Other tasks have emphasized the 
difference between positive and negative reinforcement learning, and have yielded evidence that 
individuals with schizophrenia may have more difficulty learning from positive than negative feedback 
(Cheng et al 2012; Gold et al 2012; Waltz et al 2007), particularly if they are higher in negative symptoms 
(Gold et al 2012). 
One major approach to studying reinforcement learning in human neuroimaging studies is to ask 
whether the pattern of functional activation in regions receiving dopamingeric projections is consistent 
with a prediction error signal.  Broadly, this framework would predict an increase in striatal (presumably 
dopaminergically mediated) responses to unexpected rewards, and a decrease in striatal responses 
when predicted rewards do not occur.  In a more nuanced approach, BOLD responses during learning 
tasks are analyzed to determine whether they correlate with prediction errors derived from a 
computational model fit to the behavioral data.  Studies of this kind among healthy adults have revealed 
evidence of activation consistent with a prediction error function in dorsal and ventral striatum, as well as 
orbitofrontal cortex (McClure et al 2003; O'Doherty et al 2003b).   In the schizophrenia literature, this 
approach has revealed evidence for altered striatal prediction error activity among individuals with 
schizophrenia using both Pavlovian and instrumental reward-learning tasks, and for both monetary and 
liquid rewards.  An instrumental learning study with monetary reward found evidence for reduced 
prediction error responses among schizophrenia spectrum patients in bilateral midbrain and right ventral 
striatum (Murray et al 2008), and an instrumental task with liquid reward revealed reduced prediction error 
responses in the caudate (Gradin et al 2011). In addition, a Pavlovian task with monetary reward revealed 
reduced prediction error responses in the striatum in schizophrenia, coupled with enhanced responses for 
unsurprising reward stimuli (which are not expected to elicit prediction errors) (Morris et al 2012). In a 
passive paradigm that required participants to learn about the timing of a potential juice reward, Waltz 
and colleagues found evidence for reduced positive prediction error responses in a range of regions that 
included the striatum (dorsal and ventral) as well as the insula, but relatively intact negative prediction 
errors in these same regions. However, a study of prediction errors during the MID task revealed intact 
striatal prediction error activity in schizophrenia (Walter et al 2009).  In all, these studies have revealed 
fairly consistent evidence for reduced striatal prediction errors in schizophrenia, with some suggestion 
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that positive prediction errors may be more affected than negative prediction errors.  However, these 
findings are not universal, and the striatal areas demonstrating these reductions are not always consistent 
across studies. 
In addition to these prediction error studies, two studies have used fMRI to examine 
reinforcement learning during more complex learning tasks. An imaging study using the Weather 
Prediction task found that among a sub-sample of participants defined as good learners, controls showed 
greater activation than individuals with schizophrenia in DLPFC and caudate, while patients showed 
greater activation of regions including cingulate gyrus, parahippocampal gyrus, and parietal cortex during 
Weather Prediction Task blocks versus perceptual-motor control task blocks (Weickert et al 2009). The 
authors interpret this finding as suggesting that impairments in fronto-striatal circuits may perhaps be 
balanced by compensatory increases in parahippocampal and parietal regions to allow preserved 
learning function.  In a related study examining probabilistic reinforcement learning, Koch and colleagues 
found that controls, but not patients, had reductions in fronto-parietal activation as reward predictability 
increased (Koch et al 2010). Furthermore, this study also found reduced positive prediction error 
responses in frontal cortex, cingulate, and putamen. 
There is little data on the relationship between individual differences in anhedonia/avolition and 
reinforcement learning performance or prediction error activity in individuals with schizophrenia. In 
behavioral studies, overall performance on reinforcement learning tasks has been shown to be negatively 
correlated with negative symptom severity (Waltz et al 2007; Yilmaz et al 2012).  Further, patients with 
greater negative symptom severity show greater deficits in learning from positive, but not negative, 
feedback (Gold et al 2012).  In addition, performance on Kamin blocking tasks (a behavioral indicator of 
prediction error signaling) has been shown to be impaired in schizophrenia, with greater impairments in 
performance associated with greater negative and depressive symptoms (Moran et al 2008). In 
neuroimaging studies, Waltz et al found that the magnitude of prediction errors in left putamen was 
negatively correlated with avolition scores among patients with schizophrenia during a Pavlovian 
conditioning task with juice rewards (Waltz et al 2009).  These results suggest that there may be a 
relationship between negative symptoms and impairments in the ability to learn from feedback, 
particularly positive feedback, among individuals with schizophrenia.  
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 In sum, the literature on reinforcement learning in schizophrenia suggests relatively intact learning 
on simple reinforcement learning paradigms, with evidence for overall impairment, but (perhaps) spared 
learning rate, on more difficult tasks. The degree to which these impairments reflect differences in 
striatum-influenced learning mechanisms that are more gradual and implicit vs. explicit learning 
mechanisms that may be more cortically mediated is an open question in the literature. Consistent with 
the hypothesis that some of these reinforcement learning impairments may reflect striatal mechanisms, a 
growing number of studies in the imaging literature suggest reduced striatal prediction error activity 
among this population. However, not all studies have found impaired striatal prediction error responses, 
and the striatal areas in which differences were detected have varied from study to study. Furthermore, at 
least two studies examining probabilistic reinforcement learning have also found altered activation in 
frontal regions, suggesting a potentially important role for cortically mediated mechanisms in these 
impairments. There is also evidence that the magnitude of reinforcement learning deficits and reductions 
in striatal prediction errors may be related to the severity of negative symptoms in this population. Several 
studies have suggested that reinforcement learning impairments among individuals with schizophrenia, 
especially those with severe negative symptoms, may be specific to learning from positive feedback, and 
that positive prediction errors are reduced specifically in these individuals.  Together, this findings raise 
the possibility that impairments in learning from positive outcomes, mediated by reductions in striatal 
signaling of positive prediction errors, may contribute motivational deficits in schizophrenia.  This 
possibility is examined in Chapter 4, using a probabilistic reinforcement learning paradigm allowing the 
separate assessment of learning from positive versus negative outcomes. 
 
Summary 
 The studies reported here aim to address three possible sources of anhedonia/avolition in 
schizophrenia.   The first, hedonics or “liking”, seems to be intact in schizophrenia on the basis of self-
reports of in-the-moment emotional experience and ventral striatal responses to rewarding stimuli, but 
may vary with individual differences in anhedonia severity.  The relationships between anhedonia and 
self-reported hedonic experience, and its associated functional activation, are examined in Chapter 2.  
The second process of interest is reward prediction and “wanting”.  The current literature suggests that 
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reward anticipation in ventral striatum may be reduced in unmedicated and typically medicated patients, 
but spared in those taking typical antipsychotics. However, existing results may have been influenced by 
response requirements in addition to reward prediction processes.  Chapter 3 examines reward prediction 
and its relationship to anhedonia/avolition using a Pavlovian paradigm with no response requirements.  
The third process of interest is reinforcement learning, which appears to be impaired overall for difficult 
tasks, but sometimes shows intact learning rates, in schizophrenia.  There is disagreement in the 
literature as to whether striatally-mediated mechanisms of implicit learning are disrupted, with spared 
learning rates suggesting intact striatal learning, but reduced striatal prediction errors suggesting deficits 
in this process.  Some data suggests that reinforcement learning impairments, particularly for patients 
with severe negative symptoms, may be related to specific deficits in learning from positive feedback, as 
well as specific reductions in positive prediction errors.  This possibility is addressed in Chapter 4, using a 
probabilistic reinforcement learning paradigm to assess BOLD activation during learning from positive and 
negative feedback and its relationship to anhedonia and avolition in schizophrenia. 
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Chapter 2. 
 
 Anhedonia and Emotional Experience in Schizophrenia 
 
 
 
 
 
 
 
 
 
 
This chapter was published in the May, 2010 issue of Biological Psychiatry.  My contributions to this 
paper included data analysis and writing. 
 
Reference: Dowd EC & Barch DM. Anhedonia and emotional experience in schizophrenia: neural and 
behavioral indicators. Biol Psychiatry (2010) vol. 67 (10) pp. 902-11. 
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Abstract 
 
Background: Emotional impairments such as anhedonia are often considered key features of 
schizophrenia. However, self-report research suggests that emotional experience in response to affect-
eliciting stimuli is intact in schizophrenia. Investigation of neural activity during emotional experience may 
help clarify whether symptoms of anhedonia more likely reflect alterations of in-the-moment hedonic 
experience or impairments in other aspects of goal-directed behavior. 
Methods: 40 individuals with DSM-IV-TR schizophrenia or schizoaffective disorder and 32 healthy 
controls underwent fMRI while making valence and arousal ratings in response to emotional pictures, 
words, and faces. BOLD responses were compared between patients and controls, and were correlated 
with questionnaire measures of anhedonia. 
Results: Patients showed some evidence of blunted valence, but not arousal, ratings in response to 
emotional stimuli as compared to controls. Higher anhedonia scores were associated with blunted 
valence ratings in both groups, and fully mediated the group differences in valence ratings. Functional 
activity was largely intact in patients, except for regions in right ventral striatum and left putamen, which 
showed reduced responses to positive stimuli. Higher anhedonia was associated with reduced activation 
to positive versus negative stimuli in bilateral amygdala and right ventral striatum in patients, and in 
bilateral caudate in controls. 
Conclusions: Increased anhedonia is associated with a reduced experience of valence in both patients 
and controls, and group differences in experienced valence are likely driven by individual differences in 
anhedonia. Reduced activation of the striatum and amygdala may contribute to symptoms of anhedonia 
by failing to signal the salience of positive events. 
 
Introduction 
Anhedonia, or the inability to experience pleasure, is a long-established feature of schizophrenia 
(Bleuler 1911; Kraepelin 1971) that significantly impacts functional capacity and is resistant to treatment 
(Herbener et al 2005; Shoichet and Oakley 1978). Surprisingly, however, a growing body of self-report 
(Cohen and Minor 2008; Kring and Moran 2008) and behavioral (Heerey and Gold 2007) data suggests 
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that emotional experience in schizophrenia is intact. One possible explanation for this discrepancy is that 
in schizophrenia, clinical measures of anhedonia reflect not a deficit in consummatory pleasure, but a 
deficit in anticipatory pleasure or approach motivation (Burbridge and Barch 2007; Gard et al 2007; Horan 
et al 2006).  To investigate this possibility, we asked whether neural activity during emotional experience 
is also intact in schizophrenia. 
 In studying brain responses to affect-eliciting stimuli, several structures are of particular interest. 
First, the striatum has been associated with responses to “rewarding” or pleasurable stimuli (O'Doherty 
2004; Schultz 2007; Smith and Berridge 2007). Further, reduced ventral striatal activity in response to 
positive stimuli has been associated with anhedonia in studies with both healthy (Wacker et al 2009) and 
depressed (Epstein et al 2006; Keedwell et al 2005) individuals.  Most commonly, the mesolimbic 
dopamine system and its projections to the striatum are associated with reward prediction and incentive 
salience (Berridge 2004; Schultz 1997; Schultz 2007), suggesting that this region is instrumental to 
anticipatory pleasure and approach motivation. Second, dorsomedial prefrontal cortex (dmPFC) and 
orbitofrontal cortex (OFC) are active during emotional experience across a wide range of emotion 
elicitation studies (Kober et al 2008). DmPFC may be involved in the introspective evaluation of one’s 
feelings, while OFC may be involved in establishing the threat or reward value of a stimulus (Barrett et al 
2007). Third, the amygdala is implicated in processing survival-salient, arousing stimuli, both negative 
and positive (Zald 2003). Finally, activity in the rostral anterior cingulate cortex (rACC) has been 
associated with subjective ratings of pleasantness (Rolls et al 2008a; Rolls et al 2003).  
 A number of studies have suggested that striatal activity during processing of positive stimuli may 
be altered in schizophrenia. For example, unmedicated patients have shown reduced ventral striatal 
activation during reward anticipation, which correlated with negative symptom severity (Juckel et al 
2006b). In emotion perception studies, patients failed to modulate nucleus accumbens activation when 
rating pleasant versus unpleasant odors (Crespo-Facorro et al 2001), and demonstrated reduced phasic 
(but enhanced tonic) activity in the ventral striatum to both positive and aversive stimuli (Taylor et al 
2005).  
 Studies of activity in dmPFC and OFC during emotional experience in schizophrenia have yielded 
mixed results. Given evidence of a dissociation between neural activity patterns during emotional 
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experience versus emotion perception (Wager 2008), we focus here on studies in which participants 
reported their own experienced emotion. Some of these studies found reduced activation of dmPFC and 
OFC during sadness in chronic and first-episode schizophrenia (Reske et al 2007; Takahashi et al 2004). 
However, other studies failed to find group differences in these regions in patients (Schneider et al 2007; 
Schneider et al 1998) and relatives (Habel et al 2004). Functional neuroimaging studies of amygdala 
activation in schizophrenia have also given mixed results (Aleman and Kahn 2005). Some emotional 
experience studies have shown reductions in amygdala activity in patients as compared to controls 
(Schneider et al 1998), while others found no group differences (Reske et al 2007; Schneider et al 2007). 
Similarly, most emotion perception studies have found reduced amygdala activity in response to 
emotional stimuli in patients relative to controls (Gur et al 2002b; Hempel et al 2003; Johnston et al 2005; 
Paradiso et al 2003; Takahashi et al 2004; Taylor et al 2002), and in paranoid vs. non-paranoid patients 
(Williams et al 2004). However, some studies have shown increased (Holt et al 2006; Kosaka et al 2002) 
or normal (Plailly et al 2006; Surguladze et al 2006) amygdala activation. The disparity in these results 
may reflect small sample sizes, differences in stimuli, clinical variation across samples, and the need for a 
low-level control condition given that neutral stimuli may elicit greater limbic activation in patients (Hall et 
al 2008) and their relatives (Seiferth et al 2008) than in controls. In the current study, we aimed to 
address these concerns by using a large sample and several types of stimuli, by conducting individual 
difference analyses, and by examining the pattern of responses across several emotional conditions 
rather than comparing emotional conditions to a neutral baseline.  
 This study aimed to address three questions. First, we asked whether self-reports of emotional 
experience are intact in patients. In keeping with previous data, we hypothesized that self-reports would 
be similar between patients and controls. Second, we asked whether neural activity during emotional 
experience was similar in patients and controls. If fMRI is sensitive to differences in emotional experience 
not probed by self-report measures, we would expect to see differences in functional activity in regions 
associated with emotional experience. Third, we asked whether there was a relationship between 
questionnaire measures of anhedonia and individual differences in self-reported emotion or its associated 
neural activity.  
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Methods 
Participants 
 Participants were 40 outpatients with DSM-IV-TR schizophrenia or schizoaffective disorder and 
32 healthy community controls. Controls were excluded if they had any history of, or first-order family 
member with, an Axis I psychotic disorder, or any current mood or anxiety disorder other than Specific 
Phobia. Other exclusions included: 1) DSM-IV substance abuse or dependence within six months; 2) any 
medical disorder that is unstable or severe, would confound the assessment of psychiatric diagnosis, or 
would make participation unsafe; 3) present or past head injury with neurological sequelae or causing 
loss of consciousness; and 4) DSM-IV mental retardation (mild or greater). The demographic and clinical 
characteristics of both participant groups are shown in Table 1. Groups were matched on age, parental 
education, gender, race, and handedness. All patients were taking antipsychotic medications, which were 
stable for least two weeks. 
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Participant diagnoses were based on a Structured Clinical Interview for DSM-IV-TR (First et al 
2001) and on information from medical records and corroborative sources. Clinical symptoms were rated 
using the Scales for the Assessment of Positive Symptoms (SAPS) (Andreasen 1983b) and Negative 
Symptoms (SANS) (Andreasen 1983a). We assessed anhedonia symptoms using the SANS global 
anhedonia score and the self-report Chapman physical and social anhedonia scales (Chapman et al 
1976; Eckblad et al 1982), and handedness using the Edinburgh Index (Oldfield 1971). Patients were 
recruited from local psychiatric hospitals, outpatient settings, and previous studies. Patients were 
excluded if they had been hospitalized within the past month, or if their medications had not been stable 
for at least two weeks.  Controls were recruited by advertising in local newspapers and posting flyers in 
disparity in these results might reflect small sample sizes, differences
in stimuli, clinical variation across samples, and the need for a
low-level control condition given that neutral stimuli might elicit
greater limbic activation in patients (44) and their relatives (45) than
in control subjects. In the current study, we aimed to address these
concerns by using a large sample and several types of stimuli, by
conducting individual difference analyses, and by examining the
pattern of responses across several emotional conditions rather than
comparing emotional conditions to a neutral baseline.
This study aimed to address three questions. First, we asked
whether self-reports of emotional experience are intact in pa-
tients. In keeping with previous data, we hypothesized that
self-reports would be similar between patients and control
subjects. Second, we asked whether neural activity during emo-
tional experience was similar in patients and control subjects. If
functional magnetic resonance imaging (fMRI) is sensitive to
differences in emotional experience not probed by self-report
measures, we would expect to see differences in functional
activity in regions associated with emotional experience. Third,
we asked whether there was a relationship between question-
naire measures of anhedonia and individual differences in self-
reported emotion or its associated neural activity.
Methods andMaterials
Participants
Participants were 40 outpatients with DSM-IV-TR schizophrenia
or schizoaffective disorder and 32 healthy community control
subjects. All results reported in the following text remained the same
when schizoaffective patients were excluded (see Methods and
Materials in Supplement 1). Control subjects were excluded if they
had any history of or first-order family member with an Axis I
psychotic disorder or any current mood or anxiety disorder other
than Specific Phobia. Other exclusions included: 1) DSM-IV sub-
stance abuse or dependencewithin 6months; 2) anymedical disorder
that is unstable or severe, would confound the assessment of psychi-
atric diagnosis, or would make participation unsafe; 3) present or past
head injury with neurological sequelae or causing loss of conscious-
ness; and 4) DSM-IV mental retardation (mild or greater). The demo-
graphic and clinical characteristics of both participant groups are
shown in Table 1. Groups were matched on age, parental education,
gender, race, and handedness. All patients were taking antipsychotic
medications, which were stable for least 2 weeks.
Participant diagnoses were based on a Structured Clinical
Interview for DSM-IV-TR (46) and on information from medical
Table 1. Clinical and Demographic Characteristics
Mean (SD)
t or !2 df pCON SCZ
Age 36.25 (10.85) 36.8 (8.99) .24 70 .82
Education 15.53 (4.29) 13.05 (2.27) 3.15 70 .002a
Highest Parental Education 12.76 (2.76) 13.35 (3.83) "1.65 65 .1
Gender (% Male) 65.6 65 .003 1 .95
Race (% Caucasian) 53.1 47.5 .225 1 .64
Chapman Social Anhedonia 2.35 (2.06) 5.28 (2.17) "5.748 69 .001a
Chapman Physical Anhedonia 3.45 (2.99) 7.23 (4.18) "4.253 69 .001a
SANS Global Anhedonia — 2.68 (1.21) — — —
Positive Symptoms — 1.83 (.93) — — —
Negative Symptoms — 1.81 (1.37) — — —
Disorganization Symptoms — 1.17 (.80) — — —
Duration of Illness (yrs) — 17.73 (11.25) — — —
Diagnosis Subtype (%) — — — —
Schizoaffective—bipolar — 7.5 — — —
Schizoaffective—depressive — 17.5 — — —
Schizophrenia—undifferentiated — 42.5 — — —
Schizophrenia—residual — 15 — — —
Schizophrenia—paranoid — 15 — — —
Schizophrenia—disorganized — 2.5 — — —
Medication (% Taking) — — — —
Aripiprazole — 22.5 — — —
Clozapine — 5.0 — — —
Ziprasidone — 2.5 — — —
Haloperidal — 5.0 — — —
Iloperidone — 2.5 — — —
Risperidone — 30.0 — — —
Quetiapine — 17.5 — — —
Trifluoperazine — 2.5 — — —
Olanzapine — 12.5 — — —
Average Dose (CPZ Equivalents) — 452.20 (369.60) — — —
Positive symptoms were the sum of global scores for hallucinations and delusions; negative symptoms were the
sum of global scores for alogia, anhedonia, avolition, affective flattening, and attentional impairment; and disorgani-
zation symptoms were the sum of global scores for bizarre behavior, positive thought disorder, and inappropriate
affect.
CON, control; SCZ, schizophrenia; SANS, scale for the assessment of negative symptoms; CPZ, chlorpromazine.
ap# .05.
E.C. Dowd and D.M. Barch BIOL PSYCHIATRY 2010;67:902–911 903
www.sobp.org/journal
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the St. Louis, MO, community. All subjects were paid for their participation. All clinical interviews were 
conducted by a Master’s-level clinician who was formally trained on the SCID-IV to a between-rater 
reliability of 0.8.  Inter-rater agreement was routinely assessed and exceeded 0.8 throughout the study 
using the 22 items of SCID-IV module B (psychosis and associated symptoms). 
 
Materials and Tasks 
All participants were scanned while making valence and arousal ratings of their own subjective 
responses to emotional pictures, words, and faces. Valence (pleasant-unpleasant) and arousal 
(activation-deactivation) are independent dimensions of affect (Russell 1980) that are considered vital 
features of emotional experience (Barrett et al 2007). Participants rated their experience of each stimulus 
by button press as positive, negative, or neutral during valence runs, or as highly, slightly, or not aroused 
during arousal runs. Stimuli consisted of 50 each emotional words, pictures, and faces, 10 in each of the 
following categories: negative high arousal (NHA), negative low arousal (NLA), positive high arousal 
(PHA), positive low arousal (PLA), and neutral (NEU). Emotional words were taken from the ANEW 
normed word set (Bradley and Lang 1999). Pictures were selected from the International Affective Picture 
System based on normed valence and arousal ratings (Lang et al 1999), and varied with respect to 
objects, people, locations, and actions. The faces consisted of fearful (negative), happy (positive), and 
neutral expressions derived from the Ekman (Ekman P 1976) and Gur (Gur et al 2002a) normed face 
sets.  The Gur face set contains mild and extreme intensity emotions that were used for low and high 
arousal, respectively. For the Ekman faces, morphed images were generated between neutral and 
emotional expressions for each actor (LaBar et al 2003), with 50% emotion representing the low arousal 
condition and 100% emotion representing the high arousal condition. With the exception of the pictures, 
all stimuli of equal arousal were matched for valence, and all stimuli of equal valence were matched for 
arousal. Positive and negative pictures could not be matched for arousal because too few highly arousing 
images were available for use in the study. The orders of stimulus presentation and of valence versus 
arousal judgments were counterbalanced across participants. Participants performed the task for 6 runs; 
one run each of arousal and valence judgments for each stimulus type (pictures, words, faces). Stimuli 
were presented for 2000 msec with a jittered inter-stimulus interval varying from 1000 to 10000 msec. 
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Behavioral data analysis: 
Valence and Arousal Ratings: We analyzed the valence and arousal ratings using repeated 
measures ANOVAs with group (schizophrenia, control) as a between-subjects factor and stimulus 
(picture, word, face) and condition (NHA, NLA, NEU, PLA, PHA) as within-subjects factors. To further 
characterize the pattern of responses as a function of condition, we created a priori contrasts that were 
sensitive to the valence and/or arousal characteristics of the stimuli. To examine the effect of valence 
irrespective of arousal, we used a linear contrast with weights of -1, -1, 0, 1, and 1 for NHA, NLA, NEU, 
PLA, and PHA, respectively (valence contrast). To examine the effect of arousal irrespective of valence, 
we used a quadratic contrast with weights of 2, -1, -2, -1, and 2 for NHA, NLA, NEU, PLA, and PHA, 
respectively (arousal contrast). To examine whether the valence ratings were influenced by both the 
valence and arousal characteristics of the stimuli, we also created a linear contrast in which valence was 
amplified by arousal, using weights of -2, -1, 0, 1, and 2, for NHA, NLA, NEU, PLA, and PHA, respectively 
(valenceXarousal contrast). We tested the significance of these contrasts using univariate F-tests within 
each group. 
 Individual Difference Analyses: We conducted linear regression analyses to examine the extent to 
which anhedonia scores predicted valence ratings within each group. To determine whether the 
relationship between valence ratings in response to PHA/NHA stimuli and Chapman Physical/Social 
Anhedonia scores differed between groups, we conducted hierarchical regression analyses with 
anhedonia score (physical or social) and group entered in step 1, and groupXanhedonia interaction 
entered in step 2. We also examined whether anhedonia scores mediated the effect of group on valence 
ratings. To do this, we conducted two separate multiple mediation analyses using a Sobel procedure with 
bootstrapping (Preacher and Hayes 2008), with PHA or NHA valence ratings as the dependent variable, 
group as the independent variable, and physical and social anhedonia scores as mediators. Within the 
patient group, we also conducted correlations between PHA/NHA valence ratings and SANS global 
anhedonia, and with SANS avolition, alogia, and affective flattening to examine the specificity to 
anhedonia. 
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fMRI analysis: 
fMRI Acquisition and Image Analysis:  All scans were performed on a 3T Siemens Allegra head-
only system.  We acquired structural images using a sagittal T1-weighted MP-RAGE sequence [TE = 2.9 
ms, TR = 6.6 ms, flip angle = 8˚, acquisition matrix = 96 x 128, 80 slices, 2 x 2.67 x 2 mm voxels].  To 
facilitate registration of the T1 and functional scans, we also acquired a T2 image in the same space as 
the functional scans [TE = 96 ms, TR = 5 s, 189 x 256 acquisition matrix, 48 slices, 1.02 x 1 x 3 mm 
voxels].  The functional images were collected in runs using an asymmetric spin-echo echo-planar 
sequence sensitive to blood oxygenation level-dependent (BOLD) contrast (T2*) [TR = 3000 ms, TE = 25 
ms, FOV = 205 mm, flip = 90°, 40 axial slices, 3.2 mm3 isotropic voxels]. Stimuli were presented using 
PsyScope on a G3 Macintosh computer, with each trial onset triggered directly by a pulse from the 
scanner.  A fiber-optic button box interfaced with PsyScope was used to record participants’ responses. 
 The fMRI data was preprocessed and analyzed using in-house software.  The functional images 
were first normalized across runs by scaling whole-brain signal intensity to a fixed value and removing the 
linear slope on a voxel-by-voxel basis to counteract effects of drift (Bandettini et al 1993). The MR data 
was then aligned to correct for head motion using rigid-body rotation and translation correction algorithms 
(Snyder 1996; Woods et al 1992). Frame-to-frame movement and signal-to-noise ratio were compared 
between groups, and subjects showing excessive movement or poor signal quality were excluded.  The 
structural and functional scans were registered to Talairach space (Talairach and Tournoux 1988) using a 
12 parameter linear (affine) transformation (Woods et al 1992), and smoothed with a 6 mm FWHM 
Gaussian filter.   
 Event-related analyses were used to obtain estimates of activation during the five conditions 
(NHA, NLA, PHA, PLA, and NEU) for each stimulus type (picture, word, face).  For each participant, a 
general linear model (GLM) (Friston et al 1995) was used to estimate a hemodynamic response function 
for each trial type.  The GLM included regressors for linear trends within runs and baseline shifts between 
runs.  An assumed hemodynamic response shape (Boynton function) was used to generate magnitude 
estimates for each event type, and these magnitude estimates were used in all further statistical 
analyses. Functional activation was analyzed using the valence, arousal, and valenceXarousal contrasts 
in both region-of-interest (ROI) and whole-brain analyses. We examined voxelwise t-tests at the group 
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level within predefined ROI masks including the amygdala, striatum, dmPFC, OFC, and rACC. The 
amygdala and basal ganglia ROIs were derived from manually outlined anatomical templates (Mamah et 
al 2007; Wang et al 2008) that were projected into Talairach space, and the dmPFC, rACC, and OFC 
ROIs were 15 mm diameter spherical ROIs centered on the coordinates reported in (Kober et al 2008).  
The ROI mask is shown in supplemental figure S1. Both the whole-brain and ROI analyses were 
corrected for multiple comparisons using combined p-value/cluster size thresholds, determined using 
Monte Carlo simulations to provide an overall false-positive rate of 0.05 (Forman et al 1995; McAvoy et al 
2001). These thresholds were p<.01 and 14 voxels for ROI analyses, and p<.003 and 30 voxels for 
whole-brain analyses. To identify regions whose activation patterns were consistent with the valence and 
arousal patterns of interest, we first conducted one-sample t-tests for each contrast on both groups 
combined. To identify regions showing group differences in activation, we also performed group t-tests on 
each contrast. In both analyses, significant regions were followed up with simple effects tests to 
determine the activation pattern within each group separately. To eliminate redundancy, regions identified 
by both the valence and valence X arousal contrasts were treated as follows. To determine which 
contrast better described the activation pattern in such regions, we performed post-hoc pairwise 
comparisons between the activation magnitudes for each condition. If the region showed both a valence 
effect (positive <> negative) and an arousal effect (NHA <> NLA or PHA <> PLA), it was evaluated with 
the valence X arousal contrast and removed from the valence contrast map. If it showed only a valence 
effect, it was removed from the valence X arousal map and evaluated with the valence contrast.  To 
examine individual differences in functional activity, we also conducted voxelwise correlation analyses 
between contrast scores and anhedonia scores.  Correlations were conducted within each group 
separately, and correlation coefficients were compared between groups using Fisher r-to-z 
transformations. 
In addition to the analysis using canonical hemodynamic response shapes, a separate analysis 
was conducted that estimated response magnitudes for each MR frame separately, as in (Miezin et al 
2000).  Comparable results were obtained using this analysis, and example timecourses are shown in 
Figure S5. 
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Results 
Behavioral Results: 
 Anhedonia Scores: Overall, individuals with schizophrenia had higher anhedonia scores than 
controls on both Chapman scales (Table 1).  
 Valence and Arousal Ratings: For valence (Figure 1a), there was a significant main effect of 
condition (F(4, 280) = 659.85, p<.001) and significant groupXcondition (F(4, 280) = 13.49, p<.001) and 
stimulusXcondition (F(8, 560) = 12.70, p<.001) interactions. Simple effects tests revealed significant 
effects of condition for controls (F(4, 280) = 386.85, p<.001) and patients (F(4, 280) = 273.95, p<.001). 
However, comparisons within each condition revealed that patients’ responses to negative stimuli were 
less negative (F(1,70) = 9.62, p <.004 for NHA; F(1,70) = 7.87, p<.007 for NLA), and to positive stimuli 
were less positive (F(1,70) = 15.77, p<.001 for PLA, F(1,70) = 9.75, p<.004 for PHA), than controls. Both 
the valence and valenceXarousal contrasts were significant for both groups, with similar effect sizes 
(valence contrast: F(1,70) = 521.50, p<.001, !p2 = 0.882 for controls, F(1,70) = 368.23, p<.001, !p2 = 
0.840 for patients; valenceXarousal contrast: F(1,70) = 509.33, p<.001, !p2 = 0.879 for controls; F(1, 70) = 
364.80, p<.001, !p2 = 0.839 for patients). Because stimulus type (picture, word, face) did not interact with 
group in any of our analyses (behavioral or fMRI), stimulus effects are not discussed further here (but see 
Supplemental Materials).  
 For the arousal ratings (Figure 1b), there were significant main effects of stimulus (F(2, 140) = 
23.41, p<.001) and condition (F(4, 280) = 55.96, p<.001), and significant stimulusXcondition (F(8, 560) = 
5.03, p<.001) and groupXcondition F(4, 280) = 3.15, p<.009) interactions. Simple effects tests revealed 
significant effects of condition within each group (F(4,280) = 39.35, p<.001 for controls, F(4,280) = 17.72, 
p<.001 for patients). Further, group comparisons within each condition revealed a significant group 
difference only for the NEU condition: compared to controls, patients showed higher arousal in response 
to neutral stimuli (F(1,70) = 6.87, p< 0.02). The arousal contrast was significant for both groups (F(1, 70) 
= 151.45, p<.001, !p2 = 0.654 for controls; F(1, 70) = 68.76, p<.001, !p2 = 0.496 for patients). Taken 
together, these results indicate that patients showed blunted valence ratings in response to emotional 
stimuli. However, the patterns of both valence and arousal ratings as a function of emotional condition 
were similar between groups.  
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Figure 1. Valence and arousal ratings as a function of condition in individuals with schizophrenia (SCZ) and control subjects (CON). 
(A) Average valence ratings (1 = negative, 2 = neutral, 3 = positive) collapsed across stimulus type (pictures, words, faces) for each 
emotional condition: negative high arousal (NHA), negative low arousal (NLA), neutral (NEU), positive low arousal (PLA), and 
positive high arousal (PHA). (B) Average arousal ratings (1 = highly aroused, 2 = slightly aroused, 3 = not aroused) collapsed across 
stimulus type (pictures, words, faces) for each emotional condition. *p < .05. Error bars represent standard error. 
  
  
Individual Difference Analyses: We conducted hierarchical regression analyses using Chapman 
anhedonia scores to predict valence ratings to PHA and NHA stimuli in patients and controls (Table 2). In 
all of these analyses, anhedonia score and group accounted for a significant portion of the variance in the 
valence ratings, and adding a groupXanhedonia interaction term failed to account for significantly more 
variance. As expected, higher physical and social anhedonia scores were associated with less-positive 
responses to PHA stimuli and less-negative responses to NHA stimuli in both groups (Figure 2). Similarly, 
within the patient group, SANS anhedonia correlated negatively with PHA valence ratings (r = -.37, 
p<.03), though it failed to correlate with NHA valence ratings (p>.16). Together, these results suggest that 
within both patients and controls, higher levels of anhedonia are associated with less-valenced 
experiences of emotional stimuli. 
records and corroborative sources. Clinical symptoms were rated
with the Scales for the Assessment of Positive Symptoms (SAPS)
(47) and Negative Symptoms (SANS) (48). We assessed anhedo-
nia symptoms with the SANS global anhedonia score and the
self-report Chapman physical and social anhedonia scales (49)
and handedness with the Edinburgh Index (50). See Methods
and Materials in Supplement 1 for details.
Materials and Tasks
All participants were scanned while making valence and
arousal ratings of their own subjective responses to emotional
pictures, words, and faces. Valence (pleasant–unpleasant) and
arousal (activation–deactivation) are independent dimensions of
affect (51) that are considered vital features of emotional expe-
rience (20). Participants rated their experience of each stimulus
by button press as positive, negative, or neutral during valence
runs or as highly, slightly, or not aroused during arousal runs.
Stimuli consisted of 50 each emotional words, pictures, and
faces, 10 in each of the following categories: negative high
arousal (NHA), negative low arousal (NLA), positive high arousal
(PHA), positive low arousal (PLA), and neutral (NEU); see
Methods and Materials in Supplement 1. Participants performed
the task for six runs; one run each of arousal and valence
judgments for each stimulus type (pictures, words, faces). Stimuli
were presented for 2000 msec with a jittered interstimulus
interval varying from 1000 to 10,000 msec.
Behavioral Data Analysis
Valence and Arousal Ratings. We analyzed the valence and
arousal ratings with repeated measures analyses of variance with
group (schizophrenia, control) as a between-subjects factor and
stimulus (picture, word, face) and condition (NHA, NLA, NEU,
PLA, PHA) as within-subjects factors. To further characterize the
pattern of responses as a function of condition, we created a
priori contrasts that were sensitive to the valence and/or arousal
characteristics of the stimuli. To examine the effect of valence
irrespective of arousal, we used a linear contrast with weights of
!1, !1, 0, 1, and 1 for NHA, NLA, NEU, PLA, and PHA,
respectively (valence contrast). To examine the effect of arousal
irrespective of valence, we used a quadratic contrast with
weights of 2, !1, !2, !1, and 2 for NHA, NLA, NEU, PLA, and
PHA, respectively (arousal contrast). To examine whether the
valence ratings were influenced by both the valence and arousal
characteristics of the stimuli, we also created a linear contrast in
which valence was amplified by arousal, with weights of!2,!1,
0, 1, and 2, for NHA, NLA, NEU, PLA, and PHA, respectively
(valence " arousal contrast). We tested the significance of these
contrasts with univariate F tests within each group.
Individual Difference Analyses. We conducted linear re-
gression analyses to examine the extent to which anhedonia
scores predicted valence ratings within each group. To deter-
mine whether the relationship between valence ratings in re-
sponse to PHA/NHA stimuli and Chapman Physical/Social Anhe-
donia scores differed between groups, we conducted hierarchical
regression analyses with anhedonia score (physical or social) and
group entered in Step 1 and group " anhedonia interaction
entered in Step 2. We also examined whether anhedonia scores
mediated the effect of group on valence ratings. To do this, we
conducted two separate multiple mediation analyses with a
Sobel procedure with bootstrapping (52), with PHA or NHA
valence ratings as the dependent variable, group as the indepen-
dent variable, and physical and social anhedonia scores as
mediators. Within the patient group, we also conducted correla-
tions between PHA/NHA valence ratings and SANS global anhe-
donia, and with SANS avolition, alogia, and affective flattening to
examine the specificity to anhedonia.
fMRI Analysis
For fMRI acquisition and image analysis, see Methods and
Materials in Supplement 1. Functional activation was analyzed
with the valence, arousal, and valence " arousal contrasts in
both region of interest (ROI) and whole-brain analyses. We
examined voxelwise t tests at the group level within predefined
ROI masks, including the amygdala, striatum, dmPFC, OFC, and
rACC (Methods and Materials in Supplement 1). Both the whole-
brain and ROI analyses were corrected for multiple comparisons
with combined p value/cluster size thresholds, determined with
Monte Carlo simulations to provide an overall false-positive rate
of .05 (53,54). These thresholds were p # .01 and 14 voxels for
ROI analyses and p # .003 and 30 voxels for whole-brain
analyses. To identify regions whose activation patterns were
consistent with the valence and arousal patterns of interest, we
first conducted one-sample t tests for each contrast on both
groups combined. To identify regions showing group differences
in activation, we also performed group t tests on each contrast. In
both analyses, significant r gions were followed up with simple
eff cts tests to determine the activation pattern within each group
separately. To examine individual differences in functional ac-
Figure 1. Valence and arousal ratings as a function of condition in individu-
als with schizophrenia (SCZ) and control subjects (CON). (A) Average va-
lence ratings (1 $ negative, 2 $ neutral, 3 $ positive) collapsed across
stimulus type (pictures,words, faces) for eachemotional condition: negative
high arousal (NHA), negative low arousal (NLA), neutral (NEU), positive low
arousal (PLA), and positive high arousal (PHA). (B) Average arousal ratings
(1$ highly aroused, 2$ slightly aroused, 3$ not roused) collapsed across
stimulus type (pictures,words, faces) for each emotional condition. *p# .05.
Error bars represent standard error.
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 Multiple mediation analyses revealed that for both PHA and NHA valence ratings, the effect of 
group was fully mediated by physical and social anhedonia scores (effect of group on valence rating, 
controlling for physical and social anhedonia: t(69) = -1.2, p>.24 for PHA, t(69) = 1.0, p>.31 for NHA). The 
total mediated effect was significant in both models (95% CI = -0.27, -0.01 for PHA; 0.02, 0.25 for NHA). 
For PHA ratings, only physical anhedonia was significant as a specific mediator (95% CI = -0.16, -0.003), 
and for NHA ratings, neither specific mediator was significant alone. 
 To evaluate the specificity of these results to anhedonia, we correlated PHA and NHA valence 
ratings with SANS global avolition, alogia, and affective flattening in patients, and found that avolition also 
correlated negatively with PHA valence ratings (r = -.34, p<.04) and positively with NHA valence ratings (r 
= .36, p<.03). Aside from a trend-level correlation between alogia and NHA ratings (r = .30, p<.07), alogia 
and affective flattening failed to correlate with either measure (p>.16). Therefore, a reduced experience of 
positive and negative emotion appears to be related to symptoms of anhedonia and amotivation, but not 
to other negative emotional symptoms. 
 
 
 
tivity, we also conducted voxelwise correlation analyses between
contrast scores and anhedonia scores. Correlations were con-
ducted within each group separately, and correlation coefficients
were compared between groups with Fisher r-to-z transforma-
tions.
Results
Behavioral Results
Anhedonia Scores. Overall, individuals with schizophrenia
had higher anhedonia scores than control subjects on both
Chapman scales (Table 1).
Valence and Arousal Ratings. For valence (Figure 1A), there
was a significant main effect of condition [F (4,280)! 659.85, p"
.001] and significant group # condition [F (4,280) ! 13.49, p "
.001] and stimulus # condition [F (8,560) ! 12.70, p " .001]
interactions. Simple effects tests revealed significant effects of
condition for control subjects [F (4,280) ! 386.85, p " .001] and
patients [F (4,280) ! 273.95, p " .001]. However, comparisons
within each condition revealed that patients’ responses to nega-
tive stimuli were less negative [F (1,70) ! 9.62, p " .004 for NHA;
F (1,70) ! 7.87, p " .007 for NLA] and responses to positive
stimuli were less positive [F (1,70) ! 15.77, p " .001 for PLA,
Figure 2. Scatterplots of (A) average valence ratings to
PHA stimuli as a function of Chapman physical anhedo-
nia, (B) average valence ratings to PHA stimuli as a func-
tion of Chapman social anhedonia, (C) average valence
ratings to NHA stimuli as a function of Chapman physical
anhedonia, and (D) average valence ratings to NHA stim-
uli as a function of Chapman social anhedonia, in individ-
uals with SCZ (circles) and CON (triangles). Abbreviations
as in Figure 1.
Table 2. Hierarchical Regression Analyses with Group and Anhedonia Scores to Predict Valence Ratings
Dependent Variable Predictors R2 R2 Change $
PHA Valence Rating Step 1 .229a
Group %.191
Physical anhedonia %.360b
Step 2 .231b .002
Group# physical anhedonia %.127
PHA Valence Rating Step 1 .192b
Group %.177
Social Anhedonia %.313d
Step 2 .206b .014
Group# social anhedonia %.357
NHA Valence Rating Step 1 .199b
Group .191
Physical anhedonia .326c
Step 2 .205b .006
Group# physical anhedonia %.219
NHA Valence Rating Step 1 .190b
Group .151
Social anhedonia .332d
Step 2 .197c .007
Group# social anhedonia %.246
PHA, positive high arousal; NHA, negative high arousal.
ap" .001.
bp" .005.
cp" .01.
dp" .05.
E.C. Dowd and D.M. Barch BIOL PSYCHIATRY 2010;67:902–911 905
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Figure 2. Scatterplots of (A) average valence ratings to PHA stimuli as a function of Chapman physical anhedo- nia, (B) average 
valence ratings to PHA stimuli as a func- tion of Chapman social anhedonia, (C) average valence ratings to NHA stimuli as a 
function of Chapman physical anhedonia, and (D) average valence ratings to NHA stim- uli as a function of Chapman social 
anhedonia, in individ-uals with SCZ (circles) and CON (triangles). Abbreviations as in Figure 1. 
 
 
fMRI Results: 
  Movement and Signal-to-Noise Ratio:  Three patients and three controls were excluded from 
analysis for excessive movement and/or low signal-to-noise ratio (SNR). Mean incremental (frame-to-
frame) movement was computed for each run for each subject and used to compare movement between 
groups. For the final sample of 40 patients and 32 controls, mean incremental movement and group t-test 
results for each translation axis (x, y, z) and rotation axis (pitch, roll, yaw) are summarized in Table S1.  
The groups differed significantly on movement in the y axis only.  SNR was computed by determining the 
ratio of the mean signal intensity to its standard deviation for each frame within a run, from which the 
mean, median, and maximum SNR values were determined for each run for each participant. The mean 
SNR values across runs were then calculated and compared between groups (Table S2).  Despite the 
group difference in y-axis movement, SNR did not differ significantly between groups.  Together, these 
results indicate that the groups were well matched for signal quality and that poor signal quality in patients 
is unlikely to contribute to the group results reported here. 
tivity, we also conducted voxelwise correlation analyses between
contrast scores and anhedonia scores. Correlations were con-
ducted within each group separately, and correlation coefficients
were compared between groups with Fisher r-to-z transforma-
tions.
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had higher anhedonia scores than control subjects on both
Chapman scales (Table 1).
Valence and Arousal Ratings. For valence (Figure 1A), there
was a significant main effect of condition [F (4,280)! 659.85, p"
.001] and significant group # condition [F (4,280) ! 13.49, p "
.001] and stimulus # condition [F (8,560) ! 12.70, p " .001]
interactions. Simple effects tests revealed significant effects of
condition for control subjects [F (4,280) ! 386.85, p " .001] and
patients [F (4,280) ! 273.95, p " .001]. However, comparisons
within each condition revealed that patients’ responses to nega-
tive stimuli were less negative [F (1,70) ! 9.62, p " .004 for NHA;
F (1,70) ! 7.87, p " .007 for NLA] and responses to positive
stimuli were less positive [F (1,70) ! 15.77, p " .001 for PLA,
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PHA stimuli as a function of Chapman physical anhedo-
nia, (B) average valence ratings to PHA stimuli as a func-
tion of Chapman social anhedonia, (C) average valence
ratings to NHA stimuli as a function of Chapman physical
anhedonia, and (D) average valence ratings to NHA stim-
uli as a function of Chapman social anhedonia, in individ-
uals with SCZ (circles) and CON (triangles). Abbreviations
as in Figure 1.
Table 2. Hierarchical Regression Analyses with Group and Anhedonia Scores to Predict Valence Ratings
Dependent Variable Predictors R2 R2 Change $
PHA Valence Rating Step 1 .229a
Group %.191
Physical anhedonia %.360b
Step 2 .231b .002
Group# physical anhedonia %.127
PHA Valence Rating Step 1 .192b
Group %.177
Social Anhedonia %.313d
Step 2 .206b .014
Group# social anhedonia %.357
NHA Valence Rating Step 1 .199b
Group .191
Physical anhedonia .326c
Step 2 .205b .006
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PHA, positive high arousal; NHA, negative high arousal.
ap" .001.
bp" .005.
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ROI Analyses: One-sample t-tests: As shown in Figure 3, one-sample t-tests identified several 
regions within the ROIs with activity patterns significant for the valence, arousal, and valenceXarousal 
contrasts.  These regions and their activation patterns are detailed in Table 3. 
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Table 3. Results of ROI Analyses of Valence, Arousal, and Valence# Arousal Contrasts in the Total Sample
Brain Region
Talairach
Coordinates BA
Number
Voxels Z
Activation Pattern
Regional Analyses
Valence Arousal
Main Effect
of Group
Group# Condition
Interaction
Group Difference
in Contrast
Within CON
Contrast
Within SCZ
Contrast
Valence Contrast
R OFC 41, 24, %4 47 27 %3.98 neu& neg& pos — b NS NS b b
rACC 1, 35, 3 32 17 4.61 deactivation: neu! neg& pos — NS NS NS a c
Arousal Contrast
R amygdala 26, %14, %8 — 24 3.39 — ha& la! neu NS NS NS b d
dmPFC %1, 51, 23 9 79 3.68 — ha& la! neu NS NS NS NS b
Valence# Arousal
Contrast
R amygdala 28, %10, %15 — 21 %3.41 neg& neu! pos nha& nla! neu NS NS NS d c
ROI, regionof interest; BA, Brodmannarea; CON, control; SCZ, schizophrenia; R, Right; OFC, orbitofrontal cortex; neu, neutral; neg, negative; pos, positive; rACC, rostral anterior cingulate cortex; ha, high
arousal; la, low arousal; dmPFC, dorsomedial prefrontal cortex; nha, negative high arousal; nla, negative low arousal.
ap" .001.
bp" .005.
cp" .01.
dp" .05.
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Figure 3. Results of region of interest analyses of valence, arousal, and valence X arousal contrasts in the total sample (both 
patients and control subjects). Regions are described in Table 3. Images are shown in neurologi- cal orientation. (A) Regions 
showing significant activation in the valence contrast. Positive z scores (red) indicate greater activation to positively valenced stimuli 
than to negatively valenced stimuli; negative z scores (blue) indicate greater activation to negatively valenced stimuli than to 
positively valenced stimuli. (B) Regions showing significant activation in the arousal contrast. Positive z scores (red) indicate greater 
activation to high arousal stimuli relative to neutral and low-arousal stimuli. (C) Regions showing significant activation in the valence 
X arousal contrast. Negative z scores indicate greater activation to negative high arousal stimuli than to positive and/or low-arousal 
stimuli. 
 
 
 Group t-tests: One region in right ventral striatum demonstrated a significant group difference in 
the valence contrast, and one in left putamen showed a group difference in the valenceXarousal contrast 
(Table 4 and Figure 4). As shown in Figure 4, in both of these regions, patients showed altered activation 
as compared to controls for the positive conditions. Post-hoc tests revealed that in left putamen, PHA 
activation was significantly reduced in patients (F(1,70)=5.05, p<.04). In right ventral striatum, there were 
significant group differences in both PHA (F(1.70)=5.58, p<.03) and PLA (F(1.70)=6.14, p<.03).  These 
regions showed significant activation in controls, but no significant change from baseline in patients. 
 
F (1,70) ! 9.75, p " .004 for PHA] than control subjects. Both the
valence and valence# arousal contrasts were significant for both
groups, with similar effect sizes [valence contrast: F (1,70) !
521.50, p " .001, $p
2 ! .882 for control subjects, F (1,70) !
368.23, p " .001, $p
2 ! .840 for patients; valence # arousal
contrast: F (1,70) ! 509.33, p " .001, $p
2 ! .879 for control
subjects; F (1,70) ! 364.80, p " .001, $p
2 ! .839 for patients].
Because stimulus type (picture, word, face) did not interact with
group in any of our analyses (beh vioral or fMRI), stimulus
effects are not discussed further here (but see Results in Supple-
ment 1).
For the arousal ratings (Figure 1B), there were significant
main effects of stimulus [F (2,140) ! 23.41, p " .001] and
condition [F (4,280) ! 55.96, p " .001] and significant stimulus #
condition [F (8,560) ! 5.03, p " .001] and group # condition
[F (4,280) ! 3.15, p " .009] interactions. Simple effects tests
Figure 3. Results of region of interest analyses of valence, arousal, and
valence# arousal contrasts in the total sample (both patients and control
subjects). Regions are described in Table 3. Images are shown in neurologi-
cal orientation. (A) Regions showing significant activation in the valence
contrast. Positive z scores (red) indicate greater activation to positively
valenced stimuli than to negatively valenced stimuli; negative z scores
(blue) indicate greater activation to negatively valenced stimuli than to
positively valenced stimuli. (B)Regions showing significant activation in the
arousal contrast. Positive z scores (red) indicate greater activation to high
arousal stimuli relative to neutral and low-arousal stimuli. (C) Regions show-
ing significant activation in the valence-by-arousal contrast. Negative z
scores indicate greater activation to negative high arousal stimuli than to
positive and/or low-arousal stimuli.
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Figure 4. Results of region of interest analyses of group t tests between patients and control subjects for the valence and valence X 
arousal contrasts. Regions are described in Table 4. Images are shown in neurological orientation. (A) Right ventral striatal region 
demonstrating a group difference in the valence contrast. Activation did not differ significantly in the NHA, NLA, or NEU conditions 
but was significantly lower in patients than in control subjects for the PLA and PHA conditions. (B) Left putamen region 
demonstrating a group difference in the valence X arousal contrast. Activation did not differ significantly in the negative, neutral, or 
PLA conditions but was significantly lower in patients than in control subjects in the PHA condition. *p < .05. Error bars represent 
standard error. Abbreviations as in Figure 1. 
 
 
 
Whole Brain Analyses:  
 As shown in Table S5 and Figure 5, a number of regions were identified by the valence, arousal, 
and valenceXarousal contrasts in whole-brain one-sample t-tests. In the group t-tests, however, we did 
not find a single region that showed a significant group difference in any of the contrasts. To further 
revealed significant effects of condition within each group
[F (4,280) ! 39.35, p " .001 for control subjects, F (4,280) !
17.72, p " .001 for patients]. Furthermore, group comparisons
within each condition revealed a significant group difference
only for the NEU condition: compared with control subjects,
patients showed higher arousal in response to neutral stimuli
[F (1,70) ! 6.87, p " .02]. The arousal contrast was significant for
both groups [F (1,70) ! 151.45, p " .001, #p
2 ! .654 for control
subjects; F (1,70) ! 68.76, p " .001, #p
2 ! .496 for patients].
Taken together, these results indicate that patients showed
blunted valence ratings in response to emotional stimuli. How-
ever, the patterns of both valence and arousal ratings as a
function of emotional condition were similar between groups.
Individual Difference Analyses. We conducted hierarchical
regression analyses with Chapman anhedonia scores predicting
valence ratings to PHA and NHA stimuli in patients and control
subjects (Table 2). In all of these analyses, anhedonia score and
group account d for a significant portion of the variance in the
valence ratings, and adding a group $ anhedonia interaction
term failed to account for significantly more variance. As ex-
pected, higher physical and social anhedonia scores were asso-
ciated with less-positive responses to PHA stimuli and less-
negative responses to NHA stimuli in both groups (Figure 2).
Similarly, within the patient group, SANS anhedonia correlated
negatively with PHA valence ratings (r ! %.37, p " .03),
although it failed to correlate with NHA valence ratings (p& .16).
Together, these results suggest that, within both patients and
control subjects, higher levels of anhedonia are associated with
less-valenced experiences of emotional stimuli.
Multiple mediation analyses revealed that for both PHA and
NHA valence ratings, the effect of group was fully mediated by
physical and social anhedonia scores [effect of group on valence
rating, controlling for physical and social anhedonia: t (69) !
%1.2, p & .24 for PHA, t (69) ! 1.0, p & .31 for NHA]. The total
mediated effect was significant in both models (95% confidence
interval: %.27, %.01 for PHA; .02, .25 for NHA). For PHA ratings,
only physical anhedonia was significant as a specific mediator
(95% confidence interval: %.16, %.003), and for NHA ratings,
neither specific mediator was significant alone.
To evaluate the specificity of these results to anhedonia, we
correlated PHA and NHA valence ratings with SANS global
avolition, alogia, and affective flattening in patients and found
that avolition also correlated negatively with PHA valence ratings
(r ! %.34, p " .04) and positively with NHA valence ratings (r !
.36, p" .03). Aside from a trend-level correlation between alogia
and NHA ratings (r! .30, p" .07), alogia and affective flattening
failed to correlate with either measure (p & .16). Therefore, a
reduced experience of positive and negative emotion seems to
be related to symptoms of anhedonia and amotivation but not to
other negative emotional symptoms.
fMRI Results
ROI Analyses: One-Sample t Tests. As shown in Figure 3,
one-sample t tests identified several regions within the ROIs with
activity patterns significant for the valence, arousal, and valence $
Figure4.Results of regionof interest analyses of group t tests
between patients and control subjects for the valence and
valence$ arousal contrasts. Regions are described in Table 4.
Images are shown in neurological orientation. (A) Right ven-
tral striatal region demonstrating a group difference in the
valence contrast. Activation did not differ significantly in the
NHA, NLA, or NEU conditions but was significantly lower in
patients than in control subjects for the PLA and PHA condi-
tions. (B) Left putamen region demonstrating a group differ-
ence in the valence $ arousal contrast. Activation did not
differ significantly in the negative, neutral, or PLA conditions
butwas significantly lower inpatients than in control subjects
in the PHA condition. *p" .05. Error bars represent standard
error. Abbreviations as in Figure 1.
Table 4. Results of ROI Analyses of Group t Tests Between Patients and
Control Subjects for the Valence and Valence$ Arousal Contrasts
Brain Region
Talairach
Coordinates
Number
Voxels Z
valence contrast
R ventral striatum 7, 3,%4 14 2.80
Valence$ Arousal Contrast
L putamen %28,%14,%1 17 3.44
ROI, region of interest; R, Right; L, Left.
E.C. Dowd and D.M. Barch BIOL PSYCHIATRY 2010;67:902–911 907
www.sobp.org/journal
revealed significant effects of condition within each group
[F (4,280) ! 39.35, p " .001 for control subjects, F (4,280) !
17.72, p " .001 for patients]. Furthermore, group comparisons
within each condition revealed a significant group difference
only for the NEU condition: compared with control subjects,
patients showed higher arousal in response to neutral stimuli
[F (1,70) ! 6.87, p " .02]. The arousal contrast was significant for
both groups [F (1,70) ! 151.45, p " .001, #p
2 ! .654 for control
subjects; F (1,70) ! 68.76, p " .001, #p
2 ! .496 for patients].
Taken together, these results indicate that patients showed
blunted valence ratings in response to emotional stimuli. How-
ever, the patterns of both valence and arousal ratings as a
function of emotional condition were similar between groups.
Individual Difference Analyses. We conducted hierarchical
regression analyses with Chapman anhedonia scores predicting
valence ratings to PHA and NHA stimuli in patients and control
subjects (Table 2). In all of these analyses, anhedonia score and
group accounted for a significant portion of the variance in the
valence ratings, and adding a group $ anhedonia interaction
term failed to account for significantly more variance. As ex-
pected, higher physical and social anhedonia scores were asso-
ciated with less-positive responses to PHA stimuli and less-
negative responses to NHA stimuli in both groups (Figure 2).
Similarly, within the patient group, SANS anhedonia correlated
negatively with PHA valence ratings (r ! %.37, p " .03),
although it failed to correlate with NHA vale ce ratin s (p& .16).
Together, these results suggest that, ithi b th p tients and
control subjects, higher levels of anhedonia are associated with
less-valenced experiences of emotional stimuli.
Multiple mediation analyses revealed that for both PHA and
NHA valence ratings, the effect of group was fully mediated by
physical and social anhedonia scor s [effect of group o v lence
rating, controlling for physical and social anh donia: t (69) !
%1.2, p & .24 for PHA, t (69) ! 1.0, p & .31 for NHA]. The total
mediated effect was significant in both models (95% confidence
interval: %.27, %.01 for PHA; .02, .25 for NHA). For PHA ratings,
only physical anhedonia was significant as a specific mediator
(95% confidence interval: %.16, %.003), and for NHA ratings,
neither specific mediator was significant alone.
To evaluate the specificity of these results to anhedonia, we
correlated PHA and NHA valence ratings with SANS global
avolition, alogia, and affective flattening in patients and found
that avolition also correlated negatively with PHA valence ratings
(r ! %.34, p " .04) and positively with NHA valence ratings (r !
.36, p" .03). Aside from a trend-level correlation between alogia
and NHA rati gs (r! .30, p" .07), alogia and affective flattening
failed to correlate with either measure (p & .16). Therefore, a
reduced experience of positive and negative emotion seems to
be related to symptoms of anhedonia and amotivation but not to
other negative emotional symptoms.
fMRI Results
ROI Analyses: On -Sample t Tests. As shown in Figure 3,
one-sample t test identified several regions within the ROIs with
activity patterns significant for the valence, arousal, and vale c $
Figure4.Results of regionof interest analyses of group t tests
between patients and control subjects for the valence and
valence$ arousal contrasts. Regions are described in Table 4.
Images are shown in neurological orientation. (A) Right ven-
tral striatal region demonstrating a group difference in the
valence contrast. Activation did not differ significantly in the
NHA, NLA, or NEU conditions but was significantly lower in
patients than in control subjects for the PLA and PHA condi-
tions. (B) Left putamen region demonstrating a group differ-
ence in the valence $ arousal contrast. Activation did not
differ significantly in the negative, neutral, or PLA conditions
butwas significantly lower inpatients than in control subjects
i the PHA condition. *p" .05. Error bars represent standard
error. Abbreviations as in Figure 1.
Table 4. Results of ROI Analyses of Group t Tests Between Patients and
Control Subjects for the Valence and Valence$ Arousal Contrasts
Brain Region
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Coordinates
Number
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examine whether the activity patterns were similar between groups, we conducted follow-up group 
analyses on each region identified in the one-sample t-tests. As shown in Table S5, overall activity 
differed between patients and controls in a number of these regions. However, in every region: (1) both 
patients and controls showed significant within-group effects of the relevant contrast, (2) there were no 
significant group differences in the magnitude of the contrast; and in all but two regions, (3) the pattern as 
a function of emotional condition was the same for both patients and controls. Thus, outside of the 
striatum, patients and controls demonstrated similar neural responses to both valence and arousal. 
 
Figure 5. Results of whole-brain analyses of valence, arousal, and valence X arousal contrasts in the total sample (both patients and 
control subjects). Regions are described in Table S5 in Supplement 1. Images are shown in neurological orientation. (A) Regions 
showing significant activation in the valence contrast. Positive z scores (red) indicate greater activation to positively valenced stimuli 
than to negatively valenced stimuli; negative z scores (blue) indicate greater activation to negatively valenced stimuli than to 
positively valenced stimuli. (B) Regions showing significant activation in the arousal contrast. Positive z scores (red) indicate greater 
activation to high arousal stimuli relative to neutral and low-arousal stimuli; negative z scores (blue) indicate greater activation to 
neutral and low-arousal stimuli than to high-arousal stimuli. (C) Regions showing significant activation in the valence X arousal 
contrast. Negative z scores indicate greater activation to negative high arousal stimuli than to positive and/or low-arousal stimuli. 
 
 
arousal contrasts. These regions and their activation patterns are
detailed in Table 3.
Group t Tests. One region in right ventral striatum demon-
strated a significant group difference in the valence contrast, and
one in left putamen showed a group difference in the valence !
arousal contrast (Figure 4, Table 4). As shown in Figure 4, in both
of these regions, patients showed reduced activation compared
with control subjects for the positive conditions. Post hoc tests
revealed that, in left putamen, PHA activation differed signif-
icantly between groups [F (1,70) " 5.05, p # .04]. In right
ventral striatum, there were significant group differences in
both PHA [F (1.70) " 5.58, p # .03] and PLA [F (1.70) " 6.14,
p # .03].
Whole-Brain Analyses
As shown in Figure 5 (and Table S5 in Supplement 1), a
number of regions were identified by the valence, arousal, and
valence ! arousal contrasts in whole-brain one-sample t tests. In
the group t tests, however, we did not find a single region that
showed a significant group difference in any of the contrasts. To
further examine whether the activity patterns were similar be-
tween groups, we conducted follow-up group analyses on each
region identified in the one-sample t tests. As shown in Table S5
in Supplement 1, overall activity differed between patients and
control subjects in a number of these regions. However: 1) in
every region, both patients and control subjects showed signifi-
cant within-group effects of the relevant contrast; 2) in every
region, there were no significant group differences in the mag-
nitude of the contrast; and 3) in all but two regions, the pattern
as a function of emotional condition was the same for both
patients and control subjects. Thus, outside of the striatum,
patients and control subjects demonstrated similar neural re-
sponses to both valence and arousal.
Individual Difference Analyses. We first conducted correla-
tions between anhedonia scores and average activation contrast
scores within the regions showing group differences in the
contrasts. This analysis revealed a negative correlation between
physical anhedonia and valence ! arousal contrast score in the
right ventral striatum in patients (r " $.36, p # .04), indicating
that patients with higher anhedonia scores showed less activa-
tion in this region in response to positive stimuli compared with
neutral and negative stimuli. This correlation was not significant
in control subjects (r " $.17, p % .34), although the group
difference in correlation coefficients was not significant (p% .77).
We next conducted voxelwise ROI analyses (Table 5), in which
physical anhedonia correlated negatively with the valence con-
trast in left amygdala and with the valence ! arousal contrast in
right amygdala in patients. In control subjects, social anhedonia
correlated negatively with the valence contrast in bilateral cau-
date. Comparison of correlation coefficients between groups
revealed a significant difference in the right caudate (p # .02)
Figure5.Results ofwhole-brain analyses of valence, arousal, and valence! arousal contrasts in the total sample (bothpatients and control subjects). Regions
are described in Table S5 in Supplement 1. Images are shown in neurological orientation. (A) Regions showing significant activation in the valence contrast.
Positive z scores (red) indicate greater activation to positively valenced stimuli than to negatively valenced stimuli; negative z scores (blue) indicate greater
activation tonegatively valenced stimuli than topositively valenced stimuli. (B)Regions showing significant activation in thearousal contrast. Positive z scores
(red) indicategreater activation tohigharousal stimuli relative toneutral and low-arousal stimuli; negative z scores (blue) indicategreater activation toneutral
and low-arousal stimuli than to high-arousal stimuli. (C) Regions showing significant activation in the valence! arousal contrast. Negative z scores indicate
greater activation to negative high arousal stimuli than to positive and/or low-arousal stimuli.
Table 5. ROI Results of Correlation Analyses Between Anhedonia Scores and fMRI Valence and Valence! Arousal Contrast Scores
Contrast Anhedonia Measure Talairach Coordinates Region Name Number Voxels r Z
Control
Valence Chapman social anhedonia 8, $1, 14 R caudate 14 $.550 $3.26
$13, $2, 18 L caudate 28 $.539 $3.18
Schizophrenia
Valence Chapman physical anhedonia $14, $9, $15 L amygdala 17 $.446 $2.89
Valence! Arousal Chapman physical anhedonia 17,$14, $11 R amygdala 15 $.413 $2.58
ROI, region of interest; fMRI, functional magnetic resonance imaging; R, Right; L, Left.
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Table S5: Results of whole-brain analyses of valence, arousal, and valenceXarousal contrasts in the total sample  
Brain Region BA Talairach Coordinates 
# 
Voxels Z 
Activation Pattern Regional Analyses 
Valence Arousal 
Main 
Effect of 
Group 
Group X 
Condition 
Interaction 
Group 
Difference 
in Contrast 
Within 
CON 
Contrast 
Within 
SCZ 
Contrast 
Valence Contrast:            
Midbrain - 1, -27, -3 45 -4.50 neg > neu=pos - *** * NS **** * 
R Fusiform Gyrus 37 39, -50, -13 144 -3.66 neg=neu > pos - NS NS NS **** **** 
R Orbital Frontal Cortex 47 45, 28, -4 82 -3.25 neg=neu > pos - *** * NS *** **** 
R Inferior Frontal Gyrus 9 45, 15, 29 242 -3.98 neg=neu > pos - *** NS NS **** **** 
L Inferior Frontal Gyrus 9 -47, 13, 26 163 -2.96 neg=neu > pos - *** NS NS *** **** 
L Postcentral Gyrus 40 -54, -24, 23 516 4.02 pos > neu=neg - NS NS NS **** **** 
R Central Operculum 43 51, -5, 11 130 3.56 pos=neu > neg - ** NS NS **** *** 
R Supramarginal Gyrus 40 59, -29, 30 167 3.61 pos=neu > neg - * NS NS **** **** 
R Supramarginal Gyrus 40 45, -43, 49 69 2.69 pos=neu > neg - NS NS NS ** *** 
R Superior Parietal Lobule 7 16, -60, 63 88 2.46 pos=neu > neg - ** NS NS * **** 
L Superior Parietal Lobule 7 -18, -55, 64 70 2.89 pos=neu > neg - * NS NS *** *** 
Rostral Anterior Cingulate 24 -1, 31, 6 112 3.98 deactivation: neg > pos - NS NS NS **** ** 
Arousal Contrast:            
R Middle Occipital Gyrus 37 53, -64, 7 210 5.26 - ha > la > neu NS NS NS **** **** 
R Cerebellar Declive - 3, -77, -14 191 4.65 - ha > neu=la NS NS NS * **** 
R Cuneus 18 5, -90, 10 205 4.33 - ha > neu=la NS NS NS *** *** 
L Posterior Cingulate 29 -2, -43, 2 60 3.87 - ha > neu=la * NS NS *** * 
L Middle Occipital Gyrus 37 -54, -66, 6 114 4.45 - ha > neu=la NS NS NS **** * 
R Middle Frontal Gyrus 9 46, 31, 27 49 -4.21 - neu > la > ha ** NS NS *** *** 
Dorsomedial Prefrontal 
Cortex 9 -1, 54, 21 140 4.20 - 
deactivation: 
neu > la; 
activation: ha 
NS NS NS * **** 
L Paracentral Lobule 31 -2, -28, 45 133 4.86 - 
deactivation: 
neu=la; 
activation: ha 
NS NS NS **** *** 
L Precuneus 7 -1, -55, 49 30 4.25 - deactivation: neu=la > ha NS NS NS *** *** 
ValencexArousal Contrast:            
L Fusiform Gyrus 37 -39, -62, -15 123 -4.78 neg=neu > pos nha > nla=neu NS NS NS * **** 
* p<.05, ** p<.01, *** p<.005, **** p<.001; CON = control; SCZ = schizophrenia; R = Right; L = Left; pos = positive; neg = negative; neu = neutral; ha = high arousal; 
la = low arousal; NS = not significant; BA = Brodmann Area 
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Individual difference analyses: We first conducted correlations between anhedonia scores and 
average activation contrast scores within the regions showing group differences in the contrasts. This 
analysis revealed a negative correlation between physical anhedonia and valenceXarousal contrast score 
in the right ventral striatum in patients (r = -.36, p<.04), indicating that patients with higher anhedonia 
scores showed less activation in this region in response to positive stimuli as compared to neutral and 
negative stimuli. This correlation was not significant in controls (r = -.17, p>.34), though the group 
difference in correlation coefficients was not significant (p>.77). We next conducted voxelwise ROI 
analyses (Table 5), in which physical anhedonia correlated negatively with the valence contrast in left 
amygdala, and with the valenceXarousal contrast in right amygdala, in patients. In controls, social 
anhedonia correlated negatively with the valence contrast in bilateral caudate. Comparison of correlation 
coefficients between groups revealed a significant difference in the right caudate (p<.02) and a trend level 
difference in left caudate (p <.08), but no difference in either amygdala region (p>.70). 
 
 
 
Medication Effects on fMRI Data:  In a sample restricted to the 24 patients who were taking only 
atypical antipsychotics (excluding risperidone), group t-tests within the two regions that showed group 
differences in the full sample remained significant.  In right ventral striatum (7, 3, -4; Figure S3), there 
were significant group differences in the valence contrast (t(54) = 2.25, p = .03).  The group differences 
within the positive and neutral conditions dropped to trend-level significance (F(1,54) = 3.17, p = .08 for 
NEU; F(1,54) = 3.25, p = .08 for PLA; F(1,54) = 2.75, p = .10 for PHA), perhaps reflecting reduced power 
after exclusion of the 16 patients taking typical antipsychotics or risperidone.  In left putamen (-28, -14, -1; 
Figure S4), there was a significant group difference in the valence X arousal contrast (t(54) = 3.19, p = 
.003). The group difference in PHA dropped to trend level (F(1,54) = 3.67, p = .06).  The correlations 
between physical anhedonia and activation within the right ventral striatum and bilateral amygdala 
remained significant in the subset of patients taking only atypical antipsychotics.  In ventral striatum, 
arousal contrasts. These regions and their activation patterns are
detailed in Table 3.
Group t Tests. One region in right ventral striatum demon-
strated a significant group difference in the valence contrast, and
one in left putamen showed a group difference in the valence !
arousal contrast (Figure 4, Table 4). As shown in Figure 4, in both
of these regions, patients showed reduced activation compared
with control subjects for the positive conditions. Post hoc tests
revealed that, in left putamen, PHA activation differed signif-
icantly between groups [F (1,70) " 5.05, p # .04]. In right
ventral striatum, there were significant group differences in
both PHA [F (1.70) " 5.58, p # .03] and PLA [F (1.70) " 6.14,
p # .03].
Whole-Brain Analyses
As shown in Figure 5 (and Table S5 in Supplement 1), a
number of regions were identified by the valence, arousal, and
valence ! arousal contrasts in whole-brain one-sample t tests. In
the group t tests, however, we did not find a single region that
showed a significant group difference in any of the contrasts. To
further examine whether the activity patterns were similar be-
tween groups, we conducted follow-up group analyses on each
region identified in the one-s mple t tests. As shown in Tabl S5
in Supplement 1, overall activity differed between patients and
control subjects in a number of these regions. However: 1) in
every region, both patients and control subjects showed signifi-
cant within-group effects of the relevant contrast; 2) in every
region, there were no significant group differences in the mag-
nitude of the contrast; and 3) in all but two regions, the pattern
as a function of emotional condition was the same for both
patients and control subjects. Thus, outside of the striatum,
patients and control subjects demonstrated similar neural re-
sponses to both valence and arousal.
Individual Difference Analyses. We first conducted correla-
tions between anhedonia scores and average activation contrast
scores within the regions showing group differences in the
contrasts. This analysis revealed a negative correlation between
physical anhedonia and valence ! arousal contrast score in the
right ventral striatum in patients (r " $.36, p # .04), indicating
that patients with higher anhedonia scores showed less activa-
tion in this region in response to positive stimuli compared with
neutral and negative stimuli. This correlation was not significant
in control su jects ( " $.17, p % .34), although the group
difference in correlation coefficients was not significant (p% .77).
We next conducted voxelwise ROI analyses (Table 5), in which
physical anhedonia correlated negatively with the valence con-
trast in left amygdala and with the valence ! arousal contrast in
right amygdal in patients. In control subjects, social anhedonia
correlated negatively with the valence contrast in bilateral cau-
date. Comparison of correlation coefficients between groups
revealed a significant difference in the right caudate (p # .02)
Figure5.Results ofwhole-brain analyses of valence, arousal, and valence! arousal contrasts in the total sample (bothpatients and control subjects). Regions
are described in Table S5 in Supplem t 1. Im ges are hown in n urological rientation. (A) Regions showi g significant activation in the valence cont ast.
Positive z scores (red) indicate greater activation to positively valenced stimuli than to negatively valenced stimuli; negative z scores (blue) indicate greater
activation tonegatively valenced stimuli than topositively valenced stimuli. (B)Regions showing significant activation in thearousal contrast. Positive z scores
(red) indicategreater activation tohigharou al stimuli relative toneutral and low-arousal stimuli; negative z scores (blu ) indicategreater activation toneutral
and low-arousal stimuli than to high-arousal stimuli. (C) Regions showing significant activation in the valence! arousal contrast. Negative z scores indicate
greater activation to negative high arousal stimuli than to positive and/or low-arousal stimuli.
Table 5. ROI Results of Correlation Analyses Between Anhedonia Scores and fMRI Valence and Valence! Arousal Contrast Scores
Contrast Anhedonia Measure Talairach Coordinates Region Name Number Voxels r Z
Control
Valence Chapman social anhedonia 8, $1, 14 R caudate 14 $.550 $3.26
$13, $2, 18 L caudate 28 $.539 $3.18
Schizophrenia
Valence Chapman physical anhedonia $14, $9, $15 L amygdala 17 $.446 $2.89
Valence! Arousal Chapman physical anhedonia 17,$14, $11 R amygdala 15 $.413 $2.58
ROI, region of interest; fMRI, functional magnetic resonance imaging; R, Right; L, Left.
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physical anhedonia correlated significantly with the valence X arousal contrast (r = -.454, p = .03). 
Physical anhedonia correlated with the valence contrast in left amygdala (r = -.542, p = .006), and with 
the valence X arousal contrast in right amygdala (r = -.620, p = .001). 
When we conducted correlations between antipsychotic dosage in chlorpromazine equivalents 
and activation in each contrast within the left putamen and right ventral striatal regions, none of the 
correlations reached significance.  We also conducted a voxelwise correlation within our full set of ROIs, 
and found only one region in the right dorsal caudate that showed a significant correlation in the arousal 
contrast (coordinates: 16, -14, 21; 23 voxels, r = .514, p < .001.)  This region did not overlap with the 
regions that showed group differences in activity in the valence and valence X arousal contrasts.  
 
Discussion 
Behavioral Measures of Emotional Experience 
In agreement with most clinical data, we found that individuals with schizophrenia self-reported 
more anhedonia than controls. Behaviorally, there was a groupXcondition interaction in the valence 
ratings, and post-hoc tests revealed that patients rated their experience of the valenced stimuli as less 
valenced than controls. This finding is at odds with the majority of studies, which have shown intact 
responses to emotional stimuli. However, while the arousal ratings also showed a groupXcondition 
interaction, the only post-hoc group difference was heightened arousal ratings in response to neutral 
stimuli in patients. This finding suggests that patients’ experience of arousal in response to emotional 
stimuli is intact, in agreement with previous literature. Furthermore, patients clearly showed modulation of 
both valence and arousal ratings as a function of the emotional content of the stimuli: when we conducted 
contrast analyses sensitive to valence, arousal, and valenceXarousal interaction, the relevant contrasts 
were significant within both groups, with similar effect sizes. Overall, while these findings suggest that the 
range of experienced emotion may be narrowed in patients, they also show that evoked arousal is 
relatively intact, and that affective stimuli modulate emotional experience in similar ways in patients and 
controls. 
Individual difference analyses revealed that higher anhedonia was associated with blunted 
responses to emotional stimuli within both patients and controls. Furthermore, the group differences in 
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valence ratings were fully mediated by anhedonia scores. Together, these results indicate that the level of 
anhedonia, rather than simply the diagnosis of schizophrenia, may underlie the blunted responses to 
emotional stimuli seen in patients.  This finding highlights the importance of including sufficiently powered 
individual difference analyses in future work. 
fMRI Measures of Emotion Processing 
fMRI analysis revealed that brain activity is largely intact during emotional experience in 
schizophrenia. On whole-brain analysis, we did not find any regions that showed group differences in any 
contrast, suggesting similar patterns of neural activity in patients and controls. On ROI analysis, however, 
right ventral striatum and left putamen showed reduced activation to positive stimuli in patients as 
compared to controls. Given past research showing that striatal activation is associated with the 
anticipation (O'Doherty et al 2002) and receipt (Rolls et al 2008a) of pleasurable stimuli, this finding may 
represent a failure to respond to positive experiences that contributes to an inability to anticipate or want 
such experiences in the future (Berridge and Kringelbach 2008).  
In support of this interpretation, reduced activation to positive versus negative stimuli in the same 
ventral striatal region was also associated with higher physical anhedonia in patients. This finding 
suggests that the group differences in activation seen in this region may be driven by individual 
differences in anhedonia. Similarly, bilateral amygdala activation to positive versus negative stimuli was 
reduced in patients who where higher in physical anhedonia. Within controls, greater social anhedonia 
was associated with decreased bilateral caudate activation in response to positive relative to negative 
stimuli. Because the amygdala (Zald 2003) and striatum (Zink et al 2004) are thought to be involved in 
salience attribution, these results may indicate that these regions fail to mark positive events as salient in 
anhedonic individuals, leading to a blunted experience of emotion and a reduced ability to seek out 
similar events in the future. 
Given that the ventral striatum is typically associated with reward processing, it is interesting to 
speculate on how these results relate to findings of reduced ventral striatal activation during reward 
anticipation in schizophrenia (Juckel et al 2006b). Notably, the reduced ventral striatal activation to 
positive stimuli seen here in patients may represent a deficit in motivational or reward-prediction 
processes, rather than in hedonic processes per se. During learning, dopaminergic neurons initially fire to 
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unexpected positive stimuli, shifting over time to fire to cues that predict these rewards (Schultz 1997). 
Thus, the deficient right ventral striatal activation reported here could reflect a failure of this initial 
dopaminergic firing to unpredicted positive stimuli, potentially impairing reward prediction/incentive 
salience and leading to reduced anticipatory activation. Importantly, this impairment in predictive or 
motivational processes may be independent of the hedonic response to the reward, allowing a normal 
experience of “liking” combined with reduced “wanting”. This is consistent with the view that 
consummatory pleasure is intact in schizophrenia while anticipatory pleasure is impaired (Gard et al 
2007). 
Given the finding of group differences in striatal activity, a major limitation of this study is that all 
patients were taking medications that block dopamine receptors, potentially altering striatal function. 
However, the majority of patients were taking atypical antipsychotics, which have a lesser effect on 
striatal activity during reward processing than typical antipsychotics (Juckel et al 2006a). Further, when 
we removed from analysis all patients taking typical antipsychotics or risperidone (which are 
pharmacologically similar), the group differences and correlations remained significant. In addition, 
functional activation did not correlate with antipsychotic dose within the regions showing group 
differences. While the possibility of medication effects cannot be ruled out without examination of 
unmedicated patients, we feel that these results provide reasonable evidence that the findings reported 
here were not driven by medications.  
 In summary, this study makes several important contributions to the literature on emotional 
experience and its related brain activity in schizophrenia. First, while patients showed blunted responses 
to emotional stimuli as compared to controls, these group differences in ratings were clearly mediated by 
the level of anhedonia displayed by the participants. Second, the pattern of brain activity in response to 
emotional stimuli was largely intact, with the exception of two striatal regions that showed reduced 
responses to positive stimuli. Third, blunted activation to positive vs. negative stimuli correlated with 
anhedonia in the amygdala and right ventral striatum in patients, and in the caudate in controls, 
suggesting that failure to mark stimuli as salient or rewarding may contribute to symptoms of anhedonia. 
Clinically, these results highlight the importance of individual differences, suggesting that optimal 
treatment strategies are best tailored to the individual symptomatology of the patient. Future work 
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examining the relationship between reduced neural responses to positive stimuli and deficits in motivated 
behavior, using paradigms that probe for reward anticipation and reinforcement learning in anhedonic 
individuals, may shed additional light on the questions raised here.  
 
Supplemental Information 
 
Example Task Instructions: 
Picture Rating Instructions for Valence: 
"In this part of the study, I am going to show you some pictures.  Some of the pictures will be positive, 
some will be negative, and some will be neutral.  I want you to decide how you personally feel about the 
pictures, and then to make a response based on how the picture makes you feel. What I want you to do is 
to press the button with your pointer finger every time you decide a picture is positive.  Press the button 
with your middle finger every time you decide a picture is neutral.  Press the button with your ring finger 
every time you decide a picture is negative."   
Picture Rating Instructions for Arousal: 
"In this part of the study, I am going to show you some pictures.  Some of the pictures will be highly 
arousing, some will be only a little arousing, and some will not be arousing at all.  A picture is highly 
arousing if it causes you to feel strong emotion about it.  That is, you really have strong feelings about 
what the picture means.  A picture is only a little arousing when you feel some emotion about it, but it is 
not that strong.  A picture is not arousing at all when you do not feel any emotion toward the word.  Both 
positive and negative pictures can be highly arousing or only a little arousing.  I want you to decide how 
you personally feel about the pictures, and then to make a response based on how the picture makes you 
feel. What I want you to do is to press the button with your pointer finger every time you decide a picture 
is highly arousing.  Press the button with your middle finger every time you decide a picture is not 
arousing at all.  Press the button with your ring finger every time you decide a picture is only a little 
arousing." 
 
Regions of Interest 
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Figure S1. Regions used in ROI analysis 
 
 
 
Movement analyses 
Table S1. Incremental movement 
  Control Schizophrenia   
  Mean SE Mean SE p 
x 0.022 0.010 0.046 0.009 0.092 
y 0.037 0.005 0.055 0.004 0.010* 
z 0.051 0.010 0.077 0.009 0.052 
pitch 0.052 0.009 0.072 0.008 0.097 
roll 0.025 0.007 0.039 0.006 0.131 
yaw 0.021 0.006 0.036 0.006 0.080 
SE, standard error 
* represents p < .05 
 
Table S2. Signal-to-noise ratio 
  Control Schizophrenia   
  Mean SE Mean SE p 
Mean SNR 340.286 37.116 326.077 33.197 0.776 
Median SNR 327.345 19.875 318.206 17.777 0.733 
Max SNR 720.273 277.86 789.291 248.53 0.854 
SE, standard error; SNR, signal-to-noise ratio 
 
 
Effects of Stimulus Type 
Behavioral:   Valence and arousal ratings were evaluated with separate repeated measures 
ANOVAs with stimulus (picture, word, face) and condition (NHA, NLA, NEU, PLA, PHA) as within-subjects 
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factors and group (schizophrenia, control) as a between-subjects factor.  For valence (Figure S2A), there 
was a significant stimulus-by-condition interaction (F(8,560) = 12.70, p < .001).  There was no main effect 
of stimulus (F(2,140) = 0.97, p > .37),  interaction of stimulus with group (F(2,140) = 0.77, p > .46), or 
three way interaction between stimulus, condition and group (F(8,560) = 0.52, p > .74).   Simple effects 
tests to follow up on the stimulus-by-condition interaction revealed significant effects of condition within 
each stimulus (faces: F(5,350) = 2577, p < .001; pictures: F(5,350) = 1930, p < .001; words: F(5,350) = 
2739, p < .001), and significant effects of stimulus within each condition (NHA: F(3,210) = 811.27, p < 
.001; NLA: F(3,210) = 1076, p < .001; NEU:  F(3,210) = 3003, p < .001; PLA: F(3,210) = 3640, p < .001; 
PHA: F(3,210) = 3338, p < .001).  As shown in Figure S2A, within the NHA condition, both groups tended 
to rate faces as less negative than pictures and words, and in the NLA condition, both groups rated words 
as more negative than pictures and faces.  In the neutral condition, both groups rated faces as more 
negative than pictures and words.  In the PHA and PLA conditions, both groups rated pictures as less 
positive than faces and words. 
A.  
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B.  
 
For the arousal ratings (Figure S2B), there was a significant main effect of stimulus (F(2, 140) = 23.41, p 
< .001) and a significant stimulus-by-condition interaction (F(8, 560) = 5.03, p < .001). There were no 
significant group-by-stimulus (F(2,140) = 0.36, p > .70) or group-by-condition-by-stimulus (F(8,560) = 
0.76, p > .64) interactions.  Overall, words were rated as most arousing, faces were rated as least 
arousing, and pictures were intermediate.  Simple effects tests revealed a significant effect of stimulus 
within each condition (NHA: F(3,210) = 517.12, p < .001; NLA: F(3,210) = 797.53, p < .001; NEU: 
F(3,210) = 2427.5, p < .001; PLA: F(3,210) = 810.03, p < .001; PHA: F(3,210) = 591.5, p < .001)  and a 
significant effect of condition within each stimulus (faces: F(5,350) = 1076, p < .001; pictures: F(5,350) = 
872.55, p < .001; words: F(5,350) = 702.78, p < .001).  As shown in Figure S2B, in the negative 
conditions, both groups tended to rate faces as less arousing than pictures or words, and in the positive 
conditions, both groups tended to rate words as more arousing than pictures and faces.  Arousal ratings 
to neutral stimuli did not differ between stimulus types in either group. 
 Effects of Stimulus Type: fMRI analysis: Table S3 lists regions that showed a significant 
interaction between stimulus type and each of the three contrasts at the whole-brain level, along with the 
results of follow-up analyses on the average activity within these regions.  The valence and valence X 
arousal contrasts identified a similar set of regions, most of which showed within-stimulus effects only for 
pictures, though a few also showed significant effects for faces.  The arousal contrast identified a number 
of regions driven primarily by pictures, words, or both.  As mentioned in the main text, no region was 
identified that showed a significant stimulus X group interaction for any of the contrasts at the whole-brain 
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Figure S2. Behavioral valence and arousal ratings by stimulus type 
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level.  To further probe for an interaction with group, we performed simple effects tests looking for an 
effect of group within each stimulus type.  With one exception, none of these regions showed a significant 
effect of group within any one stimulus type.  Similarly, when we looked for effects of group within each 
stimulus type, we found that most of the regions showed a significant effect of stimulus type within each 
group individually.   
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Pictures Words Faces Pictures Words Faces CON SCZ
Valence Contrast:
L Cerebellar Declive - -30, -57, -15 211 4.92 NS **** NS NS NS NS NS *** ****
R Cerebellar Declive - 33, -52, -11 346 5.16 NS **** NS NS NS NS NS *** ****
L Middle Occipital Gyrus 19 -41, -80, 5 313 4.77 NS **** NS NS NS NS NS *** ****
R Middle Temporal Gyrus 39 45, -73, 14 139 4.61 NS **** NS NS NS NS NS * ****
R Inferior Frontal Gyrus 9 43, 7, 30 50 3.93 NS **** NS **** NS NS NS *** *
L Angular Gyrus 39 -50, -71, 33 37 4.07 NS NS * **** NS NS NS NS ****
R Cuneus 19 29, -85, 31 48 4.50 NS **** NS NS NS NS NS * ****
Arousal Contrast:
L Middle Temporal Gyrus 39 -52, -64, 11 522 5.63 NS **** **** NS NS NS NS **** ****
L Inferior Frontal Gyrus 47 -42, 16, -4 116 4.88 NS *** **** NS NS NS NS *** ****
R Inferior Frontal Gyrus 47 36, 16, -6 38 4.58 NS *** *** NS NS NS NS ** ***
L Inferior Frontal Gyrus 9 -49, 16, 24 128 4.83 NS NS **** NS NS NS NS * ****
R Middle Occipital Gyrus 19 51, -75, 7 46 4.34 NS **** NS * NS NS NS *** *
L Precuneus 7 -3, -60, 32 295 4.64 NS **** NS NS NS NS NS *** ****
L Superior Frontal Gyrus 9 -4, 51, 26 32 4.22 NS **** NS NS NS NS NS NS ****
L Superior Frontal Gyrus 8 -4, 16, 49 358 4.74 NS ** *** NS NS NS NS ** ****
L Paracentral Lobule 31 -2, -21, 45 47 4.21 NS **** NS NS NS NS NS NS ****
L Middle Frontal Gyrus 6 -32, 3, 59 55 4.11 * * *** NS * NS NS NS ****
Valence X Arousal Contrast:
L Cerebellar Declive - -30, -56, -14 108 4.76 NS **** NS NS NS NS NS *** ***
R Fusiform Gyrus 37 36, -55, -11 168 4.93 NS **** NS NS NS NS NS *** ****
L Inferior Temporal Gyrus 19 -45, -76, 0 158 4.51 NS **** NS NS NS NS NS **** ***
R Middle Temporal Gyrus 39 46, -71, 16 133 4.63 NS **** NS NS NS NS NS * ****
R Inferior Frontal Gyrus 9 43, 8, 31 45 3.89 NS **** NS **** NS NS NS *** *
R Cuneus 19 29, -85, 32 42 4.46 NS **** NS NS NS NS NS * ****
*p<.05; **p<.01; ***p<.005; ****p<.001
Within-group stim effectsStim X Group 
Interaction
ZBrain Region BA Talairach 
Coordinates
# Voxels Within-stimulus effects Within-stim group effects
 
Table S3. Regions showing a significant effect of stimulus for each contrast 
L, left; R, right; BA, Brodmann area; NS, not significant; CON, controls; SCZ, schizophrenia 
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Whole-brain Correlation Analyses:  Table S4 shows the results of the whole-brain correlation analyses between anhedonia scores and activation 
in the valence, arousal, and valence X arousal contrasts.  No regions survived the threshold in controls, but several regions were significant in 
patients. 
 
Table S4. Whole-brain correlation results in individuals with schizophrenia
 L, left; R, right; SANS, Scale for the Assessment of Negative Symptoms 
Contrast Anhedonia Measure
Talairach 
Coordinates Region name
Brodmann 
Area
# 
Voxels r z
Arousal Chapman social anhedonia -3, 63, 0 L Superior Frontal Gyrus 10 89 0.68 4.81
Valence Chapman physical anhedonia -49, 17, -19 L Superior Temporal Gyrus 38 30 -0.56 -3.78
Valence-by-arousal Chapman physical anhedonia 38, -76, -23 R Cerebellar Tuber … 50 -0.56 -3.78
13, -10, -9 R Amygdala … 45 -0.63 -4.37
Arousal Chapman physical anhedonia 8, -18, -13 R Midbrain … 88 0.58 3.90
Valence-by-arousal SANS global anhedonia -28, -59, -21 L Cerebellar Culmen … 59 -0.64 -4.42
0, 8, -14 Subcallosal Gyrus 25 50 0.52 3.45
59, -53, -13 R Inferior Temporal Gyrus 20 38 0.59 4.02
Arousal SANS global anhedonia -2, 63, 0 L Superior Frontal Gyrus 10 87 0.61 4.17
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Medication Effects 
 
 
 Figure S3. Functional activation in right ventral striatum in controls and in patients taking atypical 
antipsychotics only (excluding risperidone) 
 
 
 Figure S4. Functional activation in left putamen in controls and in patients taking atypical antipsychotics 
only (excluding risperidone) 
 
Schizophrenia versus Schizoaffective Disorder:  Our sample included individuals with both schizophrenia 
and schizoaffective disorder.  There has been debate in the literature as to whether or not these 
represent similar or different disorders. We chose to include individuals with schizoaffective disorder on 
the basis of a large body of literature suggesting that it is inappropriate to treat schizoaffective disorder as 
a distinct structural diagnosis.  Critical reviews and meta-analyses of the literature in neuropsychology, 
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neuroimaging, molecular neurobiology, and genetic epidemiology have consistently failed to find 
categorical differences between schizoaffective disorder, schizophrenia, and bipolar disorder, leading 
several authors to conclude that the current diagnostic structure is somewhat artificial and a dimensional 
or spectrum approach to psychotic and affective disorders would be more appropriate (Abrams et al 
2008; Cheniaux et al 2008; Lake and Hurwitz 2006; Malhi et al 2008; Peralta and Cuesta 2008).  For this 
reason, we felt it was not necessary to exclude participants with a diagnosis of schizoaffective disorder 
from our study.   
However, to be sure that diagnosis did not have an effect on the data in our sample, we 
conducted supplemental analyses in which we excluded patients with a diagnosis of schizoaffective 
disorder from our final sample.  The major findings of the study remained unchanged.   Behaviorally, the 
group X condition interactions remained significant for both the valence and arousal ratings, and post-hoc 
analyses revealed the same group differences within individual conditions as in the full sample. In the 
fMRI analyses, the group differences in the valence contrast in right ventral striatum and in the valence X 
arousal contrast in left putamen remained significant, and the negative correlations between physical 
anhedonia and bilateral amygdala activity remained significant.  The negative correlation between right 
ventral striatal activity in the valence X arousal contrast and physical anhedonia dropped to trend level 
(from r = -.36, p < .04 to r = -.320, p < .08), possibly due to the reduction in power.  We feel that these 
results show that the diagnosis of schizophrenia vs. schizoaffective disorder did not influence the 
outcome of our study, and therefore justify inclusion of these patients in our sample. 
 
Example Timecourses 
Figure S5: Example Timecourses.  (A) Timecourses for a region in DLPFC showing a significant 
valence effect. (B) Timecourses for a region in right amygdala showing an arousal effect. (C) 
Timecourses for a region in left putamen showing group differences in the valence effect. (D) 
Timecourses for a region in right ventral striatum showing group differences in the valence effect. 
  49 
 
  
  50 
 
 
 
 
 
 
 
Chapter 3. 
 
Pavlovian reward prediction and receipt in schizophrenia: Relationship to anhedonia 
 
 
 
 
 
 
 
 
 
 
This chapter was published in the May, 2012 issue of PLOS One.  My contributions to this paper included 
data collection, analysis, and writing. 
 
Reference: Dowd EC & Barch DM. Pavlovian reward prediction and receipt in schizophrenia: relationship 
to anhedonia. PLoS ONE (2012) vol. 7 (5) pp. e35622. 
 
  
  51 
Abstract 
Reward processing abnormalities have been implicated in the pathophysiology of negative symptoms 
such as anhedonia and avolition in schizophrenia.  However, studies examining neural responses to 
reward anticipation and receipt have largely relied on instrumental tasks, which may confound reward 
processing abnormalities with deficits in response selection and execution. 25 chronic, medicated 
outpatients with schizophrenia and 20 healthy controls underwent functional magnetic resonance imaging 
using a Pavlovian reward prediction paradigm with no response requirements.  Subjects passively viewed 
cues that predicted subsequent receipt of monetary reward or non-reward, and blood-oxygen-level-
dependent signal was measured at the time of cue presentation and receipt.   
At the group level, neural responses to both reward anticipation and receipt were largely similar between 
groups.  At the time of cue presentation, striatal anticipatory responses did not differ between patients 
and controls. Right anterior insula demonstrated greater activation for nonreward than reward cues in 
controls, and for reward than nonreward cues in patients. At the time of receipt, robust responses to 
receipt of reward vs. nonreward were seen in striatum, midbrain, and frontal cortex in both groups. 
Further, both groups demonstrated responses to unexpected versus expected outcomes in cortical areas 
including bilateral dorsolateral prefrontal cortex.  Individual difference analyses in patients revealed an 
association between physical anhedonia and activity in ventral striatum and ventromedial prefrontal 
cortex during anticipation of reward, in which greater anhedonia severity was associated with reduced 
activation to money versus no-money cues.  In ventromedial prefrontal cortex, this relationship held 
among both controls and patients, suggesting a relationship between anticipatory activity and anhedonia 
irrespective of diagnosis. These findings suggest that in the absence of response requirements, brain 
responses to reward receipt are largely intact in medicated individuals with chronic schizophrenia, while 
reward anticipation responses in left ventral striatum are reduced in those patients with greater anhedonia 
severity. 
 
Introduction 
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 The role of reward processing in the pathophysiology of schizophrenia has garnered significant 
attention in recent years.  Aberrant reward processing has been implicated in both positive (Heinz and 
Schlagenhauf 2010; Kapur 2003) and negative (Barch and Dowd 2010; Gold et al 2008) symptomatology, 
and advances in neuroimaging techniques have allowed new insights into the mechanisms of reward 
processing that may be disrupted in this illness. One such process is reward prediction, or the ability to 
anticipate a reward when presented with a predictive cue. Reward prediction is strongly associated with 
dopaminergic activity in the midbrain and striatum (O'Doherty 2004; Schultz 2001), which is thought to be 
dysregulated in schizophrenia (Guillin et al 2007). If disruptions in reward signaling prevent predictive 
stimuli from taking on the appropriate significance, they could contribute to important negative symptoms 
of schizophrenia such as decreased motivation and anhedonia (a reduced ability to experience pleasure) 
(Barch and Dowd 2010; Gold et al 2008; Ziauddeen and Murray 2010). Here, we examine this possibility 
using a Pavlovian reward prediction task to examine functional activity during reward anticipation and 
receipt in schizophrenia and its relationship to symptoms of anhedonia and amotivation. 
 A number of previous neuroimaging studies have examined reward prediction in schizophrenia. 
Studies using monetary incentive delay paradigms have shown reduced ventral striatal responses to 
reward-predictive cues in patients who are unmedicated (Juckel et al 2006b), or taking typical, but not 
atypical, antipsychotics (Juckel et al 2006a). Notably, this reduction in anticipatory activation was 
associated with negative symptom severity. Several studies in patients taking atypical antipsychotics 
have shown intact striatal anticipatory activation (Simon et al 2010; Walter et al 2009; Waltz et al 2010), 
though some of these studies also demonstrated negative correlations between ventral striatal activation 
and negative symptoms (Simon et al 2010; Waltz et al 2010).  
Work examining brain responses to reward receipt has also revealed alterations in schizophrenia. 
Some studies have shown blunted striatal reward responses or prediction errors (responses to outcomes 
that do not match expectation) (Gradin et al 2011; Koch et al 2010; Murray et al 2008; Schlagenhauf et al 
2009; Waltz et al 2009), while others have shown intact responses (Simon et al 2010; Waltz et al 2010). 
Notably, several of these studies also found inverse relationships between striatal responses to reward 
receipt and negative or depressive symptoms (Simon et al 2010; Waltz et al 2009; Waltz et al 2010). In 
addition, abnormal outcome or prediction error responses have been reported in cortical regions including 
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insula (Gradin et al 2011) and medial (Murray et al 2008; Schlagenhauf et al 2009; Walter et al 2009; 
Waltz et al 2010), ventrolateral (Walter et al 2010; Walter et al 2009), and dorsolateral (Corlett et al 2007; 
Waltz et al 2010) prefrontal cortex. In several of these studies, attenuated cortical prediction errors or 
outcome responses were associated with increased severity of either positive (Corlett et al 2007; Gradin 
et al 2011; Murray et al 2008) or negative (Walter et al 2010; Waltz et al 2010) symptoms.   
Importantly, the literature examining reward processing in schizophrenia has largely relied on 
instrumental learning tasks, in which rewards must be earned via correct and/or rapid response 
execution. In these tasks, the ability to anticipate a reward depends upon the ability to earn the reward by 
responding appropriately. This requires not only reward prediction, but also action selection and response 
execution, any of which may be impaired in schizophrenia. Here, we examined reward prediction in 
schizophrenia in the absence of requirements for response selection and execution.  Using a passive 
Pavlovian paradigm, we examined functional activation in response to rewarding stimuli and to predictive 
cues that had been associated with rewards based on pre-scan instructions.  
Previous work using aversive Pavlovian conditioning has revealed abnormal brain responses 
among individuals with schizophrenia.  Using a task in which colored cues were associated with 
affectively negative or neutral pictures, Romaniuk et al (Romaniuk et al 2010) demonstrated reduced 
responses to aversive cues in bilateral amygdala, as well as decreased prediction error responses in the 
midbrain.  Further, inappropriate midbrain activation to neutral stimuli correlated with delusional symptom 
severity.  Similarly, work by Jensen et al (Jensen et al 2008) using aversive noise stimuli revealed 
increased right ventral striatum activation to neutral cues in patients.  These studies suggest that even in 
the absence of response requirements, brain responses to neutral cues in an aversive context may be 
augmented among individuals with schizophrenia.  In addition, two studies have examined functional 
activity using Pavlovian paradigms with appetitive rewards in schizophrenia (Morris et al 2012; Waltz et al 
2009). Waltz et al used a timing-sensitive paradigm to examine anticipation and receipt of primary reward 
(juice), and found reduced positive (but not negative) prediction errors and reward responses in 
schizophrenia in widespread regions throughout the brain. However, integrating these results with others 
in the literature is challenging because the timing-sensitive paradigm and primary reward differ greatly 
from the tasks typically used in instrumental studies. Morris et al used a Pavlovian prediction error task to 
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examine responses to expected and unexpected rewards and omissions. In this study, ventral striatal 
responses in patients were intact for reward receipt vs. omission, but failed to differentiate between 
expected and unexpected rewards. However, this study did not examine brain activity at the time of cue 
presentation.  Here, we used a Pavlovian monetary reward prediction task to examine whether functional 
activation during reward anticipation and receipt is altered in schizophrenia even in the absence of 
response requirements, and whether it relates to symptoms of anhedonia and amotivation. 
 
Methods and Materials 
Participants: Participants were 29 stable outpatients with DSM-IV schizophrenia or 
schizoaffective disorder and 22 healthy controls with no personal or family history of psychosis. All 
patients were taking antipsychotic medications, which were stable for at least two weeks. Participants 
were group matched on sex, age, parental education, handedness (Oldfield 1971), and smoking status. 
Inclusion criteria were 1) age 18-50 years and 2) ability to give informed consent. Exclusion criteria were 
1) DSM-IV substance abuse or dependence within the past 6 months (except nicotine); 2) DSM-IV major 
depressive disorder or dysthymia in the past year; 3) past head injury with neurological sequelae and/or 
loss of consciousness; 4) DSM-IV mental retardation, and 5) any contraindication to MRI including 
pregnancy, claustrophobia, any metallic object in the body, etc. Participant diagnoses were based on a 
Structured Clinical Interview for DSM-IV-TR (First et al 2001) conducted by a Masters-level clinician. 
Clinical symptoms were rated using the Scales for the Assessment of Positive Symptoms (SAPS) 
(Andreasen 1983b) and Negative Symptoms (SANS) (Andreasen 1983a), and summarized using the 
following symptom domain scores (Andreasen et al 1995): 1) positive symptoms – hallucinations and 
delusions; 2) negative symptoms – alogia, anhedonia, avolition, affective flattening and attentional 
impairment; and 3) disorganization – bizarre behavior, positive thought disorder, and inappropriate affect. 
Anhedonia was assessed using the Chapman revised physical and social anhedonia scales (Chapman 
and Chapman 1978; Chapman et al 1976; Eckblad et al 1982). This study was conducted in accord with 
APA standards for ethical treatment of human subjects. Written informed consent was obtained from all 
participants, and all procedures were approved by the Washington University Human Research 
Protection Office. Participant demographic and clinical characteristics are shown in Table 1. 
  55 
Materials and Tasks: All participants underwent fMRI while performing a Pavlovian reward 
prediction task. Subjects were presented with one of two visual cues (pink cross or green circle), one 
predicting receipt of 75¢ for the trial, and one predicting receipt of 0¢ for the trial. The cues were followed 
by their predicted outcome 75% of the time, and with the opposite outcome 25% of the time. Participants 
were informed of the cue-outcome associations before the scan, and were told that the cue usually, but 
not always, predicted its associated outcome.  They were also told that they could keep any money they 
were awarded during the task.  In each trial, the visual cue was presented for 10 seconds, followed by a 
symbol indicating the outcome (+75¢ or +0¢) for 4 seconds. Inter-trial intervals varied pseudorandomly 
between 4 and 8 seconds. Participants completed four runs of 16 trials each, for a total of 64 trials (32 per 
cue type). Participants were paid $25/hour for their time, and were awarded an additional $20 in reward 
money upon session completion. 
 Image Acquisition and Processing: Imaging data was acquired on a 3T Siemens TIM TRIO system 
with a 12-channel head coil. High-resolution T1 images (TE=3.16ms, TR=2400ms, 176 slices, 1X1X1mm 
voxels) and T2 images (TE=96ms, TR=5s, 48 slices, 1.02x1x3mm voxels) were acquired to aid in 
registration to a common atlas space. Functional images were collected in four runs of 182 frames each 
using an asymmetric spin-echo echo-planar sequence (TR=2000ms, TE=27ms, FOV=256mm, flip=90°, 
33 slices). Functional runs acquired axial images parallel to the anterior-posterior commissure plane with 
4mm3 isotopic voxels. Stimuli were presented using PsyScope on a G3 Macintosh, with each trial onset 
triggered directly by a pulse from the scanner. The MR data was normalized across runs by scaling 
whole-brain signal intensity to a fixed value and removing the linear slope on a voxel-by-voxel basis to 
counteract effects of drift (Bandettini et al 1993). The MR data was then aligned to correct for head 
motion using rigid-body rotation and translation correction algorithms (Friston et al 1994; Snyder 1996; 
Woods et al 1992), which provide estimated movement parameters used to evaluate movement 
differences between groups. We also compared signal-to-noise ratios (SNR=mean/variance) between 
groups (Barch et al 2002), and removed runs or participants with movement or SNR values not meeting 
predetermined criteria (Table S1). Of the 29 patients and 22 controls who underwent the experimental 
protocol, four patients and two controls were excluded for excessive head motion, yielding the final 
sample of 20 controls and 25 patients. The images were then resampled into 3mm3 voxels, registered to 
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Talairach space using 12-parameter affine transformations, and smoothed with a 6mm FWHM Gaussian 
filter.  
 fMRI Data Analysis: All functional data was analyzed using in-house software. Data analysis was 
conducted using general linear models (GLMs) (Friston et al 1995; Friston et al 1994; Worsley 1994), 
which included task-related regressors as well as nuisance regressors for linear trends within runs and 
baseline shifts between runs. Canonical hemodynamic response shapes (Boynton functions) were used 
to estimate cue- and receipt-related activation. Regressors included two cue types (money and no-
money) and four outcome types (expected money, expected no-money, unexpected money, unexpected 
no-money). The parameter estimates from the GLMs for each subject were entered into ANOVAs using 
subject as a random factor. To identify regions in which activation related to anticipation of reward (cue-
related activity), we performed a repeated measures ANOVA with cue type (money, no-money) as a 
within-subjects factor and group (schizophrenia, control) as a between subjects factor. To identify regions 
in which activation related to reward receipt, we used cue type (cue money, cue no-money) and receipt 
type (receive money, receive no-money) as within-subjects factors and group (schizophrenia, control) as 
a between-subjects factor. Cue type was included as a factor in analyses of receipt in order to evaluate 
potential prediction error effects, which would be expected to modulate responses to receipt according to 
whether the outcome was expected or unexpected.  
  These ANOVAs were used in voxelwise whole-brain and ROI analyses. Whole-brain analyses 
were corrected for multiple comparisons using a p-value/cluster size threshold of p<.003 (two-tailed) and 
13 voxels. This correction factor was determined by Monte Carlo simulations to provide a whole-brain 
false-positive rate of p<.05 (Forman et al 1995; McAvoy et al 2001); an approach equivalent to that 
employed by the Alphasim program in the AFNI software package. Second, voxelwise ROI analyses were 
conducted within an a priori mask consisting of a network of regions implicated in reward processing, an 
approach equivalent to the “small volume correction” procedure in the SPM software package. This mask, 
developed by Beck et al (Beck et al 2010), consisted of regions that were hand-drawn in Talairach space 
on the basis of anatomical landmarks and previously published coordinates (Ahsan et al 2007; Jensen et 
al 2007; Kable and Glimcher 2007; Knutson et al 2001; Knutson et al 2003; Kringelbach and Rolls 2004; 
Nitschke et al 2006; O'Doherty et al 2003a; O'Doherty et al 2004), including the dorsal and ventral 
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striatum, ventral tegmental area, substantia nigra, amygdala, orbitofrontal cortex (OFC), ventromedial 
prefrontal cortex (VMPFC), and insula (Figure S1). This analysis was corrected for multiple comparisons 
using a combined p-value/cluster size threshold  (p<.01 (two-tailed) and 19 voxels) determined using 
Monte Carlo simulations to provide !<.05 for the whole ROI mask. 
  We also conducted correlation analyses between BOLD contrasts and anhedonia scores.  In 
these analyses, Cue Money – No-money and Receive Money – No-money contrasts were created for 
each subject and correlated with Chapman physical and social anhedonia scores. These correlations 
were conducted voxelwise, and were corrected using the same small-volume and whole-brain correction 
procedures described above.  To explore whether these relationships were unique to the patient group, 
regions demonstrating significant correlations were also examined within the control group.   
  In addition to the analysis using canonical hemodynamic response shapes, a separate analysis 
was conducted that estimated response magnitudes for each MR frame separately (e.g. (Miezin et al 
2000)), allowing examination of response timecourses across both cue and receipt.  This analysis was 
analyzed using ANOVAs with time as a factor, including timepoints 1-7 (0-12 seconds) in the analysis for 
Cue, and 8-14 (14-26 seconds) in the analysis for Receipt.  This analysis yielded comparable results, and 
example timecourses are shown in Figure S5. 
 
Results 
Participant characteristics:  
  Participant demographic and clinical characteristics are presented in Table 1. The patient and 
control groups did not differ significantly on age, sex, race, smoking status, or parental education.  The 
control group demonstrated significantly higher personal education than the patient group. With respect to 
anhedonia severity, individuals with schizophrenia demonstrated significantly higher scores than controls 
on both the Chapman physical (t(38)=-4.06, p<.001) and social (t(38)=-2.20, p<.001) anhedonia scales.  
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fMRI results: Reward Anticipation  
  Results of the voxelwise ROI and whole-brain analyses are reported in Table 2. No regions 
demonstrated a significant main effect of cue. There was a significant main effect of group in VMPFC in 
the ROI analysis and significant main effects of group in VMPFC, cerebellum and left posterior cingulate 
in the whole-brain analysis, all of which demonstrated greater activation overall in controls than in 
patients. In addition, a significant Cue X Group interaction was seen in a region in right anterior insula in 
the ROI analysis.  This region showed greater activity for no-money than money cues in controls 
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(F(1,19)=8.74, p<.009), and greater activity for money than no-money cues in patients (F(1,24)=8.15, 
p<.009). There were no significant Cue X Group interactions in the whole-brain analysis. 
 
Table 2. Cue-related activation. 
Effect Analysis Brain Region Brodmann Area 
Talairach 
Coordinates Voxels Z Activation Pattern 
Group ROI VMPFC 32/10 +0, +44, +8 93 3.63 CON > SCZ 
 WB R Cerebellum - +14, -57, -46 18 4.06 CON > SCZ 
  R VMPFC 32/10 +1, +47, +8 58 3.95 CON > SCZ 
  L VMPFC 32/10 -12, +44, +0 20 3.75 CON > SCZ 
  L Posterior Cingulate 31 -2, -38, +34 23 3.74 CON > SCZ 
CueXGroup ROI R Anterior Insula 13 +32, +15, +0 25 3.79 
CON: No Money > Money; 
SCZ: Money > No Money 
R = Right, L = Left, CON = control, SCZ = schizophrenia, VMPFC = Ventromedial prefrontal cortex. Z 
values represent mean activation across the region. 
 
 
 Given past findings with similar paradigms, we had expected to see greater activity for money than 
no-money cues in striatal regions among controls.  Thus, to further explore the nature of the striatal 
responses within each group, we extracted the mean activation across voxels within caudate, putamen, 
and nucleus accumbens ROIs ((Mamah et al 2007); Figure S2) for money and no-money cues.  Cue 
(Money, No-Money) X Group (Control, Schizophrenia) ANOVAs revealed a significant main effect of cue 
within bilateral caudate (left: F(1,43)=4.16, p<.05; right: F(1,43)=5.12, p<.03), with greater activation to 
money than no-money cues (Figure 1). Post-hoc paired t-tests revealed that this effect was driven largely 
by the patient group, which demonstrated significant activation to money cues and deactivation to no-
money cues (left: t(24)=2.33, p<.03; right: t(24)=2.23, p<.04). Controls showed activation to both money 
and no-money cues, with no significant differences between cue types.  No other regions demonstrated a 
main effect of cue, and there were no significant main effects of group or Cue X Group interactions in the 
striatal ROIs.  We also wished to examine the possibility that stronger anticipatory responses were 
evident only in the later runs, which could have resulted if the stimulus-outcome associations that were 
formed based on pre-scan instruction were strengthened by experience during the early trials of the scan.  
To this end, we repeated our cue-related analyses after excluding the first BOLD run, in essence treating 
this run as a practice.  This analysis did not reveal any additional reward-related regions showing 
significant main effects of cue or cue X group interactions.   
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Figure 1. Cue-related activation in bilateral caudate ROIs. Activation shown is mean activation 
across voxels within regions of interest. Error bars represent standard error. 
 
fMRI results: Reward Receipt 
  Results of voxelwise ANOVA analyses are presented in Table 3. The ROI analysis revealed a 
main effect of receipt in bilateral caudate, which showed greater activation for receipt of money than no-
money. On whole brain analysis, a number of additional regions also showed this pattern, including 
bilateral DLPFC, dorsomedial PFC, left posterior parietal cortex, and several occipital and cerebellar 
regions (Figure 2). Post-hoc tests revealed that each group individually demonstrated greater activation 
for money than no-money receipt within each region at trend level or higher. In addition, several regions 
demonstrated a significant Cue X Receipt interaction (Figure 3). These included bilateral anterior insula 
and left ventrolateral prefrontal cortex, which activated more strongly for unexpected than expected 
outcomes (i.e. when money was cued but no-money received, or no-money cued and money received). 
Additional regions showing this pattern were also identified on whole-brain analysis.  These included 
several regions commonly implicated in cognitive control and working memory (Owen et al 2005; Wager 
and Smith 2003), such as bilateral DLPFC, DMPFC, posterior parietal cortex, and anterior insula/frontal 
operculum.  Post-hoc tests revealed that each of these regions demonstrated a significant cue X receipt 
interaction within each group separately (Table 3).  To further explore the patterns of activity in these 
regions, we conducted paired t-tests comparing unexpected versus expected rewards and unexpected 
versus expected non-rewards within each group (table S2). All regions demonstrated significantly greater 
activation for unexpected than expected outcomes when collapsing across reward versus nonreward.  
When reward and non-reward were examined separately, all regions demonstrated greater activation for 
unexpected than expected rewards and for unexpected than expected non-rewards, though not every 
effect was significant in each group (details presented in Table S2). For example, the region in left 
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ventrolateral prefrontal cortex showed significantly greater activation for unexpected than expected 
rewards in controls, but not patients, and for unexpected than expected non-rewards in patients, but not 
controls (figure S3). These results suggest that the activation patterns driving the cue X receipt 
interactions were not identical between groups. However, no interactions with group were present, and 
both groups did show clear effects of unexpected versus expected outcomes. In addition to the regions 
showing main effects of receipt or cue X receipt interactions, a main effect of group was seen in right 
DLPFC, which demonstrated greater activity in controls than patients, as well as in left pre- and post-
central gyri, which activated more strongly in patients than controls. Finally, one region in right inferior 
temporal gyrus demonstrated a Receipt X Group interaction wherein controls responded more strongly to 
no-money than money receipt, while patients responded more strongly to money than no-money receipt. 
  
Figure 2. Regions demonstrating a significant main effect of receipt. All regions showed greater activation 
for receipt of money than no money.  Both ROI results (threshold of p<.01 and 19 voxels within ROI mask 
) and  whole-brain results (threshold of p<.003 and 13 voxels) are displayed. Graphs represent mean 
activation magnitudes across voxels within example regions among individuals with schizophrenia (SCZ) 
and controls (CON).  Error bars represent standard error. 
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Table 3: Receipt-related activation
Brodmann Talairach #
Effect Analysis Brain Region Area Coordinates Voxels Z Activation Pattern CON SCZ
Receipt ROI L Caudate - -15, -4, +10 99 3.92 Money > No Money p<.002 p<.02
R Caudate - +12, +2, +13 74 3.94 Money > No Money p<.001 p<.02
WB R Cerebellum - +1, -28, -41 40 4.09 Money > No Money p<.02 p<.002
L Cerebellum - -10, -46, -40 70 4.50 Money > No Money p<.003 p<.002
R Cerebellum - +11, -40, -43 15 3.70 Money > No Money p<.03 p<.004
L Cerebellum - -35, -62, -24 47 4.48 Money > No Money p<.07 p<.001
R Cerebellum - +53, -63, -24 15 4.38 Money > No Money p<.005 p<.001
R Cerebellum - +35, -65, -23 39 4.60 Money > No Money p<.03 p<.001
R Cerebellum - +12, -79, -19 22 4.14 Money > No Money p<.03 p<.001
L Middle Occipital Gyrus 37 -47, -62, -8 75 4.55 Money > No Money p<.02 p<.001
L Inferior Occipital Gyrus 18 -37, -84, -13 18 3.84 Money > No Money p<.03 p<.002
L Fusiform Gyrus 18 -25, -92, -12 20 4.12 Money > No Money p<.02 p<.002
R Cuneus 17 +11, -96, +1 40 3.86 Money > No Money p<.06 p<.001
L Thalamus - -12, -7, +10 107 4.39 Money > No Money p<.001 p<.004
R Caudate - +13, +1, +11 92 4.38 Money > No Money p<.001 p<.005
R Middle Frontal Gyrus 46 +43, +40, +22 44 4.18 Money > No Money p<.002 p<.005
L Inferior Frontal Gyrus 9 -42, +4, +26 55 3.61 Money > No Money p<.03 p<.005
Cingulate Gyrus 23 +0, -27, +28 65 4.14 Money > No Money p<.006 p<.003
L Angular Gyrus 39 -37, -57, +38 359 4.36 Money > No Money p<.002 p<.003
L Precuneus 7 -12, -74, +34 22 3.77 Money > No Money p<.07 p<.002
L Superior Frontal Gyrus 6 -2, +9, +48 141 4.07 Money > No Money p<.02 p<.001
L Precentral Gyrus 4 -44, -13, +42 16 3.59 Money > No Money p<.1 p<.001
Group WB R Middle Frontal Gyrus 9 +43, +29, +33 14 3.76 CON > SCZ - -
L Precentral Gyrus 4 -34, -28, +64 17 3.47 SCZ > CON - -
L Postcentral Gyrus 3 -10, -32, +67 15 3.87 SCZ > CON - -
Cue X Receipt ROI L Ventrolateral PFC 47 -44, +22, -6 20 3.41 Unexpected > Expected p<.001 p<.04
R Anterior Insula 13 +34, +17, +4 57 4.12 Unexpected > Expected p<.002 p<.005
L Anterior Insula 13 -34, +16, +4 60 3.68 Unexpected > Expected p<.005 p<.02
WB R Anterior Insula 13/45 +41, +21, +4 208 4.55 Unexpected > Expected p<.002 p<.002
L Anterior Insula 13/45 -40, +17, +0 89 4.21 Unexpected > Expected p<.001 p<.009
L Superior frontal Gyrus 9 -31, +47, +28 26 4.12 Unexpected > Expected p<.006 p<.003
L Posterior Cingulate 43 -1, -31, +26 25 3.39 Unexpected > Expected p<.008 p<.04
R Middle Frontal Gyrus 6 +42, +11, +42 137 4.65 Unexpected > Expected p<.02 p<.001
L Middle Frontal Gyrus 9 -44, +19, +32 18 3.84 Unexpected > Expected p<.02 p<.004
L Middle Frontal Gyrus 6 -39, +4, +34 14 3.65 Unexpected > Expected p<.003 p<.02
R Inferior Parietal Lobule 40 +44, -52, +40 151 4.40 Unexpected > Expected p<.04 p<.001
L Inferior Parietal Lobule 7 -39, -60, +42 139 4.11 Unexpected > Expected p<.03 p<.001
L Superior Frontal Gyrus 8 -1, +20, +48 67 4.17 Unexpected > Expected p<.002 p<.007
Receipt X Group WB R Inferior Temporal Gyrus 37 +51, -70, +3 17 3.56
CON: No Money > Money 
SCZ: Money > No Money
- -
Post-hoc Tests:
R = Right, L = Left, ROI = Region of Interest analysis, WB = Whole Brain analysis, CON = control, SCZ = schizophrenia, PFC = prefrontal cortex. Z and p values 
represent mean activation across the region.
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Figure 3. Regions demonstrating a Cue X Receipt interaction. All regions showed greater activity for 
unexpected than for expected outcomes. Both ROI results (threshold of p<.01 and 19 voxels within ROI 
mask) and whole-brain results (threshold of p<.003 and 13 voxels) are displayed.   Graphs represent 
mean activation magnitudes across voxels within example regions among individuals with schizophrenia 
(SCZ) and controls (CON).  Error bars represent standard error. 
 
 
Correlations with Anhedonia 
  Cue-Related Activity Correlations. In the patient group significant negative correlations were 
found between Chapman physical anhedonia and the Cue Money – No-money contrast in regions in left 
ventral striatum and VMPFC (Figure 4a). As shown in Table 4, post-hoc analyses revealed that this 
relationship was primarily driven by activation in response to money cues, which correlated negatively 
with physical anhedonia, rather than by activation in response to no-money cues. This indicates that in 
patients, greater physical anhedonia is associated with less ventral striatal activity during the anticipation 
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of rewards.  On whole-brain analysis, a similar pattern was observed in left inferior frontal gyrus. In 
VMPFC, the negative correlation was driven by activation to both the money cue, which correlated 
negatively with physical anhedonia, and the no-money cue, which correlated positively with physical 
anhedonia.  Thus, individuals who were higher in anhedonia demonstrated both decreased responses to 
money cues and increased responses to no-money cues in VMPFC.  To determine whether these 
relationships were also present among controls, we conducted correlation analyses in the control group 
between the Cue Money – No Money contrast and physical anhedonia scores within the ventral striatal 
and VMPFC regions that had reached significance in the patient group (Table 4).  A significant negative 
correlation was found within the VMPFC region, indicating that greater physical anhedonia is associated 
with lower VMPFC anticipatory activity among both patients and controls.  In the ventral striatal region, 
there was a negative relationship between anhedonia and cue-related activity in controls, but this 
relationship failed to reach significance. No significant regions were identified for social anhedonia. 
 
 Receipt Related Activity Correlations. At the time of receipt, significant positive correlations were 
seen between physical anhedonia and the Receive Money – No-money contrast in left superior and 
middle frontal gyri (Figure 4b). These correlations were driven primarily by responses to no-money 
receipt, which correlated negatively with physical anhedonia.  In other words, patients who were higher in 
anhedonia showed less activation to no-money receipt in these regions.  In addition, social anhedonia 
correlated negatively with activity in left uncus and right cerebellum in the Receive Money – No-money 
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contrast. These relationships were driven by activity in response to the receipt of both money and no-
money; thus, patients with higher social anhedonia showed smaller responses in these regions to money 
receipt and larger responses to no-money receipt.  In controls, only the left superior frontal gyrus showed 
a significant correlation, which was in the negative direction. 
 
Figure 4. Regions demonstrating correlations between activation and anhedonia severity. (A) Results of 
voxelwise correlation between Chapman physical anhedonia score and the Cue Money – No Money 
contrast in patients, ROI analysis (threshold of p<.01 and 19 voxels within ROI mask). (B) Results of 
voxelwise correlation between Chapman physical anhedonia and the Receive Money – No Money 
contrast in patients, whole brain analysis (threshold of p<.003 and 13 voxels.)   Graphs represent mean 
activation across the region. 
 
 
Medication Analyses 
To explore the possibility that antipsychotic medications may have influenced the results, we 
conducted correlations between medication dose in chlorpromazine equivalents (Gardner et al 2010)and 
cue- or receipt-related brain activation.  First, we examined the regions that had shown correlations 
between cue- or receipt-related activity and anhedonia ratings, none of which showed significant 
correlations between antipsychotic medications and the relevant contrast (all p values > 0.16).  Similarly, 
antipsychotic dosage failed to correlate significantly with physical or social anhedonia scores (all p values 
> 0.4).  To look for more general medication effects, we also conducted voxelwise ROI and whole-brain 
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correlations between antipsychotic dose and activation for the money – no-money cue and receipt 
contrasts.  There were no regions whose cue-related activity correlated significantly with antipsychotic 
dosage.  For receipt, no regions within the ROI mask correlated significantly with medication dose.  
Whole-brain analysis revealed two regions that correlated positively with dose, such that higher doses 
were associated with greater responses to receipt of money versus no-money.  One of these regions was 
within left prefrontal cortex (-30, 55, 0; 14 voxels) and the other fell within the lateral ventricles adjacent to 
caudate (3, 11, 12; 22 voxels). 
In addition, given past results showing effects of typical vs. atypical antipsychotic medications on 
striatal anticipatory activation, we wished to determine to what extent our results were affected by 
medication type.  To do this, we repeated our analyses with the 5 subjects taking typical antipsychotics 
removed (unfortunately, we had too few subjects taking typical antipsychotics to examine this group 
separately).  All ANOVA and correlation results reported in Tables 2-4 remained significant at trend level 
or above, though some decreased slightly in significance perhaps reflecting the reduction in power.  
Further, no new correlations or group effects on striatal activation emerged at the time of cue presentation 
or receipt.  
 
 
Discussion 
The goal of this study was to examine cue- and receipt- related brain activation during Pavlovian 
reward prediction in schizophrenia, and to examine the relationship between this activation and 
symptoms of anhedonia and amotivation.  Our results demonstrate few activation differences at the group 
level during reward anticipation and receipt.  However, we observed that left ventral striatal and VMPFC 
activation during reward anticipation in schizophrenia was reduced in patients who are higher in 
anhedonia.  These findings are consistent with a number of studies showing similar results in instrumental 
paradigms, consistent with the interpretation of these studies as reflecting abnormal reward prediction 
mechanisms in patients experiencing anhedonia and/or motivational deficits. 
 Cue-related activation: At the group level, we did not see striatal cue-related activity that differed 
significantly between groups.  Upon ROI analysis, there was a main effect of cue in bilateral caudate with 
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greater activity for money than no-money cues, an effect that was driven by the patient group and was not 
significant in controls alone. We speculate that this relative lack of differential cue-related activity among 
controls as compared to published studies may reflect a difference between our passive Pavlovian 
paradigm and the instrumental paradigms typically used in reward prediction studies.  Instrumental tasks 
require that information in the cue be used to plan and execute a correct motor response, which may 
enhance cue-related activation as compared to Pavlovian paradigms. Our task, modeled after O’Doherty 
et al 2002 (O'Doherty et al 2002), was designed to be completely passive in order to eliminate 
confounding variables associated with execution of a motor response.  However, the O’Doherty study 
used primary reward (juice), and it is possible that the monetary rewards used here were less salient and 
therefore less capable of eliciting the expected cue-related activation.  Similarly, it is possible that the 
monetary rewards were more salient for patients than controls given their lower socioeconomic status, 
which may underlie the finding of significant striatal anticipatory activation in patients but not controls.  
Outside the striatum, we saw group differences in cue-related activity in the right anterior insula, 
such that patients showed greater activation to money than no-money cues, while controls showed the 
opposite pattern.  The insula has been implicated in the detection of, and allocation of attention to, salient 
events (Menon and Uddin 2010), and has been shown to respond to unpleasant stimuli, including cues 
predicting negative (Jensen et al 2007) or low-expected-value (Rolls et al 2008b) outcomes.  This is 
consistent with the pattern seen in controls, where insula activation was strongest to the less-pleasant, 
less-frequent cue.  Patients, on the other hand, showed the opposite pattern, consistent with prior 
hypotheses (Kapur 2003) about an altered pattern of salience attribution in this group.  
 Receipt-related activation:  Patients and controls showed similar activation at the time of reward 
receipt.  A number of regions including bilateral caudate responded more strongly to money than no-
money receipt in both groups, suggesting that brain responses to reward receipt were largely intact in this 
sample of patients.  Similarly, we found greater responses to unexpected than expected outcomes in both 
groups in several regions of the cognitive control network (Cole and Schneider 2007), such as bilateral 
DLPFC, anterior insula, and posterior parietal cortex.  These findings suggest that expectancy violations 
resulted in the recruitment of cognitive control regions in both patients and controls.     
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The results reported here are compatible with some, but not all, aspects of the results reported by 
Morris et al (Morris et al 2012). Both studies showed globally intact responses to reward receipt vs. 
omission, with both patients and controls showing reward responses in regions such as midbrain, insula, 
cingulate, and inferior frontal cortex.  However, unlike Morris et al, we showed surprise responses in a 
number of cortical regions in both groups.  In addition, while Morris et al reported group differences in 
ventral striatal prediction error activity, we failed to identify any regions whose activity pattern resembled a 
prediction error signal. This result is not surprising given the design of the task, which was intended to 
examine reward anticipation and receipt, not prediction error signaling.  Because appreciable learning 
was not expected to occur and cue-outcome contingencies remained constant during the session, one 
would expect prediction error activity to be minimal.  
 Overall, our results demonstrate a pattern of largely intact responses to reward receipt throughout 
the brain at the group level among individuals with schizophrenia. The robust striatal responses to reward 
receipt among individuals with schizophrenia are consistent with recent studies demonstrating intact 
outcome responses in this region (Simon et al 2010; Waltz et al 2010). However, the pattern of intact 
cortical responses to reward receipt seen here contrasts with recent findings (Walter et al 2010; Walter et 
al 2009; Waltz et al 2010).  One possible source of this discrepancy is that the referenced studies used 
instrumental tasks, which may engage cortical structures upon reward receipt to a greater extent than 
Pavlovian paradigms due to the requirements for updating future action plans.  These results therefore 
suggest that responses to receipt of monetary reward per se may be intact in schizophrenia, and that 
reward processing deficits in this illness may therefore lie downstream in processes required to translate 
reward information into action plans.  This conclusion is consistent with a large body of data suggesting 
intact hedonic responses to pleasant stimuli in schizophrenia, despite clinically evident deficits in 
motivation (Kring and Moran 2008). It is also consistent with the view that motivational deficits in 
schizophrenia are related to deficits in value representation (Gold et al 2008).  In order to influence goal-
directed behavior, information about reward receipt must be integrated and represented in a way that 
makes it available to guide value-based decision-making.  Deficits in this process may not be evident 
during simple Pavlovian tasks, but may become evident in tasks where reward information must be used 
to guide future choices.  
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 Relationships to Anhedonia:  Correlation analyses revealed an inverse relationship between 
anticipatory activity in left ventral striatum and VMPFC and Chapman physical anhedonia scores in the 
patient group.  This relationship is consistent with the findings of several reward prediction studies in 
schizophrenia showing that higher negative symptoms, particularly anhedonia and avolition, are 
associated with reduced striatal responses to reward-predicting cues (Juckel et al 2006b; Simon et al 
2010).  Along with Waltz et al (Waltz et al 2009), we have shown that this relationship is present in 
Pavlovian paradigms, suggesting that patients who are higher in anhedonia/avolition have larger deficits 
in reward prediction processes even in the absence of response requirements.  Interestingly, the negative 
correlation seen in patients within the VMPFC region was also significant among controls, suggesting a 
relationship between activation to reward-predictive cues and individual differences in anhedonia 
irrespective of diagnosis.  Previous studies in the literature examining non-clinical samples have identified 
relationships between anhedonia severity and brain activity in similar regions.  Harvey et al (Harvey et al 
2010) showed a negative correlation between anhedonia severity and activation in a rostral anterior 
cingulate cortex (rACC) region that overlaps with the VMPFC region identified here, and EEG studies by 
Wacker et al (Wacker et al 2009) showed increased resting delta activity (i.e. decreased resting activity) 
in rACC among more severely anhedonic individuals.  These findings suggest that altered VMPFC activity 
is associated with anhedonia as a clinical dimension that is elevated in and associated with vulnerability 
to schizophrenia (Erlenmeyer-Kimling et al 1993; Kwapil 1998), but which crosses diagnostic boundaries. 
 We also observed relationships between anhedonia scores and activation at the time of receipt. 
In left frontal cortex, higher physical anhedonia was associated with decreased responses to 
nonrewarding outcomes.  Because this study did not have a punishment condition and nonreward may 
have been considered a negative outcome in this context, this relationship may perhaps be thought of as 
a blunted response to negative outcomes among the more severely anhedonic patients.  This finding is 
similar to past results, where anhedonia was found to relate to a reduced experience of both positive and 
of negative emotion (Dowd and Barch 2010). 
 When considering the relationships between anhedonia and brain activity in this study, it is worth 
noting that our sample had lower mean anhedonia scores than previous studies in the literature (Dowd 
and Barch 2010; Walter et al 2009).  Given the relationship found between physical anhedonia and 
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anticipatory activity in patients, it is possible that a sample of patients who were higher in anhedonia may 
have shown differences at the group level between patients and controls, and that differences in 
anhedonia severity between samples may underlie some of the discrepant findings in the literature.  
There is ample evidence from basic science research that hedonic experience and motivation are 
dissociable constructs subserved by different neurobiological systems (Berridge and Robinson 1998).  
However, the majority of clinical and self-report instruments available to assess anhedonia in 
schizophrenia, including the Chapman physical and social anhedonia scales used here, predate these 
findings and tend to contain items relevant to both constructs (Horan 2005).  Here, we used the Chapman 
scales because of their wide range, which is well-suited to correlation analyses, as well as their 
widespread use and demonstrated reliability in the schizophrenia literature. It is important to note, 
however, that the non-specificity of these scales means that the relationships seen here may be driven by 
deficits in motivated behavior rather than by deficits in the experience of pleasure per se, consistent with 
the idea that a reduced ability to anticipate rewards may contribute to deficits in goal-directed behavior.  
Future studies using new clinical instruments that carefully distinguish between hedonic and motivational 
deficits, such as the Clinical Assessment Interview for Negative Symptoms scale (Horan et al 2011), will 
be required to dissociate the relationships of these two constructs to reward processing in schizophrenia. 
 Limitations:  The passive task used in this study, while essential to address our experimental 
question about reward processing in the absence of response requirements, also confers an important 
limitation in that it did not allow the collection of behavioral data demonstrating attention to the task.  This 
raises the possibility that our failure to find striatal reward anticipation responses among controls may 
have been driven by lack of attention to the stimuli.  However, while we did not see significant differential 
responses between Money and No-money cues, we did see robust responses to cue presentation 
(irrespective of cue type) in regions including visual cortex, anterior insula, DLPFC, and posterior 
cingulate (figure S4). Further, we saw clear effects of money vs. no-money receipt in several brain 
regions within both groups, indicating that participants were attending to the outcome stimuli.  Finally, we 
saw differential responses to unexpected versus expected outcomes, suggesting that participants were 
attending to the cues, developing cue-based expectancies, and reacting to expectancy violations upon 
outcome presentation.  Together, we feel that these results provide reasonable evidence that participants 
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were indeed attending to the stimuli.  We acknowledge that the degree of attentional engagement here 
was likely less than that required by active tasks, which is an additional reason to speculate that the 
relative lack of differential cue-related activity may reflect a difference between the Pavlovian paradigm 
used here and instrumental paradigms in the literature.  An additional consequence of the passive task is 
that no behavioral measure of learning was available to determine whether stimulus-outcome 
associations were fully formed based on pre-scan instructions, or whether they were strengthened by 
experience during the early trials of the scan.  Given the simplicity of the task, we expected instructed 
learning to be sufficient to establish cue-outcome associations and in-scanner learning to be minimal.  
However, to examine whether our results may have been influenced by any learning that took place 
during early trials, we examined anticipatory activity in runs 2, 3, and 4 only, after participants had had an 
additional 16 trials of training during run 1.  This analysis did not reveal additional anticipatory activity or 
group differences in cue-related effects in striatum or other regions associated with reward processing.  
This suggests that although we are unable to assess the extent to which learning may have taken place 
in the scanner, it is not likely that additional pre-scan training would have resulted in stronger anticipation 
effects.   
Another important limitation of this study is that patients were taking antipsychotic medications 
that block dopamine receptors, potentially affecting reward-related brain activation. However, our 
medication analyses failed to reveal significant relationships between antipsychotic dose and anhedonia 
score or BOLD signal within the regions of interest. These analyses suggest that the results reported here 
are not likely to be accounted for by medication effects, although studies including unmedicated patients 
are required to fully appreciate the extent to which medication may influence the processes examined 
here.   
In sum, these findings suggest that while at the group level there were no differences between 
patients and controls in striatal activity during reward anticipation or receipt, those individuals with 
schizophrenia who were higher in anhedonia showed decreased striatal and VMPFC activity in 
anticipation of reward, even in the absence of requirements for response selection and execution.  This 
suggests that the process of reward prediction may be abnormal in those patients experiencing the most 
severe anhedonia and motivational deficits.  
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Supplementary Materials 
Regions of Interest 
Figure S1: Regions of interest mask used in voxelwise ROI analyses: 
 
 
Movement analysis 
Four patients and two controls were excluded from analysis for excessive movement and/or low signal-to-
noise ratio (SNR). Mean incremental (frame-to-frame) movement was computed for each run for each 
subject and used to compare movement between groups. SNR was computed by determining the ratio of 
the mean signal intensity to its standard deviation for each frame within each run, and mean SNR values 
were then calculated for each participant.  For the final sample of 25 patients and 20 controls, mean SNR 
and incremental movement for each translation axis (x, y, z) and rotation axis (pitch, roll, yaw), as well as 
group t-tests results for each, are summarized in Table S1. The groups differed significantly only in 
movements along the y axis.  Further, neither SNR nor movement along any axis correlated significantly 
with Chapman physical or social anhedonia score in patients.  Together, these results indicate that the 
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groups were well matched for signal quality and that poor signal quality in patients is unlikely to contribute 
to the group or correlation results reported here.   
 
Table S1. Incremental movement and signal-to-noise ratio 
  Control Schizophrenia   
  Mean SE Mean SE p 
x 0.028 0.003 0.029 0.005 0.766 
y 0.063 0.008 0.094 0.012 0.062 
z 0.063 0.008 0.085 0.013 0.182 
pitch 0.055 0.006 0.067 0.008 0.243 
roll 0.024 0.002 0.029 0.003 0.212 
yaw 0.021 0.002 0.026 0.004 0.333 
SNR 276.34 72.83 277.90 76.11 0.945 
SE, standard error; SNR, Signal-to-noise ratio 
* represents p < .05 
 
Cue-Related activity: Striatal ROI analyses 
 
Figure S2: Caudate, Putamen, and Nucleus Accumbens ROIs used in mean-activation ROI analyses 
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Receipt-related activity: Post-hoc analyses for regions displaying CueXReceipt interactions 
Table S2: Paired t-tests for unexpected versus expected rewards and non-rewards within patient and control groups 
 
Unexpected vs Expected Non-reward
CON (p) SCZ (p) CON (p) SCZ (p) CON (p) SCZ (p)
L VLPFC 47 -44, +22, -6 20 0.00072 0.032 0.0017 0.22 0.53 0.0073
R Anterior Insula 13 +34, +17, +4 57 0.0019 0.0049 0.1 0.4 0.0027 0.0004
L Anterior Insula 13 -34, +16, +4 60 0.0048 0.014 0.073 0.55 0.014 0.001
R Anterior Insula 13/45 +41, +21, +4 208 0.0015 0.0011 0.062 0.044 0.0084 0.00072
L Anterior Insula 13/45 -40, +17, +0 89 0.0007 0.0082 0.015 0.62 0.012 0.00023
L Superior frontal Gyrus 9 -31, +47, +28 26 0.0051 0.0028 0.038 0.0065 0.037 0.047
L Posterior Cingulate 43 -1, -31, +26 25 0.0073 0.035 0.08 0.13 0.01 0.05
R Middle Frontal Gyrus 6 +42, +11, +42 137 0.012 0.000097 0.078 0.0096 0.18 0.0016
L Middle Frontal Gyrus 9 -44, +19, +32 18 0.011 0.0036 0.06 0.083 0.057 0.03
L Middle Frontal Gyrus 6 -39, +4, +34 14 0.0025 0.015 0.1 0.037 0.07 0.12
R Inferior Parietal Lobule 40 +44, -52, +40 151 0.035 0.000091 0.46 0.066 0.026 0.000045
L Inferior Parietal Lobule 7 -39, -60, +42 139 0.024 0.00018 0.26 0.0051 0.028 0.0065
L Superior Frontal Gyrus 8 -1, +20, +48 67 0.0017 0.0064 0.03 0.72 0.026 0.0014
Unexpected vs Expected Reward
Paired t-tests
Unexpected vs Expected Outcomes
Brodmann 
Area
Talairach 
Coordinates
# 
VoxelsBrain Region
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Figure S3: Receipt-related activation magnitudes for Left VLPFC  
 
 
 
Figure S4: Cue-related activation for both cue types combined (money and no-money) across both 
groups.  Color scale represents Z value. 
 
Example Timecourses 
 
Figure S5: Example timecourses across both Cue and Receipt for a right caudate region showing a main 
effect of receipt. 
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Chapter 4. 
 
 
Probabilistic Reinforcement Learning in Schizophrenia 
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Introduction: 
 
As discussed in Chapter 1, reinforcement learning (RL), the process by which actions that result 
in rewarding outcomes are strengthened and those that do not are suppressed, is an essential 
component of the translation of reward information into goal-directed behavior. Converging data from 
electrophysiology, neuroimaging, and computational modeling implicates the mesolimbic and nigrostriatal 
dopamine systems in RL, suggesting that these systems code reward prediction errors that gradually 
integrate outcomes over several trials (O'Doherty et al 2003b; Schultz et al 1997). This process is formally 
described by computational RL algorithms, which may be used to make predictions about data in 
neurophysiology and neuroimaging studies.  
In addition to abstract RL algorithms, which describe information processing from a machine 
learning standpoint and do not make assumptions about physiology, several anatomically constrained 
neural network models have also been developed to describe the role of DA in RL (Cohen and Frank 
2009). One such model (Frank et al 2004) emphasizes the separate contributions of D1Rs and D2Rs in 
the striatum to Go and NoGo learning. This model is founded upon the anatomy of the antagonistic 
“direct” and “indirect” pathways of the basal ganglia (Figure 1). Phasic dopaminergic activity in the 
substantia nigra pars compacta (SNc) can modulate activity in “Go” cells via D1Rs, which have excitatory 
effects, and in “NoGo” cells via D2Rs, which have inhibitory effects. When an action results in a positive 
prediction error, bursts of DA from SNc enhance direct pathway activity and inhibit indirect pathway 
activity, thereby driving long-term potentiation in the corticostriatal circuit and enhancing the 
representation of the chosen action in frontal cortex. Conversely, when a chosen action results in a 
negative prediction error, the resulting decrease in SNc dopaminergic activity inactivates the direct 
pathway and activates the indirect pathway, suppressing corticostriatal activity and weakening the cortical 
representation of the chosen response. In this way, associations between the stimuli and actions leading 
to positive outcomes are strengthened, while associations with actions leading to negative outcomes are 
weakened. 
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 The Frank model makes specific predictions about the effects of perturbations in dopaminergic 
function on RL, several of which have garnered empirical support. For example, the model predicts that 
Parkinson’s Disease patients taking L-DOPA will show enhanced positive RL and impaired negative RL 
as compared to unmedicated patients because greater dopamine availability should increase the efficacy 
of phasic firing, but decrease sensitivity to transient decreases in firing. Behavioral data from a 
probabilistic RL task allowing the separate assessment of learning from positive and negative outcomes 
supported both predictions (Frank et al 2004): while controls learned equally well from both positive and 
negative outcomes, there was a crossover effect in patients where medicated patients showed enhanced 
Go learning and impaired NoGo learning, while unmedicated patients showed impaired Go learning and 
enhanced NoGo learning. An analogous crossover effect was seen in a pharmacological study of healthy 
adults given a D2R agonist or antagonist (Frank and O'Reilly R 2006). Finally, a behavioral genetics study 
found that a polymorphism in the DARPP-32 protein, associated with striatal D1R function, was shown to 
modulate positive RL, while a polymorphism in the DRD2 gene, which affects postsynaptic D2R density in 
the striatum, modulated negative RL (Frank et al 2007). This data showing that the Frank model has 
made specific and supported predictions about RL in several cases of altered DA function makes it an 
ideal framework within which to examine RL in schizophrenia, which is associated with DA dysregulation 
(Goto and Grace 2007; Guillin et al 2007; Howes et al 2009).  
 Two studies using different tasks have examined Go and NoGo learning in medicated patients with 
schizophrenia (Waltz et al 2007), and found evidence of impaired Go learning but intact NoGo learning. 
The first study used a probabilistic stimulus selection task with transfer measures sensitive to Go vs 
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NoGo learning, on which patients demonstrated reduced performance on the Go learning measure, but 
not the NoGo learning measure. The second study obtained similar results, and also used the Frank 
neural network model of Go and NoGo learning to simulate behavior on the task. This simulation showed 
that modeling an increase in tonic dopamine coupled with a decrease in phasic dopamine, alterations 
consistent with current evidence about dopaminergic dysfunction in schizophrenia, reproduced the 
behavior seen in the patient group.  These findings are consistent with the hypothesis that the 
effectiveness of phasic dopamine signals in response to positive feedback is reduced in schizophrenia, 
thereby impairing Go learning.   
 In addition to examining gradual basal ganglia-mediated learning, these studies also examined 
measures of win-stay/lose-shift activity during early learning, an indication of explicit learning thought to 
rely on PFC function.  Both studies revealed decreases in this behavior, consistent with the hypothesis 
discussed in Chapter 1 that cortical explicit learning is more impaired in schizophrenia than gradual 
striatal-based learning.  Importantly, in the studies discussed above, negative symptom severity 
correlated with decreases in early performance or win-stay/lose-shift behavior, but not with indicators of 
Go and NoGo learning impairment, suggesting that negative symptoms may be related to impairments in 
cortical rather than striatal learning.  Further supporting this hypothesis are results from a recent study 
using two computational models, an actor-critic model thought to simulate striatal learning and a mixed 
actor-critic/Q-learning model thought to simulate learning from both striatal and cortical mechanisms.  In 
this study, the behavior of patients who were high in negative symptoms was reproduced by the actor-
critic model, while controls and patients with less severe negative symptoms were better described by the 
hybrid model.  These results again suggest that impairments in cortical explicit learning may be related to 
negative symptoms in schizophrenia.   
 As discussed in Chapter 1, studies examining reinforcement learning in schizophrenia have revealed 
evidence for reduced striatal prediction error signaling, particularly for positive prediction errors (Gradin et 
al 2011; Morris et al 2012; Murray et al 2008; Waltz et al 2009), although normal striatal responses have 
also been reported (Walter et al 2009). However, these studies had a different emphasis than ours here, 
which was to probe striatal responses to determine whether they behaved consistently with prediction 
errors, not to understand the contribution of these prediction errors to learning.  To this end, these studies 
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relied on simple associative learning tasks that minimized performance differences between patients and 
controls. In some cases, learning took place before the scan session began (Morris et al 2012; Waltz et al 
2009), effectively probing prediction errors during reward-prediction rather than during reinforcement 
learning. While prediction errors, reward prediction, and reinforcement learning are all intimately related, 
we wished to determine whether any reductions in striatal prediction errors were associated with 
reinforcement learning impairments, especially in learning from positive outcomes, among individuals with 
schizophrenia.  We also examined cortical activity during learning to determine whether impairments in 
striatal or cortical learning systems are impaired in schizophrenia, and whether these impairments are 
associated with anhedonia/avolition. 
 
Methods and Materials 
Participants: Participants were 49 stable outpatients with DSM-IV schizophrenia or 
schizoaffective disorder and 41 healthy controls with no personal or family history of psychosis.  Both 
medicated and unmedicated patients were recruited from the community, and medication status and dose 
was required to have been stable for at least two weeks. Participants were group matched on sex, age, 
race, parental education, handedness (Oldfield 1971), and smoking status. Inclusion criteria were 1) age 
18-50 years and 2) ability to give informed consent. Exclusion criteria were 1) DSM-IV substance abuse 
within the past year, or substance dependence within the past 2 years (except nicotine); 2) DSM-IV major 
depressive disorder or dysthymia in the past year; 3) any unstable or severe medical disorder; 4) past 
head injury with neurological sequelae and/or loss of consciousness; 5) DSM-IV mental retardation, and 
6) any contraindication to MRI including pregnancy, claustrophobia, any metallic object in the body, 
history of heart rhythm abnormalities, and presence of a heart pacemaker.  After undergoing the MRI 
protocol, 10 individuals with schizophrenia and 4 healthy controls were excluded for excessive movement 
(described below), and an additional patient was excluded for having more than 50% nonresponse trials, 
yielding a final sample size of 37 controls and 38 patients (35 medicated, 3 unmedicated). This study was 
conducted in accord with APA standards for ethical treatment of human subjects. Written informed 
consent was obtained from all participants, and all procedures were approved by the Washington 
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University Human Research Protection Office. Participants were compensated for their time at a rate of 
$25 per hour, plus an extra $20 in reward money. 
Diagnosis and clinical assessment:  Participant diagnoses were based on a Structured Clinical 
Interview for DSM-IV-TR (First et al 2001) conducted by a Masters-level clinician. Clinical symptoms were 
rated using the Scales for the Assessment of Positive Symptoms (SAPS) (Andreasen 1983b) and 
Negative Symptoms (SANS) (Andreasen 1983a), which were summarized using the following symptom 
domain scores (Andreasen et al 1995): 1) positive symptoms – hallucinations and delusions; 2) negative 
symptoms – alogia, anhedonia, avolition, affective flattening and attentional impairment; and 3) 
disorganization – bizarre behavior, positive thought disorder, and inappropriate affect.   Clinician-rated 
symptoms of anhedonia and avolition were assessed with the SANS and the Brief Negative Symptom 
Scale (BNSS) (Kirkpatrick et al 2011).  Given that anhedonia and avolition scores derived from the SANS 
correlate significantly with those derived from the BNSS, and that anhedonia and avolition scores load 
onto a single factor in both scales (Kirkpatrick et al 2011), we created a single score for clinician-rated 
symptoms of anhedonia and avolition by Z-scoring and summing across measures.  Anhedonia and 
avolition were also assessed using the following self-report questionnaires, administered on a computer: 
The Revised Chapman Physical and Social Anhedonia Scales (Chapman and Chapman 1978; Chapman 
et al 1976), the Temporal Experience of Pleasure Scale (Gard et al 2007), the Snaith-Hamilton Pleasure 
Scale (Snaith et al 1995), and the Apathy Scale (Starkstein et al 1992), which were Z-scored and 
summed to create a composite measure of self-reported anhedonia/avolition.  In addition the Wechsler 
Test of Adult Reading was administered as an estimate of premorbid IQ, and the Matrix Reasoning 
subtest of the Wechsler Adult Intelligence Test – III was administered as an estimate of current cognitive 
ability.  Participants were required to pass a urine drug screen and breathalyzer test at the start of each 
session. 
Materials and Tasks:  The experimental paradigm was a modified version of the Probabilistic Stimulus 
Selection Task developed by Frank and colleagues (Figure 2) (Frank et al 2004). The task consisted of 
an acquisition phase, during which fMRI scanning took place, and a test phase that was completed 
outside the scanner. Stimuli consisted of grayscale drawings from the revised Snodgrass and Vanderwart 
object pictorial set (Rossion and Pourtois 2004), matched for luminance and contrast, visual complexity, 
  82 
and object familiarity. Object-condition mappings were counterbalanced across subjects. During the 
acquisition phase, participants were presented on each trial with one of three pairs of stimuli (“AB”, “CD”, 
or “EF”), presented in pseudorandomized order, and were instructed to choose the stimulus in each pair 
that they find to be more often rewarded. Stimuli were displayed for 2000ms, during which the participant 
was required to choose one of the stimuli via button press. After a jittered inter-stimulus interval ranging 
from 2000-6000ms, feedback consisting of the words “Correct! +$” in green text, “Incorrect $0” in red text, 
or “Too Slow!” in red text were presented on screen for 2000ms. Subjects were told that for each 
“Correct” choice, they would win some extra money, with a total of up to $20 available to be won (in 
actuality, all subjects were paid an additional $20 upon completion).  For stimulus pair AB, choice of A 
was rewarded 80% of the time, while B was rewarded 20% of the time; pair CD was 70:30, and pair EF 
was 60:40. Feedback was followed by an inter-trial interval jittered from 2000-6000ms. The stimuli were 
presented in 10 blocks of 36 trials (12 per stimulus pair), after which the test phase was administered 
outside the scanner. In this phase, the three original stimulus pairs were presented, along with 12 novel 
pairs in which the 3 original pairs were recombined. Each pair was presented 10 times, and participants 
were asked to choose the more frequently rewarded member of each pair based on the knowledge 
acquired earlier. No feedback was given at this stage.  Trials were separated with 1000ms crosshairs 
triggered upon response, and no time limit was imposed on test-phase responses.  As in previous studies 
using this task (Frank et al 2004), the recombined pairs from the test phase were used to calculate 
transfer measures indicative of learning from positive versus negative outcomes.  Because A was the 
most highly reinforced stimulus during training, a “ChooseA” measure created by averaging performance 
on all novel pairs including A was used to indicate Go learning, and an analogous “AvoidB” measure to 
index NoGo learning. 
 Given pilot data indicating that individuals with schizophrenia had more difficulty understanding 
the task than controls, patients underwent a training session within the week prior to scanning where they 
completed 360 task trials with different stimuli.  Both groups also completed a 12-trial practice session 
immediately before scanning.    
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 Image Acquisition and Processing: Imaging data was acquired on a 3T Siemens TIM TRIO 
system with a 12-channel head coil. High-resolution structural images were acquired using a sagittal 
magnetization-prepared rapid acquisition gradient echo (MP-RAGE) sequence (TR = 2.4s, TE = 3.08ms, 
inversion time = 1s, flip angle = 8°, 176 slices, 1 mm3 voxels).  Functional images were collected in 10 
runs of 213 frames each using a gradient echo echo-planar sequence (TR=2030ms, TE=27ms, flip=90°, 
36 slices). Functional runs acquired axial images parallel to the anterior-posterior commissure plane with 
4mm3 isotopic voxels. Stimuli were presented using E-prime 2.0, with each trial onset triggered directly by 
a pulse from the scanner. The MR data was normalized across runs by scaling whole-brain signal 
intensity to a fixed value and removing the linear slope on a voxel-by-voxel basis to counteract effects of 
drift (Bandettini et al 1993). The MR data was then aligned to correct for head motion using rigid-body 
rotation and translation correction algorithms (Friston et al 1994; Snyder 1996; Woods et al 1992), which 
provide estimated absolute and frame-by-frame movement parameters used to evaluate movement 
differences between groups. We also compared mean voxelwise standard deviation values between 
groups (Table S1), and removed participants with movement or SD values not meeting predetermined 
criteria. The images were then resampled into 3mm3 voxels, registered to Talairach space using 12-
parameter affine transformations, and smoothed with a 6mm FWHM Gaussian filter.  
 fMRI analysis: Statistical analysis of fMRI data was conducted based on the general linear model 
(GLM) (Friston et al 1995) using in-house software as described in (Miezin et al 2000).  The general linear 
model for each subject included time as a 9-level regressor, made up of the 9 MR frames following each 
event. Response magnitude was therefore estimated at each time point separately, without assuming a 
specific shape for the hemodynamic response. Activation at the time of stimulus presentation and at the 
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time of feedback were modeled separately. At the time of stimulus presentation, 6 choice types were 
modeled (A, B, C, D, E, and F), and at the time of feedback, 12 feedback types were modeled (positive 
and negative feedback for each choice).  Non-response trials were coded as a variable of no interest, and 
nuisance regressors for linear trends within runs and baseline shifts between runs were also included.  
Given that the choices for several subjects were not variable enough to code all event types, we also 
conducted a separate analysis in which all three stimulus pairs were combined.  This analysis included 
only two choice types (high-probability (A/C/E), low-probability (B/D/F) and four feedback types 
(ACE/positive, ACE/negative, BDF/positive, BDF /negative). The parameter estimates from the GLMs for 
each subject, including time (the 9 time points of the response), were entered into ANOVAs using subject 
as a random factor. A significant main effect of time for a voxel or region indicates activation or 
deactivation, and a significant interaction of any other factor with time indicates that the hemodynamic 
response varies across that factor.   
Activation at the time of stimulus presentation was evaluated using a repeated measures ANOVA 
with choice type (ACE/BDF) and time (1-9) within-subjects factors and group (schizophrenia, control) as a 
between subjects factor. Feedback-related activity was examined using a repeated measures ANOVA 
with choice type, feedback type (positive, negative), and time as within-subjects factors and group as a 
between subjects factor. Choice type was included as a factor in analyses of receipt in order to evaluate 
potential prediction error effects, which would be expected to modulate responses to receipt according to 
whether the outcome was expected or unexpected. These ANOVAs were used in voxelwise whole-brain 
and regionwise ROI analyses. Whole-brain analyses were corrected for multiple comparisons using a p-
value/cluster size threshold of p<.003 (two-tailed) and 13 voxels, as determined by Monte Carlo 
simulations to provide a whole-brain false-positive rate of p<.05 (Forman et al 1995; McAvoy et al 2001). 
All regions demonstrating significant effects in whole-brain analyses were followed up with appropriate 
post-hoc tests conducted on the mean activation within the region.  In addition, only regions 
demonstrating a significant main effect of time were reported. ROI analyses were conducted using mean 
activation within regions including bilateral caudate, putamen, and nucleus accumbens.  These regions 
were defined anatomically (Mamah et al 2007) and were applied at the group level in Talairach atlas 
space.  Significance levels in ROI analyses were False Discovery Rate corrected for multiple 
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comparisons using the Benjamini-Hochberg procedure (Benjamini and Hochberg 1995) to yield an alpha 
of .05 across all 6 regions. 
  We also conducted correlation analyses within the patient group between BOLD signal and 
anhedonia/avolition scores.  In these analyses, activation at time points 4 and 5 (the peak of the 
hemodynamic response) was averaged and correlated with clinical and questionnaire-based 
anhedonia/avolition scores. Correlations were conducted for A/C/E choice events and for positive 
feedback events. These correlations were conducted using the same voxelwise whole-brain and 
regionwise ROI procedures described above. To explore whether these relationships were unique to the 
patient group, regions demonstrating significant correlations were also examined within the control group.   
 Model-based analyses.  Behavioral data was modeled using a Q-learning algorithm with separate 
learning rates from positive feedback (“gains”; !!) and negative feedback (“losses”, !!) (Frank et al 
2007).   This algorithm models subjects’ choices by calculating a Q value, which is an estimate of 
expected reward value, for each stimulus (A-F).  This value is modified on each trial according to the 
reward!! !  received, where ! ! ! ! for positive feedback and ! ! ! ! for negative feedback. Expected 
value for stimulus ! on trial ! ! ! is calculated as follows: !! ! ! ! ! !!! ! !! ! ! ! ! !! ! ! !!! ! ! ! !! ! ! 
where ! ! ! !! !  , the reward received minus the reward expected, represents prediction error. In 
other words, the expected value for a given stimulus on a given trial is equal to its expected value on the 
previous trial plus an adjustment factor equal to prediction error times learning rate. Positive prediction 
errors (rewards that are higher than expected) are multiplied by the gain learning rate, and negative 
prediction errors (rewards that are lower than expected) are multiplied by the loss learning rate.  Learning 
rates reflect the degree to which Q values are affected by reinforcement outcomes, with higher learning 
rates associated with larger changes in Q value on each trial.  Action selection was modeled using a 
softmax logistic function, a standard stochastic decision rule that calculates the probability of choosing 
one stimulus over another given the expected reward values of both options: 
!! ! ! ! !!! !!!!! !! ! !!! !!  
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where ! is an inverse gain parameter and reflects the participant’s tendency to exploit (stick with 
responses that have yielded reward in the past) vs explore (try out different choices to determine whether 
a more rewarding option is available).  The model was fit to each subject’s trial-by-trial choices by 
adjusting the three free parameters (!!,! !,and !) to maximize the log likelihood estimate (LLE): !!" ! !"#!! !!!!!!!  
This was accomplished by incrementing each of the parameters from 0.01 to 1 by 0.03 and selecting the 
combination of parameters that maximized LLE (i.e. that best predicted the actual choices made by the 
subject on a trial-by-trial basis).  Model fits for each subject were characterized using LLE values as well 
as Bayesian Information Criterion (BIC) (Schwarz 1978), which penalizes for the number of free 
parameters used to protect against overfitting. 
 Model-based fMRI analyses were conducted by including trial-by-trial values of Q and prediction 
error as parametric regressors in the general linear model. The Q value of the chosen stimulus was 
included as a regressor at the time of choice, and prediction error was coded at the time of feedback.  In 
the first analysis, positive and negative prediction errors were included in one regressor for signed 
prediction error; in a second analysis, positive and negative prediction errors were coded separately.  As 
described above, a regressor for time was also included in these GLMs, and regions displaying significant 
effects of the parametric regressors were identified using whole-brain and ROI-level ANOVA analyses 
including time as a factor.  
 
Results 
 
Demographic and Clinical Characteristics 
 Participant demographic and clinical characteristics are shown in Table 1.  There were no 
significant differences between patients and controls in age, sex, race, or handedness.  Personal 
education was higher among controls than patients, an expected finding given the effects of 
schizophrenia on function, but parental education (a surrogate for premorbid socioeconomic status) was 
similar between groups. Smoking status also did not differ significantly between groups, both in terms of 
the number of participants who smoke, and the Fagerstrom nicotine dependence scores among smokers.  
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SANS scores for positive and negative symptoms were higher among patients than controls, though 
disorganization scores were low in patients and did not differ between groups.  Anhedonia and avolition 
scores were higher among patients than controls on all clinical and self-report measures except the TEPS 
anticipatory pleasure score.  All but three patients were taking antipsychotic medications, which were 
primarily atypical antipsychotics, and a number of patients were taking additional medications including 
antidepressants, mood stabilizers, anxiolytics, and anticholinergics.  Two controls and seven patients had 
a lifetime history of Major Depressive Disorder, and two controls and seven patients had a lifetime history 
of substance abuse/dependence. 
 
Table 1: Clinical and Demographic Characteristics 
  Mean (SD) 
  CON SCZ 
N 37 38 
Age 36.43(8.44) 35.00(9.25) 
Education (years) 14.14(2.10) 12.95(2.29)* 
Highest Parental Education (years) 13.78 (1.64) 18.84 (3.43) 
Sex (% Male) 43.2 63.2 
Race (% Caucasian) 29.7 42.1 
Smoking Status (% Smokers) 43.2 57.9 
FagerstromTest for Nicotine Dependence 7.4(5.488) 9.21(4.023) 
Handedness 4.31(0.95) 4.97(0.19) 
SAPS/SANS Positive 0.03(0.16) 3.5(2.64) * 
SAPS/SANS Negative 1.49(2.09) 7.92(2.97) * 
SAPS/SANS Disorganization 2.38(1.30) 2.63(2.65) 
BNSS Total Anhedonia 0.68(2.15) 1.05(1.91) * 
BNSS Total Avolition 5.76(3.48) 5.38(2.44) * 
Chapman Social Anhedonia 8.92(6.26) 15.39(7.98) * 
Chapman Physical Anhedonia 11.78(6.12) 18.53(10.13) * 
Snaith-Hamilton Pleasure Scale 52.38(3.21) 48.45(8.21) * 
TEPS Anticipatory Pleasure 48.22(5.69) 46.05(8.31) 
TEPS Consummatory Pleasure 38.41(5.64) 35.03(7.37) * 
Apathy Scale 22.19(3.57) 26.11(7.26) * 
Past Major Depressive Disorder (#) 2 7 
Past Substance Dependence (#) 2 7 
Antipsychotic Medication (# Taking) - 35 
Typical Only - 4 
Atypical Only - 29 
Typical + Atypical - 2 
Clozapine Only - 2 
Clozapine + Other - 3 
Antipsychotic Dose (CPZ equivalent) - 717.78(474.25) 
Antidepressant Medication (# Taking) - 17 
Antianxiety Medication (# Taking) - 6 
Mood Stabilizer Medication (# Taking) - 9 
Anticholinergic Medication (# Taking) - 12 
*p < .05; CON = control, SCZ = schizophrenia, SD = standard deviation; SAPS/SANS = Scale for the Assessment of 
Positive/Negative Symptoms; BNSS =Brief Negative Symptom Scale; TEPS = Temporal Experience of Pleasure Scale; CPZ = 
Chlorpromazine 
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 Ten individuals with schizophrenia and 4 healthy controls were excluded for movement that 
exceeded a predetermined criterion (mean voxelwise standard deviation values of 20 for 4 or more BOLD 
runs).  In addition, one patient chose to end the experiment early and did not complete the final BOLD run 
or the test phase.  Data for absolute movement, frame-by-frame movement, and mean voxelwise 
standard deviation for the remaining 38 patients and 37 controls is shown in Table S1.  Repeated-
measures ANOVAs with BOLD run (1-10) as a within-subjects factor and Group (CON, SCZ) as a 
between-subjects factor revealed no significant main effects of group or BOLD run X group interactions 
for any of the three measures (all p values > .27), indicating that movement did not differ between 
patients and controls.  However, there was a main effect of BOLD run in all three measures (absolute: 
F(9,648)=2.97,p< .02; frame-by-frame: F(9,648)=3.20, p<.002; SD: F(9,648)=6.42, p<.001), indicating 
that movement increased significantly over time in both groups. 
 
Behavioral Analysis 
 Acquisition Phase:  Choice behavior during the acquisition phase was analyzed by calculating the 
proportion of trials in which participants chose the more frequently rewarded stimulus (A, C, or E) over the 
less-frequently rewarded stimulus (B, D, or F).  To examine how this proportion changed over the course 
of learning, the acquisition phase was divided into 5 blocks of 72 trials each (24 trials per stimulus pair), 
which were used in a repeated measures ANOVA with Block (1-5) and Pair (AB, CD, EF) as within-
subjects factors and Group (CON, SCZ) as a between-subjects factor.  This analysis revealed significant 
main effects of Block (F(4,292) = 8.74, p<.001), with increasing proportions of high-probability choices 
over time, and Pair (F(2,146) = 22.00, p<.001), with the greatest proportion of high-probability choices for 
AB pairs, followed by CD, then EF.  The main effect of group was not significant, nor were any 
interactions (p values > .1).  However, post-hoc simple effects tests revealed trend-level group differences 
within the AB (F(1,73) = 3.45, p < .07 and EF (F(1,73) = 3.22, p<.08) pairs, but not the CD pair (p>.8).  As 
shown in Figure 3a, performance for the CD pair is similar between patients and controls, whereas 
patients performed more poorly than controls on the AB and EF pairs.  
Test Phase: Test phase choice data is shown in Figure 3b.  For the original AB, CD, and EF pairs 
that had been presented during acquisition, a Pair X Group ANOVA revealed a main effect of pair 
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(F(2,144) = 13.81, p < .001), but no main effect of group (F(1,72) = 2.67, p > .1) or Pair X Group 
interaction (F(2,144) = 0.86, p > .42).  However, post-hoc simple effects tests revealed a significant group 
difference for the AB pair only (F(1,72) = 4.44, p < .04), in which patients performed more poorly than 
controls.  Performance on the CD and EF pairs did not differ significantly between groups.  In order to 
examine whether learning from positive versus negative feedback differed between groups, we compared 
ChooseA and AvoidB measures derived from test phase performance.  The ChooseA measure was 
created by averaging performance on test phase trials in which stimulus A was presented in a novel 
pairing against a less frequently reinforced stimulus  (AC, AD, AE, AF).  Similarly, the AvoidB measure 
(BC, BD, BE, BF) was created as an index of learning from negative outcomes.  Performance on these 
transfer measures was compared using a repeated measures ANOVA with ChooseA vs AvoidB as a 
within-subjects factor and Group as a between subjects factor, which revealed a trend-level main effect of 
Group (F(1.72) = 3.61, p <.07), but no main effect of or interaction with the ChooseA vs Avoid B factor.  
As shown in Figure 3b, individuals with schizophrenia performed more poorly than controls on both the 
ChooseA and AvoidB measures.  However, it is important to note that while the ChooseA/AvoidB 
measure has been the transfer measure of interest in previously published versions of this task, the 
appropriateness of this measure in this sample is called into question by the fact that patients performed 
more poorly on the AB pair than controls.  This raises the possibility that the sensitivity of transfer 
measures relying on this pair to pick up any bias toward choosing A or avoiding B is reduced in the 
patient group.  To avoid this problem, an equivalent transfer measure was created that relies on the CD 
pair, performance on which was very closely matched between groups: ChooseC (CE, CF) vs. AvoidD 
(DE, DF).  ANOVA analysis of this measure revealed a significant ChooseC/AvoidD X Group interaction 
(F(1,72) = 5.21, p< .03), with no significant main effects (p values > .2).  As shown in Figure 3b, ChooseC 
performance was significantly lower in patients than controls (t(72) = 2.40, p <.02), while performance on 
the AvoidD measure did not differ significantly between groups (p>.5).  
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Figure 3: Behavioral results. (A) Acquisition phase performance. Proportion of high-probability choices 
(A/C/E) per 24-trial block. (B) Test-phase performance for original AB, CD, and EF pairs, and 
ChooseA/AvoidB and ChooseC/AvoidD transfer measures. 
 
 
 
Modeling Results: As an additional measure of positive versus negative learning, a Q-learning 
algorithm with separate estimates of positive and negative learning rate was fit to the behavioral data for 
each subject.  Model fits as demonstrated by LLH and BIC values (in which smaller numbers indicate 
better fit) did not differ significantly between groups, as shown in Table 2.  However, there were a number 
of subjects in both groups who showed no appreciable learning during the task. Model fits for these 
subjects were poor, in many cases demonstrating BIC values that exceeded the null BIC associated with 
chance.  In order to restrict the modeling analysis to those subjects whose choices were well-described 
by the model, a subset of “nonlearners” was excluded.  This group was defined as those participants who 
failed to perform significantly above chance on the AB pair during the second half of the acquisition 
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phase, and consisted of 11 patients and 10 controls.  Model fits remained similar between patients and 
controls after exclusion of nonlearners (Table 2). 
 
    Table 2: Model Fit Data 
Sample Criterion CON SCZ 
Full Sample LLH -173.13 (57.56) -184.68 (52.90) 
(38 CON, 37 SCZ) BIC 363.83 (115.13) 386.89 (105.85) 
Learners Only LLH -154.6 (52.98) -171.62 (53.78) 
(28 CON, 26 SCZ) BIC 326.78 (105.96) 360.83 (107.55) 
LLH = Log likelihood; BIC = Bayesian Information Criterion 
 
 
To compare learning rates from positive and negative feedback between groups, fitted learning 
rate parameters were compared in a Learning Rate (Gain, Loss) X Group ANOVA.  As shown in figure 
4a, the pattern seen for gain and loss learning rates is similar to that seen for the ChooseC and AvoidD 
transfer measures, which index learning from gain and loss respectively.  However, the learning rate 
ANOVA failed to reveal a significant learning rate X group interaction (F(1,52) = 1.24, p>.2) or significant 
main effects of learning rate or group (p values > .3).  Of note, there were 3 outliers in the patient group, 
the removal of which yielded a trend-level main effect of group (F(1,49) = 3.15, p<.09) and a post-hoc 
group difference in Gain learning rate (t(49) = 2.09, p<.05).  Given that gain learning rate and the 
ChooseC transfer measure both index a tendency to learn from positive outcomes, we expected a 
positive correlation between these two measures; analogously, we also expected a positive relationship 
between loss learning rate and AvoidD because both of these measures index learning from negative 
outcomes.  Partial correlations controlling for group revealed a significant positive relationship between 
ChooseC and gain learning rate (r(50)=.333, p<.02; see figure 3b), but not between AvoidD and loss 
learning rate (p>.9).  To test the specificity of the relationship between gain learning rate and ChooseC, 
we also correlated ChooseC with loss learning rate and AvoidD with gain learning rate.  Neither 
correlation was significant (p values > .4). 
 
Figure 4: Model parameter comparisons.  (A) Gain and loss learning rates for patients and controls. (B) 
Correlations between gain learning rate and ChooseC transfer measure among patients and controls. 
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Strategy Analysis:  Previous studies of reinforcement learning in schizophrenia have revealed 
that patients often rely on explicit strategies during early learning to a lesser extent than controls (Gold et 
al 2008).  To examine this possibility, we examined use of Win-Stay/Lose-Shift strategy among patients 
and controls during the first 4 acquisition runs (48 trials per pair).  This was accomplished by calculating 
the proportion of Wins (positive feedback) that were followed by Stays (choosing the same stimulus again 
the next time the same pair was presented) and the percentage of losses (negative feedback) that were 
followed by shifts (choosing the opposite stimulus the next time the pair was presented).  Independent 
samples t-tests revealed a significant difference in win-stay proportion (t(73) = 2.08, p<.05), in which 
patients showed a lower proportion of stays after wins than controls (Figure 5).  Lose-shift proportion did 
not differ between groups (p>.3).  In order to examine whether the difference in win-shift activity was 
related to a more general tendency among patients to shift more often regardless of feedback, we also 
examined the total proportion of stays versus shifts.  An independent samples t test was significant at a 
trend level (t(73)=1.71, p<.1), with patients staying less often (and therefore shifting more often) overall 
than controls.  Similar results were obtained when the analysis was restricted to the first 2 acquisition 
runs. 
 
Figure 5: Win-Stay/Lose-Shift strategy use during the first four learning blocks in patients and controls.  
WinStay: the proportion of wins that were followed by stays; LoseShift: the proportion of losses that were 
followed by shifts; Stay: the total percentage of stays. 
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Individual Differences Analyses:  We had hypothesized that clinical symptoms of 
anhedonia/amotivation would be related to a reduced ability to learn from positive outcomes in individuals 
with schizophrenia.  To examine this possibility, we conducted correlations between the summary 
anhedonia/amotivation scores created from our clinical and questionnaire measures and ChooseC scores 
among all patients.  We also correlated anhedonia/amotivation scores with gain learning rates among 
learners.  Neither analysis revealed a significant relationship between anhedonia score and Go learning 
(p values > .1).  Finally, we correlated win-stay rates with anhedonia/avolition scores, which also failed to 
reveal a significant relationship (p > .1).  Because several studies in the literature reported correlations 
with total negative symptoms rather than with anhedonia/avolition specifically, we also conducted the 
above correlations with SANS negative symptom scores, but failed to find significant relationships with 
this measure as well. 
Behavior Summary:  In summary, our analyses of choice behavior during both acquisition and 
test are suggestive that patients chose A over B less often than controls, although these effects were 
small.  On transfer measures designed to assess learning from positive vs. negative feedback, patients 
demonstrated a specific reduction in learning from positive feedback.   Gain vs. loss learning rates 
derived from a reinforcement learning model showed a similar (albeit weaker) pattern, and there was a 
significant positive relationship between the model- and transfer-derived measures of learning from 
positive feedback in both groups.  Early in learning, patients demonstrated a greater tendency to shift 
after wins than controls.  Contrary to our predictions, none of the behavioral measures of interested 
showed a significant relationship with anhedonia/avolition severity. 
 
fMRI Analysis 
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Choice-related activation 
 Analysis 1: Full acquisition phase; collapsed across trial type. GLMs for the first analysis included 
regressors for two choice types (A/C/E, B/D/F).  Stimulus pairs were combined for the purposes of this 
analysis because a number of subjects had too few “B” choices to model activity for each pair type 
separately.  Effects that differed across stimulus pair were addressed in a separate analysis that excluded 
these subjects, described below.  In analysis 1, we examined activity associated with choices of high vs. 
low-probability stimuli, using a repeated-measures ANOVA with Choice (A/C/E, B/D/F) and Time (1-9) as 
within-subjects factors and Group (CON, SCZ) as a between-subjects factor. 
A priori ROI analysis within bilateral caudate, putamen, and nucleus accumbens revealed 
significant main effects of time in all regions, but no significant interactions with time.  Whole-brain 
analysis revealed a number of regions demonstrating a significant choice x time interaction, shown in 
Figure 6a and Table 3.  For clarity, only regions demonstrating a significant choice x time effect within 
both groups separately on post-hoc tests are included here.  This analysis revealed a significant choice x 
time effect in several members of the cognitive control network (Cole and Schneider 2007) including 
bilateral DLPFC, posterior parietal cortex, cerebellum, and ACC/preSMA.  All of these regions 
demonstrated greater activation for low-reward than high-reward choices for both patients and controls 
(Figure 6b). In addition, a region in dorsomedial prefrontal cortex demonstrated greater deactivation for 
high-probability than low-probability choices in both groups. Table 3 also includes post-hoc tests 
conducted within each stimulus pair, and shows that most of these patterns were driven by the AB and/or 
EF pairs, with little contribution of the CD pair. 
 
Figure 6: Choice ANOVA results: main effect of choice in the full acquisition phase. (A) Regions 
demonstrating a main effect of choice on whole-brain analysis (Z " 3, n " 13).  All regions showed greater 
activity for incorrect than correct choices. (B) Example timecourses for cognitive control regions, 
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demonstrating greater activation for incorrect than correct choices in both patients and controls. 
 
 
 
Time x Group interactions (Table 3) were seen in regions in bilateral superior parietal lobule, left 
superior frontal gyrus, and cuneus, which demonstrated greater activation overall (i.e. for both choice 
types) among controls than patients.  Greater activation for patients than controls was seen in bilateral 
cuneus, left inferior parietal lobule, and right superior parietal lobule. 
 
!" #"
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Table 3. Choice ANOVA: Regions demonstrating main effects 
Effect Region BA Coordinates # Voxels Z Pattern AB CD EF 
Choice x Time R Cerebellar Tonsil - +16, -66, -49 19 4.32 BDF>ACE NS NS *** 
  L Middle Frontal Gyrus 9 -40, +27, +33 267 5.12 BDF>ACE NS NS *** 
  R Middle Frontal Gyrus 9 +39, +28, +34 366 6.61 BDF>ACE *** NS *** 
  R Pons - +2, -19, -20 23 5.09 BDF>ACE NS NS *** 
  L Middle Frontal Gyrus 10 -26, +54, -7 15 4.62 BDF>ACE NS NS *** 
  R Inferior Parietal Lobule 40 +41, -53, +44 285 6.21 BDF>ACE *** NS *** 
  L Inferior Parietal Lobule 40 -45, -51, +41 236 5.00 BDF>ACE *** NS *** 
    Medial Frontal Gyrus 8 +0, +21, +46 228 4.71 BDF>ACE *** NS ** 
  L Middle Frontal Gyrus 6 -19, +11, +62 18 4.96 BDF>ACE NS NS *** 
  R Superior Frontal Gyrus 6 +18, +11, +63 44 5.84 BDF>ACE * NS *** 
  R Medial Frontal Gyrus 8 +6, +49, +42 33 4.43 (-) ACE>BDF NS NS *** 
  L Uncus 20 -38, -15, -28 23 4.31 ACE: early peak, then (-) NS NS *** 
Time x Group R Precuneus 7 +27, -66, +30 16 3.87 CON > SCZ *** *** ** 
  L Superior Frontal Gyrus 10 -18, +52, -3 42 4.95 CON > SCZ *** ** *** 
  L Superior Frontal Gyrus 6 -1, +19, +58 94 3.37 CON > SCZ * NS *** 
  R Superior Parietal Lobule 7 +15, -67, +59 63 4.43 CON > SCZ *** *** *** 
  R Cuneus 19 +14, -91, +24 43 4.14 SCZ > CON *** *** ** 
  L Cuneus 19 -21, -91, +26 34 4.71 SCZ > CON *** *** *** 
  L Inferior Parietal Lobule 40 -52, -32, +54 14 3.65 SCZ > CON *** *** ** 
  R Superior Parietal Lobule 7 +32, -45, +61 15 3.13 SCZ > CON *** *** * 
  L Insula 13 -44, -19, +0 13 3.50 (-) CON > SCZ NS *** ** 
  R Inferior Temporal Gyrus 20 +55, -23, -18 18 3.38 (+) SCZ, (-)CON *** NS * 
 
 
Regions showing a significant Choice x Time x Group interaction are shown in Figure 7 and Table 
4.  The majority of these regions, those predominantly located in the cerebellum and occipital lobe, 
activated more strongly for low- than high-probability choices in controls, but for high- than low-probability 
choices in patients.  Another subset of regions including bilateral precuneus also showed greater 
activation for low-probability choices in controls, but no differentiation between choice types in patients. 
Finally, regions including right superior frontal gyrus showed greater activation for high- than low-
probability choices in patients, and no differentiation among controls. 
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Table 4. Choice ANOVA: regions demonstrating Choice x Time x Group interactions 
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Figure 7. Choice ANOVA: Regions with Choice x Time x Group interactions  
 
 
ANOVA Analysis 2: within AB pair.  Given that the greatest group differences in behavior were 
seen for the AB pair, we conducted an additional analysis to examine choice effects within this pair. After 
exclusion of subjects who failed to make sufficient numbers of B choices, which yielded an N of 32 
controls and 38 patients, a Choice (A,B) x Time (1-9) x Group (CON, SCZ) ANOVA was conducted to 
examine choice-related activity for the AB pair.   The results of this analysis showed considerable overlap 
with the results of the previous analysis.  The striatal ROI analysis again revealed no significant effects or 
interactions with choice or group.  On whole-brain analysis, the Choice x Time results were nearly 
identical, with several cognitive control regions demonstrating greater activation for “B” choices than “A” 
choices among both patients and controls.  The Choice X Time X Group results were also similar, with a 
number of cerebellar and occipital regions showing significant interactions.  However, within the AB pair, 
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additional regions were with greater responses to “B” choices among controls, but not patients, were 
identified.  These included regions typically associated with error or conflict processing (Dosenbach et al 
2006), such as bilateral anterior prefrontal cortex, dorsal ACC, and thalamus (Figure 8a).   To examine 
how this activation related to performance, we conducted partial correlations controlling for group 
between activation for B choices in these regions and average performance on the AB pair. Greater 
activation was associated with better AB performance among both patients and controls in several of the 
regions including left aPFC (r = .256, p < .04) and left superior parietal lobule (r = .452, p < .001), with 
several more regions including dACC and right aPFC showing trend-level correlations (Figure 8b).  These 
correlations were driven more by controls than patients, but were in the same direction in both groups.  
Left superior parietal lobule also correlated with win-stay (but not lose-shift) behavior for the AB pair 
among patients (r = .446, p < .007) and controls (r = .518, p < .004).  
 
  100 
Figure 8. Choice ANOVA: within AB pair. (A) Regions and example timecourses for significant Choice x Time x Group 
interactions. (B) Correlations between activation for B choices and performance on the AB pair (proportion of “A” 
choices during the full acquisition phase), or early Win-Stay performance (proportion of wins followed by stays during 
the first 2 blocks). 
 
 
 
 
 In sum, analyses 1 and 2 revealed no group differences in striatal activation for choices 
associated with higher versus lower probability of reward.  This was true for all stimulus pairs combined, 
and within the AB pair.  In addition, both groups showed greater activation in many cognitive control 
regions for lower-probability than higher-probability choices. However, group differences were seen in a 
!"
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number of regions, including regions implicated in error or conflict processing (particularly for the AB pair), 
which activated more strongly for low-probability choices among controls, but not patients.  In one of 
these regions, left superior parietal lobule, activation for B choices was also associated with higher 
proportions of A choices and more frequent win-stay behavior in both groups. 
 Analysis 3: Learning Phase.   The previous analyses examined choice-related activation 
throughout the full course of the acquisition phase, and therefore did not take into account any changes in 
this activity that may have occurred during the course of learning.  In order to examine such changes, the 
acquisition phase was divided into Early and Late learning phases comprising the first and last 60 trials 
per stimulus pair, respectively. As shown in Figure 3a, group-level performance began to plateau during 
Block 3, suggesting that on average the Early learning phase represents a period of ongoing learning, 
while the Late phase represents the learning plateau. ANOVAs for choice-related activity collapsed 
across all pairs and within the AB pair alone, analogous to analyses 1 and 2 above, were conducted 
within the early learning phase to examine activation patterns that may have been present during 
learning, but obscured by post-plateau trials in the previous analyses.  In addition, a repeated measures 
ANOVA using Learning Phase (Early, Late), Choice, and Time as within-subjects factors and Group as a 
between-subjects factor was conducted to identify activation patterns that differed across learning stage. 
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Table5: Choice ANOVA results within early learning phase 
Effect Region BA Talairach Voxels Z Pattern Post-Hoc 
CON SCZ CON SCZ 
Choice x Time R Cuneus 18 +11_-70_+13 523 5.02 ACE > BDF * * 
  L Inferior Frontal Gyrus 47 -29_+28_-8 14 4.28 ACE > BDF * * 
  L Inferior Frontal Gyrus 10 -36_+43_+0 41 4.90 ACE > BDF * * 
  R Anterior Insula 13 +39_-3_+7 104 4.63 ACE > BDF * * 
  R Middle Occipital Gyrus 19 +40_-66_+13 15 4.04 ACE > BDF * * 
  R Postcentral Gyrus 3 +57_-13_+21 137 6.37 ACE > BDF * * 
  L Posterior Cingulate 30 -17_-62_+7 299 5.23 ACE > BDF * * 
  L Caudate - -12_+22_+06 155 5.27 ACE > BDF NS * 
  R Caudate - +16_+27_+03 99 4.64 ACE > BDF NS * 
  L Cerebellar Peduncle - -26_-51_-42 20 4.70 ACE > BDF NS * 
  R Fusiform Gyrus 37 +37_-60_-13 47 4.83 ACE > BDF NS * 
  L Middle Occipital Gyrus 19 -35_-88_+11 14 4.11 ACE > BDF NS * 
  R Middle Frontal Gyrus 9 +35_+26_+28 14 3.63 ACE > BDF NS * 
  L Middle Frontal Gyrus 46 -40_+30_+19 44 4.56 BDF > ACE * * 
  L Precentral Gyrus 6 -52_+4_+34 18 4.31 BDF > ACE * * 
  L Angular Gyrus 39 -43_-76_+32 25 4.52 (-) BDF > ACE * * 
  R Posterior Insula 13 +42_-28_+15 44 4.63 (-) BDF > ACE * * 
  L Middle Temporal Gyrus 39 -51_-73_+13 30 4.82 (-) BDF > ACE * * 
  R Superior Temporal Gyrus 21 +53_-3_-9 17 4.65 (-) BDF > ACE * * 
  R Superior Temporal Gyrus 22 +70_-36_+7 26 5.93 (-) BDF > ACE * * 
  L Superior Temporal Gyrus 22 -54_-37_+10 184 5.99 (-) BDF > ACE * * 
Time x Group L Thalamus - -1_-31_+11 43 3.36 CON > SCZ - - 
  L Precuneus 7 -25_-67_+36 62 4.82 CON > SCZ - - 
  L Superior Parietal Lobule 7 -29_-59_+60 27 3.45 CON > SCZ - - 
  L Inferior Parietal Lobule 40 -47_-43_+42 43 4.30 CON > SCZ - - 
  R Superior Frontal Gyrus 6 +0_+19_+57 169 5.01 CON > SCZ - - 
  R Superior Parietal Lobule 7 +25_-62_+48 345 5.67 CON > SCZ - - 
  R Precuneus 7 +27_-68_+37 16 3.88 CON > SCZ - - 
  R Cerebellar VIIIa - +32_-43_-51 15 3.66 CON > SCZ - - 
  R Middle Frontal Gyrus 9 +38_+22_+27 21 3.90 CON > SCZ - - 
  R Inferior Frontal Gyrus 45 +53_+16_+4 28 4.92 CON > SCZ - - 
Choice x Time x Group R Cerebellar Crus I - +55_-61_-30 14 5.54 BDF > ACE ACE > BDF * * 
  R Midbrain - +1_-32_-11 14 3.78 BDF > ACE ACE > BDF * * 
  R Thalamus - +16_-19_+19 29 4.27 - ACE > BDF NS * 
  R Precentral Gyrus 4 +55_-14_+42 22 4.18 ACE > BDF - * NS 
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 On ROI analysis, a Choice X Time X Group ANOVA within in the early phase once again 
revealed significant main effects of time in all regions, but no effects of choice or group that survived 
correction for multiple comparisons.  For whole-brain activity, the patterns of activation for high- versus 
low-probability choices within the early learning phase were quite different than those seen in the full 
acquisition phase (Table 5).  Several regions demonstrated Choice X Time interactions in which activity 
was greater for high-probability than low-probability choices, including regions in bilateral caudate, left 
inferior frontal gyrus, right anterior insula, and right postcentral gyrus (Figure 9a).  An example timecourse 
is shown in figure 9b.  In a set of regions including bilateral caudate, post-hoc tests within each group 
separately revealed that the ACE > BDF patterns were significant among patients, but not controls.  For 
example, as illustrated in Figure 9c, controls activated left ventral striatum similarly for both choice types, 
while in patients, activation was sustained longer for high- than low-probability choices.   A pattern of 
greater activation for low- than high-probability choices was seen in left DLPFC and precentral gyrus, 
similar to the pattern seen for the full acquisition phase (Figure 9a, blue).  As shown in Figure 9d, while 
activation was lower in patients in these regions overall, both groups showed the same pattern of greater 
activation for low- than high-probability choices.  Lastly, there was a subset of regions that deactivated 
more strongly for low- than high-probability choices, which included regions in bilateral superior temporal 
gyrus, right posterior insula, and left angular gyrus (figure 9e).  
 
  104 
Figure 9.  Choice ANOVA during early learning phase: Choice x Time interactions. (A) Regions demonstrating 
significant Choice x Time interactions. Red = ACE>BDF, Blue = BDF > ACE, Green = deactivation (BDF > ACE). 
 
 
 
A Time x Group interaction was present in a number of cognitive control regions including 
bilateral posterior parietal cortex, right DLPFC, preSMA, thalamus, and right anterior insula/inferior frontal 
gyrus (Table 5 and Figure 10).  All of these regions activated more strongly in controls than patients 
during the early learning phase regardless of choice type.  This pattern is similar to that seen during the 
full acquisition phase, where preSMA and superior parietal lobule showed greater activity in controls 
overall; however, in early learning this pattern is present more extensively in regions associated with 
cognitive control.  In addition, while the full acquisition phase also revealed superior parietal regions that 
activated more strongly in patients than controls, during early learning all significant regions activated 
more strongly in controls than patients. Choice x Time x Group interactions were also seen in a few 
regions; among these were midbrain and right cerebellar crus I, which activated more strongly for low 
than high-probability choices among controls, with the opposite pattern among patients (Table 5).  
 
Figure 10. Time x Group interactions in the early learning phase. 
!" #"
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 We also conducted analyses using learning phase as a factor in order to identify regions whose 
activity differed between the early and late learning phases.  Because some subjects made very few low-
probability choices during the late learning phase, a number of subjects were excluded from this analysis, 
yielding a sample of 32 controls and 33 patients.  ROI analysis results revealed significant Learning 
Phase x Choice x Time interactions in bilateral caudate (L: F(8,504)=3.59, p<.0001; R: (F(8,504) = 2.90, 
p<.004) and bilateral putamen (L: F(8,504)=2.33, p<.02; R: F(8,504) = 2.91, p<.004).  These regions 
activated equally for both choice types during the early learning phase, but more strongly for high- than 
low-probability choices during the late learning phase (Figure 11). 
 
!"#$%&' (()' *+(,)'
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Figure 11. Learning Phase ANOVA results.  (A) ROI analysis: example timecourses for regions showing Learning 
Phase x Choice x Time interactions. (B) Whole-brain analysis: Learning Phase x Time x Group interactions.  Red = 
Early > Late in CON but not SCZ; Blue =  Early > Late in SCZ but not CON; Green = Early > Late in CON, Late > 
Early in SCZ.
 
 
 
On whole-brain analysis, several regions demonstrated a Learning Phase x Time x Group 
interaction, such that overall activation (irrespective of choice type) changed between early and late 
learning in a way that differed between groups.  These regions are shown in Figure 11b and Table 6.  
Controls activated regions including bilateral caudate, superior frontal gyrus, and left fusiform gyrus more 
strongly during the early stages of learning, while patients showed less differentiation between early and 
late.  To determine whether activation in the caudate regions was related to learning, correlations were 
conducted between early learning phase activation in these regions and learning rate, but did not yield 
significant relationships. 
  
!"
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Table 6. Learning Phase x Time x Group interactions 
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In sum, the learning phase analyses revealed several activation patterns that differed between 
early and late learning.  During early learning, a number of regions including bilateral caudate activated 
more strongly for high- than low-probability choices among both patients and controls, which was not 
apparent when collapsing across learning phase.  Further, several cognitive control regions were 
activated more strongly in controls than in patients overall during early learning.  When early and late 
learning are compared, dorsal striatum ROIs developed differential activation for A/C/E greater than 
B/D/F choices during late learning.  In addition, regions including bilateral caudate activated more strongly 
during early than late learning in controls, with no difference in patients (primarily due to lower activation 
during the early phase).   
 
 Modeling Analysis: Q-values.  In addition to providing information about learning rates as 
discussed in the behavioral analysis section, the Q-learning algorithm is also able to provide trial-by-trial 
estimates of expected value (Q values) and prediction error.  Here, we wished to determine whether the 
expected value of choosing a given stimulus was related to brain activity at the time that the choice is 
made.  As described in Methods, we created GLMs in which the Q value of the chosen stimulus was 
included as a trial-by-trial parametric modulator, and then conducted whole-brain ANOVAs by time to 
identify regions in which this modulation was significant.  In this analysis, regions demonstrating a 
significant effect of time for the Q-value regressor are regions whose trial-by-trial variation in activation 
was captured by trial-by-trial variation in the expected value of the chosen stimulus.  The modulatory 
effect may be conceptualized as a correlation between Q value and activation on each trial; for positive 
values, activation will be greater (or deactivation smaller) for larger Q values, and for negative values, 
  108 
activation will be smaller (or deactivation greater) for larger Q values.  As in the behavioral modeling 
analysis, this analysis was restricted to the “learners” group in order to avoid drawing conclusions from 
poorly fitting models.   
Striatal ROI analysis of Q value-related activity revealed significant positive modulation in bilateral 
nucleus accumbens (L: F(8,416) = 6.92, p < 10-7) , R: F(8,416) = 5.89, p < 10-8).  This effect was 
significant within each group individually, and no group interactions were present. These regions 
demonstrated activation that was positively modulated, indicating greater activation on trials with higher Q 
values, in both patients and controls.  These regions were also identified as part of the whole-brain 
analysis, for which example timecourses are shown in Figure 12b. 
Whole-brain regions demonstrating a significant parametric effect of Q value among both groups 
combined are shown in Figure 12a and Table 7; for clarity, only regions that were significant on post-hoc 
tests within both patients and controls separately are discussed here. Several distinct subsets of regions 
showing similar activation patterns were identified.  Similar to the ROI analysis results, right ventral 
striatum demonstrated a pattern of overall activation that was modulated positively by Q value, as did 
regions in right caudate, right postcentral gyrus, and left inferior frontal gyrus.  As shown in Figure 12b, 
the magnitude of the Q value effect was larger in patients than in controls for the ventral striatum region, 
particularly at the time of peak activation; however, no significant interaction with group was present. A 
second pattern was seen in cognitive control network regions including bilateral DLPFC, posterior parietal 
cortex, anterior insula, and ACC/preSMA, among other regions.  These regions had a pattern of overall 
activation with negative modulation, meaning that the lower the Q value of the chosen stimulus, the 
greater the activation in these regions.  As shown in Figure 12c, the activation patterns and magnitudes 
were highly similar between patients and controls for all of these regions.  Other activation patterns 
identified in this analysis included regions whose deactivation was reduced for higher Q values, including 
rACC (Figure 12d), and one region in inferior parietal lobule whose deactivation was increased for higher 
Q values. 
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Table 7. Regions demonstrating significant Q value modulation. 
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Figure 12: Q value effects. (A) Regions demonstrating significant Q-value modulation. Red = activation with positive 
modulation; blue = activation with negative modulation; green = deactivation with positive modulation; orange = 
deactivation with negative modulation. (B) Timecourse for right ventral striatum showing activation with positive 
modulation. (C) Timecourse for DLPFC showing activation with negative modulation. (D) Timecourse for rACC 
showing deactivation with positive modulation
 
 
Comparatively few regions had a significant Time X Group interaction in the Q value effect 
(Figure 13a).  Regions in brainstem, bilateral cerebellum, and left superior frontal gyrus displayed 
activation that was negatively modulated in controls but positively modulated in patients (Figure 13b).  
Similarly, left parahippocampal gyrus was modulated positively in patients, but not in controls (Figure 
13c), and right superior parietal lobule was modulated negatively in controls, but not in patients (Figure 
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13d).  Finally, precuneus showed deactivation that was negatively modulated in patients, but not controls 
(Figure 13e). 
 
Figure 13: Group interactions in Q value effect. (A) Regions with significant Q value x Time x Group effects. (B)-(D) 
Example timecourses as described in text.  
 
 
 Choice Analysis Summary.  When the ANOVA and modeling analyses are taken together, a 
number of consistent patterns emerge.  First, when activity from across the full acquisition phase is 
examined, activation patterns in patients and controls show a great deal of similarity, and comparatively 
few differences, particularly among cognitive control and reward-related regions. Second, across the full 
acquisition phase, differential choice-related activity is almost exclusively driven by regions activating 
more strongly for low-probability than high-probability choices.  For example, the cognitive control network 
shows both strong activation for B/D/F choices and trial-by trial increases in activity for choices with lower 
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Q values, among both patients and controls. This pattern seems to be driven most strongly by the AB 
pair, and seems to be stronger late in learning.   
Regions activating more strongly for high- than low-probability choices emerge when analysis is 
restricted to early learning, and include striatal regions and orbitofrontal cortex.  Striatal regions also 
demonstrate trial-by-trial increases in activation when choosing stimuli with higher Q values.   There was 
no evidence of a reduction in these effects among patients; in fact, while there were no significant group 
differences, the main effects were often driven more strongly by the patient group. 
Despite these similarities, a few group differences were apparent.  Across the full acquisition 
phase, activation in cognitive and error-related regions was reduced in patients when making “B” choices, 
with lower activity associated with lower performance on the AB pair.  Further, during early learning, 
patients activated the cognitive control network to a lesser extent than controls overall.  When activation 
was compared across learning phases, group differences in striatal activity were present, with controls 
showing a reduction in activation across learning, while patients showed little activation in either phase. 
 
Feedback-Related Activation 
 ANOVA analysis 1: Whole acquisition phase, collapsed across stimulus pair.   The first ANOVA 
analysis is equivalent to that described for choice-related activity, and examined functional activation 
using a Choice (A/C/E, B/D/F) x Time (1-9) x Feedback (Positive, Negative) ANOVA for trials across the 
whole acquisition phase.  In the striatal ROI analysis, all regions demonstrated significant Feedback x 
Time interactions that survived correction for multiple comparisons (all p values < .02).  Example 
timecourses are shown in Figure 14, and demonstrate that both groups activated bilateral caudate, 
putamen, and nucleus accumbens more strongly for positive than negative feedback.  There was no 
evidence of a reduction in this effect among patients as compared to controls.  In fact, activation 
magnitudes for positive versus negative feedback in these regions were greater in patients than controls, 
although no Feedback x Time x Group interactions survived correction for multiple comparisons.  
 
Figure 14.  Feedback ANOVA ROI results showing Feedback x Time interactions in all regions. 
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A large number of regions outside the striatum also displayed a significant feedback by time 
interaction, as shown in Figure 15a. Only regions whose interaction was significant within each group 
separately are included here.  A subset of these regions, including bilateral ventral striatum, caudate, and 
amygdala activated more strongly for positive than negative feedback in both patients and controls (Table 
8a).  A second subset of regions demonstrated greater activation for negative than positive feedback, and 
included ACC/preSMA, bilateral anterior insula, and bilateral superior parietal lobule (Table 8b). A similar 
activation pattern, in which peak activation was greater for negative than positive feedback, but activation 
for positive feedback was sustained longer than for negative feedback, was seen in regions including 
bilateral DLPFC, precentral gyrus, thalamus, and dorsal ACC (Table 8c). Finally, a set of regions 
including rACC and middle cingulate gyrus displayed deactivation that was greater for negative than 
positive feedback (Table 8d).  Table 8 also includes post-hoc analyses within each stimulus pair, and 
shows that most of these relationships were driven by the CD and EF pairs more than the AB pair. 
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Table 8. Feedback ANOVA: Feedback x Time Interaction.  
(a) Regions with greater activation for positive than negative feedback.  
Region BA Talairach Voxels Pattern Z AB CD EF 
L Amygdala - -23, -05, -11 77 Pos > Neg 5.38 NS * ** 
R Caudate - +16, +12, +17 113 Pos > Neg 5.55 * *** *** 
L Caudate - -22, -09, +24 33 Pos > Neg 4.07 NS *** * 
R Cuneus 19 +17, -88, +29 154 Pos > Neg 4.79 NS * ** 
R Inferior Frontal Gyrus 46 +44, +37, +12 55 Pos > Neg 4.89 NS NS ** 
L Inferior Parietal Lobule 40 -59, -34, +29 131 Pos > Neg 6.30 * *** *** 
R Inferior Parietal Lobule 40 +55, -27, +34 93 Pos > Neg 4.89 NS ** ** 
L Inferior Parietal Lobule 40 -51, -53, +50 16 Pos > Neg 4.86 NS NS * 
L Middle Occipital Gyrus 18 -29, -89, +05 92 Pos > Neg 4.96 NS ** ** 
L Middle Occipital Gyrus 18 -38, -82, -08 28 Pos > Neg 4.81 ** NS ** 
L Middle Temporal Gyrus 39 -45, -72, +20 46 Pos > Neg 4.56 NS ** * 
L Middle Temporal Gyrus 21 -55, -15, -05 42 Pos > Neg 4.81 * ** *** 
R Middle Temporal Gyrus 21 +56, -08, -04 25 Pos > Neg 4.85 NS NS *** 
L Middle Temporal Gyrus 37 -52, -53, +01 13 Pos > Neg 3.99 NS ** ** 
L Parahippocampal Gyrus 35 -21, -24, -11 99 Pos > Neg 5.86 NS *** ** 
R Parahippocampal Gyrus 30 +15, -32, -03 34 Pos > Neg 5.64 NS *** *** 
L Postcentral Gyrus 3 -59, -17, +33 55 Pos > Neg 4.98 * ** *** 
L Posterior Cingulate 29 -04, -41, +07 172 Pos > Neg 6.55 NS *** *** 
R Posterior Cingulate 30 +07, -52, +18 147 Pos > Neg 4.97 NS *** *** 
R Precentral Gyrus 6 +57, -10, +36 87 Pos > Neg 5.46 NS ** ** 
R Putamen - +28, -16, -08 129 Pos > Neg 5.72 NS ** ** 
L Superior Temporal Gyrus 41 -58, -26, +08 59 Pos > Neg 5.19 NS NS ** 
R Superior Temporal Gyrus 42 +57, -36, +14 105 Pos > Neg 5.04 NS NS *** 
L Superior Temporal Gyrus 41 -42, -37, +13 40 Pos > Neg 4.57 NS ** ** 
R Transverse Temporal Gyrus 41 +53, -17, +08 64 Pos > Neg 4.58 NS NS ** 
R Ventral Striatum - +20, +04, -01 200 Pos > Neg 8.39 ** *** *** 
L Ventral Striatum - -17, +07, +00 183 Pos > Neg 6.33 NS *** *** 
 
Table 8b: Regions with greater activation for negative than positive feedback. 
Region BA Talairach Voxels Pattern Z AB CD EF 
  ACC/preSMA 32 +01, +14, +45 359 Neg > Pos 5.15 NS ** *** 
L Cuneus 18 -11, -85, +12 226 Neg > Pos 5.12 NS ** *** 
L Inferior Frontal Gyrus 47 -46, +14, -04 20 Neg > Pos 4.72 NS * NS 
L Inferior Parietal Lobule 40 -38, -39, +41 32 Neg > Pos 4.23 NS ** * 
L Anterior Insula 13 -34, +18, +07 97 Neg > Pos 4.86 NS * ** 
R Anterior Insula 13 +32, +17, +11 49 Neg > Pos 4.18 NS * * 
L Lingual Gyrus 18 -12, -73, -05 108 Neg > Pos 4.84 NS ** *** 
R Lingual Gyrus 17 +06, -84, +03 126 Neg > Pos 4.46 NS ** ** 
R Superior Frontal Gyrus 6 +07, +07, +60 212 Neg > Pos 5.93 NS *** *** 
L Superior Parietal Lobule 7 -30, -52, +40 36 Neg > Pos 4.13 NS NS ** 
R Superior Parietal Lobule 7 +28, -57, +44 65 Neg > Pos 4.11 NS NS *** 
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Table 8c: Regions with greater activation for negative than positive feedback at peak, but sustained positive 
responses 
Region BA Talairach Voxels Pattern Z AB CD EF 
L Cingulate Gyrus 24 -07, -10, +41 93 Pos Sustained 4.19 NS ** ** 
L Cuneus 19 -14, -81, +30 277 Pos Sustained 5.05 NS *** *** 
L Cuneus 18 -03, -74, +21 208 Pos Sustained 4.91 NS *** ** 
L Fusiform Gyrus 37 -24, -64, -13 23 Pos Sustained 4.33 NS ** NS 
R Insula 13 +46, +12, -03 44 Pos Sustained 4.75 NS ** ** 
L Insula/Central Operculum 13 -42, -15, +20 39 Pos Sustained 4.65 NS * * 
R Lingual Gyrus 18 +25, -74, -10 77 Pos Sustained 4.34 * * ** 
L Lingual Gyrus 18 -25, -59, +07 62 Pos Sustained 4.82 NS *** ** 
L Medial Frontal Gyrus 6 -05, -18, +62 36 Pos Sustained 4.66 NS * *** 
L Middle Frontal Gyrus 9 -44, +20, +33 59 Pos Sustained 4.12 NS * ** 
R Middle Occipital Gyrus 19 +36, -67, +13 57 Pos Sustained 4.31 NS * *** 
R Middle Temporal Gyrus 37 +50, -62, +10 29 Pos Sustained 4.24 NS NS ** 
L Postcentral Gyrus 3 -40, -21, +36 152 Pos Sustained 5.37 NS *** * 
L Posterior Cingulate 30 -09, -61, +14 249 Pos Sustained 5.92 NS *** *** 
R Precentral Gyrus 4 +44, -13, +47 222 Pos Sustained 5.66 NS ** ** 
R Precentral Gyrus 6 +58, -01, +11 70 Pos Sustained 5.88 NS *** ** 
L Precentral Gyrus 4 -46, -08, +47 209 Pos Sustained 5.48 NS *** *** 
L Precentral Gyrus 6 -31, -01, +33 97 Pos Sustained 4.57 NS * *** 
R Sub-Gyral 40 +27, -40, +54 131 Pos Sustained 4.83 NS NS *** 
L Superior Frontal Gyrus 6 -13, -03, +63 164 Pos Sustained 5.46 * ** *** 
R Superior Occipital Gyrus 19 +31, -78, +24 95 Pos Sustained 4.40 NS NS *** 
L Superior Parietal Lobule 7 -22, -48, +60 155 Pos Sustained 5.45 NS NS *** 
R Supramarginal Gyrus 40 +44, -38, +29 98 Pos Sustained 5.53 NS * *** 
R Thalamus - +02, -26, +12 99 Pos Sustained 5.09 * *** *** 
  
Table 8d: Regions with greater deactivation for negative than positive feedback 
Region BA Talairach Voxels Pattern Z AB CD EF 
  rACC 32 -01, +42, +05 256 (-) Neg > Pos 6.47 ** *** *** 
  rACC 24 -02, +28, -03 98 (-) Neg > Pos 5.58 ** ** ** 
L Cingulate Gyrus 31 -11, -27, +45 30 (-) Neg > Pos 4.15 NS ** * 
L Angular Gyrus 19 -39, -72, +34 23 (-) Neg > Pos 4.07 NS ** NS 
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Figure 15. Feedback ANOVA: Feedback x Time interactions. (A) Regions with significant Feedback x Time 
interactions. Red = Positive > Negative; Blue = Negative > Positive; Green = Deactivation, Neg > Pos; Purple = 
Negative > Positive at peak, with sustained positive response.  (B) Example timecourses for each response pattern. 
 
 
 
 
Table S2 and Figure S1 in the supplement describe additional effects and interactions found in 
the feedback ANOVA analysis that did not interact with group.  A set of regions including several 
members of the cognitive control network (left DLPFC, PPC, anterior insula, ACC/preSMA, and right 
dorsal premotor cortex) activated more strongly to feedback received after high-probability choices, 
regardless of feedback type, yielding significant Choice x Time interactions. In addition, one region in right 
middle frontal gyrus showed a Choice x Feedback x Time interaction with reduced activation for low-
probability choices that received positive feedback as compared to all other conditions.  
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Table 9 describes effects and interactions found in the feedback ANOVA analysis that did interact 
with group. A Time x Group interaction with greater activity in controls than patients irrespective of 
feedback type was seen in regions including right inferior parietal lobule and left middle frontal gyrus, 
while greater activity for patients than controls was seen in occipital regions. Figure 16a shows the few 
regions that displayed a Feedback x Time x Group interaction.  These include regions in left superior and 
inferior frontal gyri and right precentral gyrus that activated more strongly for negative than positive 
feedback in controls, with less differentiation between conditions in patients. There were also a few 
regions displaying a significant Choice x Time x Group interaction, whose activation patterns differed 
between groups for high- versus low-probability choices regardless of feedback.  These regions included 
R superior frontal gyrus, which activated for BDF choices in controls and ACE choices in patients; 
cerebellar crus I which showed the opposite patterns, and right angular gyrus and inferior frontal gyrus, 
which activated for A/C/E choices in patients, but not in controls.  Finally, there was a Choice x Feedback 
x Time x Group interaction in a small set of regions including left insula and VMPFC.  Activation 
timecourses for the VMPFC region are shown in Figure 16b, and reveal deactivation that was strongest 
for low-probability choices given negative feedback among controls, with little differentiation among 
conditions in patients. 
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Table 9: Feedback ANOVA: Interactions with Group 
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Figure 16.  Feedback ANOVA: Interactions with Group. (A) Regions with Feedback x Time x Group interactions. (B) 
VMPFC region with a Choice x Feedback x Time x Group interaction. 
 
 
 Overall, the feedback ANOVA revealed robust main effects of feedback that did not differ 
between groups in most regions associated with reward or cognitive control.  Striatal regions activated 
more strongly for positive than negative feedback, while cognitive control regions showed the opposite 
pattern.  Several cognitive control regions also demonstrated greater activation for high- than low-
probability choices at the time of feedback, regardless of the feedback actually received, in both groups.  
In terms of group effects, a few cortical regions demonstrated reduced feedback responses overall, or 
reduced responses to negative vs. positive feedback, while a set of cerebellar regions activated more 
strongly in patients overall, and VMPFC showed responses that varied with both choice and feedback 
among controls, but were absent in patients. However, no evidence was found for altered striatal 
responses to feedback among patients. 
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 Analysis 2: AB only.  As in the analysis for choice-related activity, the AB pair was also examined 
alone using a repeated measures ANOVA with Choice (A, B), Feedback (Positive, Negative), and Time 
(1-9) as within-subjects factors and Group (CON, SCZ) as a between subjects factor.   Striatal ROI 
analysis revealed significant feedback x time (F(8,504) = 2.94, p < .004) and choice x time (F(8,504) = 
3.59, p < .0005) interactions in right ventral striatum, which were driven by elevated responses to “B” 
choices that yielded positive feedback (in essence, a positive prediction error).  This activity was seen in 
both groups, and no significant interactions with group were present (Figure 17). The whole brain 
Feedback x Time activation map for the AB pair was much more sparse than that seen for all three pairs 
combined, with only the rACC and bilateral ventral striatal regions reaching significance. There were no 
additional regions demonstrating interactions with group that were not present in the analysis for all three 
pairs combined. 
Figure 17. Feedback ANOVA, AB pair: ROI analysis.  Example timecourses shown for nucleus accumbens ROI with 
significant Feedback x Time and Choice x Time interactions. 
 
 
 Analysis 3: Learning Phase.  To examine whether responses to positive and negative feedback 
differed during the early stages of learning, the Choice x Feedback x Time x Group ANOVA was repeated 
within the early learning phase.  ROI analysis revealed significant Feedback x Time interactions in right 
caudate, right nucleus accumbens, and bilateral putamen (all p values < .002). There was also a Choice x 
Feedback x Time x Group interaction in left caudate (F(8,440) = 2.77, p<.006), in which patients had 
stronger responses, especially to positive feedback, after low-probability choices, while controls 
responded to positive feedback after both choice types (Figure 18).  While there were no interactions with 
choice in the other regions, the pattern of activity in right nucleus accumbens and bilateral putamen 
!"#$ %!&$
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resembled what one might expect for a prediction error signal, particularly in the patient group, with the 
strongest activation for unexpected positive outcomes (B/D/F choices with positive feedback; red) and 
deactivation for unexpected negative outcomes (A/C/E choices with negative feedback; blue).   On whole-
brain analysis, feedback effects during early learning closely mirrored those seen in the full acquisition 
phase; the major activation patterns were the same as those reported above, and no new meaningful 
effects emerged upon restriction of the analysis to early learning.   
 
Figure 18.  Feedback ANOVA within early learning phase, ROI analysis. 
 
When learning phase was included as a factor, there were no significant effects or interactions 
with this factor in the striatal ROI analysis.  The whole-brain ANOVA revealed a number of regions whose 
activation differed between early and late learning, however, which are described in Table S3.  The only 
factor that interacted significantly with learning phase was choice, with several regions demonstrating a 
Learning Phase x Choice x Time interaction.  The majority of these regions showed the development of 
an effect of choice on feedback-related activation during late learning that had not been present during 
!"#$ %!&$
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early learning (Figure S2).  There were no results in the learning phase analysis that interacted with 
group. 
 
Modeling Analysis: Prediction Errors.  In addition to examining functional activation changes associated 
with positive and negative feedback, we wished to examine whether trial-by-trial fluctuations in activation 
at the time of feedback were correlated with prediction error values derived from the reinforcement 
learning model.  As described previously, GLMs for this analysis included signed prediction error (i.e. 
positive and negative) as a parametric regressor, which was analyzed for significance using ANOVAs 
with time as a factor. A separate analysis also examined positive and negative prediction errors coded 
separately.  As in the other modeling analyses, only “learners” were included to ensure that the prediction 
error terms were derived from well-fitting models.  On striatal ROI analysis, all regions demonstrated 
significant prediction error effects (all p values < .007) with positive modulation, none of which interacted 
with group.  These regions were also identified by the whole-brain analysis and are discussed further 
below. 
Whole-brain regions with a significant prediction error effects are shown in Table 10 and Figure 
19, and show a high degree of overlap with those regions with a feedback by time interactions in the 
ANOVA analyses.  A set of regions demonstrating activation that was positively modulated (Table 10a), 
such that activation increased on trials with larger positive prediction errors, included bilateral ventral 
striatum and amygdala.  Regions including rostral ACC and medial frontal gyrus demonstrated 
deactivation that positively modulated, and therefore reduced for larger positive prediction errors.  A 
second subset of regions demonstrated activation with negative modulation, such that activation was 
higher for smaller positive (or larger negative) prediction errors (Table 10b).  These regions included 
cognitive control regions such as bilateral DLPFC, PPC, anterior insula, and preSMA. Examples of each 
type of activation pattern are shown in Figure 19b. 
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Table 10a. Prediction error analysis: regions demonstrating positive modulation in both groups. 
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Table 10b.  Prediction error analysis: regions demonstrating negative modulation in both groups. 
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Figure 19. Prediction error analysis: Prediction Error x Time interactions. (A) Regions with significant prediction error 
effects in both groups. Red = activation with positive modulation; blue = activation with negative modulation; green = 
deactivation with positive modulation; orange = deactivation with negative modulation. (B) Example timecourses for 
each activation pattern. 
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 In addition to the main effects of prediction error, there were two regions that demonstrated an 
interaction between prediction error and group (Figure 20).  These regions included right inferior frontal 
gyrus and right superior temporal gyrus.  Superior temporal gyrus showed deactivation that was 
negatively modulated in controls and positively modulated in patients, such that activation was increased 
for smaller positive or greater negative prediction errors in controls, but greater positive prediction errors 
in patients.  Right inferior frontal gyrus showed activation that was negatively modulated in controls but 
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not patients, such that smaller positive or greater negative prediction errors yielded greater activation in 
controls only. 
Figure 20: Prediction Error x Time x Group interactions 
 
  
In order to determine whether positive and negative prediction errors were differentially affected 
in the patient group, we also examined positive and negative prediction errors separately.  The positive 
prediction error effect was significant in bilateral nucleus accumbens (Left: F(8,408)=3.86, p<.0003; Right: 
F(8,408)=2.71, p<.003), while the negative prediction error effect was not significant in the striatal ROIs.  
No significant effects of group emerged on ROI or whole-brain analysis of positive and negative prediction 
errors separately. 
 Overall, activation at the time of feedback was highly similar between patients and controls. Both 
groups demonstrated greater activation of striatal regions for positive than negative feedback, and of 
cognitive control regions for negative more than positive feedback.  Analysis of prediction error 
modulation revealed the same pattern.  In addition, in both groups there was activity driven by the choice 
that had been made irrespective of the feedback received; this activity developed later in learning and 
was present in both groups.  The only group difference identified in striatal regions was in left caudate, 
which demonstrated an unexpected pattern in which controls responded primarily to positive versus 
negative feedback, while patients showed a modulation of feedback response by choice type. Outside the 
striatum, VMPFC showed activation that was modulated by both choice and feedback in controls, but not 
!"#$%#&'( )*(+&,-.%#&'(
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patients, though the pattern of activity was not consistent with prediction error coding.  Overall, there were 
few robust group differences in regions associated with reward processing or learning. 
 
 Individual Differences Analysis.  To determine whether there was a relationship between choice- 
or feedback-related activation and anhedonia/avolition severity, we conducted correlation analyses 
between activation averaged at timepoints 4 and 5 (peak activation) and the summary 
anhedonia/avolition scores derived from our clinical and self-report measures. First, we examined 
whether activity during high-probability choices was reduced in patients who were higher in 
anhedonia/avolition, using both striatal ROI and whole-brain analyses.  This analysis was conducted 
within the early learning phase, because we had identified greater activity for high- than low-probability 
choices only during early learning.  No significant results were obtained.  Next, we examined whether 
anhedonia/avolition scores were associated with responses to positive feedback or positive prediction 
errors, using both striatal ROI and whole-brain analyses.  There were no significant associations with 
positive prediction errors, and ROI analysis of responses to positive feedback did not survive correction 
for multiple comparisons.  However, whole-brain analysis revealed significant negative relationships 
between anhedonia/avolition self-report scores and responses to positive feedback in several regions 
including left caudate and bilateral posterior DLPFC (Brodmann areas 44/6) (Figure 21).  These regions 
showed reduced activation in response to positive feedback in those patients who were higher in 
anhedonia/avolition.  When these same regions were examined in controls, no significant relationships 
were found.  Lastly, we examined the regions that had demonstrated group differences in the above 
analyses to determine whether the effect that differed between groups further varied with 
anhedonia/avolition severity.  This analysis failed to identify any significant relationships. 
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Figure 21. Correlation analyses: Regions with significant negative correlations between responses to positive 
feedback and self-reported anhedonia/avolition among patients. 
 
 
 Medication Effects.  Given that the vast majority of our patients were taking antipsychotic 
medications that block dopamine receptors, we wished to examine whether there was a relationship 
between medication dose and striatal activation during either choice or feedback.  To do this, we 
converted antipsychotic doses to standard chlorpromazine dose-equivalents (Gardner et al 2010), and 
conducted correlations between these dosages and our behavioral and neuroimaging measures of 
interest.  Behaviorally, there was a significant relationship between medication dose and AvoidD (rho = 
.408, p < .02), wherein AvoidD scores were higher for larger medication doses.  Dose did not correlate 
with ChooseC, gain or loss learning rate, or anhedonia/avolition.  In the neuroimaging data, we examined 
all regions with significant group differences in the analyses above to determine whether the effect that 
differed between groups correlated with medication dose.  None of the examined relationships were 
significant.  Next, we conducted the same ROI and whole-brain correlations as described for the 
anhedonia/avolition analysis above, which also failed to yield significant results. 
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Discussion: 
 
 In this study, we asked a number of questions about whether probabilistic reinforcement learning 
was impaired in a sample of medicated individuals with schizophrenia.  First, we asked whether patients 
had a specific deficit in learning from positive feedback, and whether this deficit was related to symptoms 
of anhedonia and avolition.  Behavioral results using transfer measures sensitive to Go vs NoGo learning 
and gain versus loss learning rates from RL modeling suggested impairments in learning from positive, 
but not negative, feedback in patients as compared to controls.  While the effect for the learning rates was 
less robust than that seen for the transfer measures, it is important to keep in mind that the sample for 
modeling analysis included only those subjects who demonstrated above-chance performance on the 
task, reducing the power and limiting the dynamic range of this analysis.  It is also notable that the 
ChooseC and gain learning rate measures were correlated among both groups, supporting the claim that 
these measures both assess learning from positive feedback; however, the lack of the analogous 
correlation between AvoidD and loss learning rate, which has been demonstrated in past studies (Frank 
et al 2007), calls into question the extent to which these measures tapped into the same construct of 
NoGo learning in this sample.  
 While the behavioral results demonstrated the expected impairment in Go learning, we found no 
evidence in the neuroimaging results for a reduction in striatal responses among patients as compared to 
controls.  We had hypothesized that Go learning impairments would be associated with reduced positive 
prediction error activity, and with reduced anticipatory reward responses (responses to high-probability 
choices), in striatal regions among patients.  Instead, we found that striatal activity was intact in patients 
at the time of choice and feedback.  We found no group differences in striatal activity for positive versus 
negative choices or feedback, expected values, or prediction errors when collapsing across the full 
acquisition phase.  Separate analysis of positive and negative prediction errors also demonstrated intact 
striatal activation. During early learning, choice-related activity did not differ between groups, while at 
feedback, left caudate activated more strongly for positive feedback after any choice in controls, but for 
positive (and, to a lesser extent, negative) feedback after BDF choices in patients.  This pattern is 
unexpected and contrary to our hypotheses, as it demonstrates a greater modulatory effect of choice on 
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activation at the time of feedback in patients than in controls.  In fact, this and other striatal regions 
demonstrated activity that was if anything more characteristic of a prediction error signal in patients than 
in controls, although the group differences were not significant.  The only suggestion of reduced striatal 
activation in patients as compared to controls was in the learning phase comparison, where bilateral 
caudate showed a greater reduction in overall activation at the time of choice between early and late 
learning in controls than in patients.  This relationship was driven by lesser activation during early learning 
in patients as compared to controls, suggesting that patients may have a deficit in early recruitment of 
these regions. However, this effect did not differ by choice type, as would be expected if it represented a 
difference in reward anticipation; nor did it correlate with learning rate, overall performance, or clinical 
symptoms.  Therefore, any claims about the importance of this activation difference in interpreting group 
differences in behavior or symptomatology are necessarily weak. 
 Our findings of largely intact striatal activation during learning contrast with the findings of several 
studies in the literature demonstrating reduced striatal prediction errors in medicated patients (Gradin et 
al 2011; Koch et al 2010; Morris et al 2012; Murray et al 2008; Waltz et al 2009). However, Walter et al 
(Walter et al 2009) also found intact striatal prediction errors in medicated schizophrenia patients, and the 
studies indicating reduced prediction errors have found these effects in mostly non-overlapping striatal 
subregions. Further, sample sizes in these studies were small (all Ns < 21, with two studies with N < 15), 
raising concern about the reliability of the reported effects.  Another possible source of these differences 
are clinical differences in the populations examined; our patients had lower positive symptom severity 
than many published reports, and there is evidence in the literature that aberrant prediction error activity 
is related to positive symptoms in schizophrenia (Kapur 2003).  
 The lack of significant relationships between anhedonia/avolition scores and striatal prediction 
error activity reported here also differs from some reports in the literature (Morris et al 2012; Waltz et al 
2009), although at least one other study looked for these relationships and did not find them (Gradin et al 
2011).  While our null findings may reflect a failure to detect an effect that exists in the population, it is 
worth noting that the present study is the only one in the literature with appropriate power to detect 
individual differences within the patient group.  However, behavioral studies with larger samples have 
also reported relationships between reinforcement learning impairments and negative symptom severity 
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(Gold et al 2012; Waltz et al 2011), which we failed to detect in our behavioral results.  We can only 
speculate that these differences may have been influenced by the specifics of the experimental design, 
as discussed below. 
 One important difference between our task and many in the literature is that patients received 
additional practice on the task before the scanning session.  This was done to avoid an influence of 
confusion about task procedures, which was common among patients but not controls, on our results.  
We acknowledge that this procedure introduced a practice mismatch between groups, but wish to point 
out that mismatches in the amount of practice given are not unusual in prediction error studies, which 
sometimes have subjects train to criterion before entering the scanner.  We gave a fixed number of 
practice trials because the goal of our practice session was not to establish conditioned associations, but 
to ensure familiarity with experimental procedures.  Controls underwent a shorter practice session 
immediately prior to scanning, and were also administered additional practice trials in the event that they 
demonstrated confusion about task instructions.  It is possible that this additional practice in patients 
contributed to the relative lack of group differences in our study as compared to others in the literature, 
which has interesting implications both clinically and for future studies in this population. 
 Given that explicit learning systems associated with prefrontal cortical function are also expected 
to contribute to learning in this task, we also examined measures of explicit learning and whole-brain 
activity.  While the basal ganglia learning system supports the gradual integration of feedback over 
several trials, regions such as orbitofrontal cortex, prefrontal cortex, and medial temporal lobe are 
commonly associated with more rapid, explicit forms of learning.  Orbitofrontal cortex is thought to be 
involved in a form of working memory for value, and is commonly implicated in tasks where reward 
contingencies must be updated more rapidly than can be accommodated by the basal ganglia (Frank and 
Claus 2006). Medial temporal lobe is associated with declarative memory, and may be involved in the 
earliest stages of implicit learning tasks that later rely on the basal ganglia, as well as in making 
inferences from learned associations (Poldrack et al 2001). Prefrontal cortex is thought to be involved in 
representing contextual information about the states of the environment and of the actor in order to exert 
top-down bias on choice behavior (Doya 1999).  While this task was designed to rely heavily on the basal 
ganglia system, it is likely that these explicit systems contributed to learning as well, and may have 
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differed between groups. Our behavioral data provides some evidence that this may have been the case.  
At both acquisition and test, we found evidence of reduced performance on the AB pair in patients as 
compared to controls, while performance on the CD pair and EF pair (at test) did not differ between 
groups.  We speculate that this finding may be related to an impairment in explicit learning among 
patients, given that the AB pair had the highest probability ratio and was therefore the easiest to learn via 
explicit mechanisms. This is because higher ratios require fewer trials to be held in working memory in 
order for explicit representations of reward contingencies to be formed, while lower ratios require 
integration over many more trials and are better suited to the gradual, implicit learning system of the basal 
ganglia.  This interpretation is consistent with the hypothesis in the literature that cortical learning is 
impaired in patients, while striatal learning is intact (Gold et al 2008).  We also examined win-stay/lose-
shift behavior during early learning, and found that win-stay behavior (and, to a lesser extent, all stay 
behavior) was less frequent in patients than in controls. This suggests that patients relied on explicit 
strategy use to a lesser extent than controls, which is also consistent with the hypothesis that explicit 
mechanisms may have been impaired in this population. 
 While the whole-brain results from the full acquisition phase showed intact activation among 
patients in regions associated with cognitive control, there were some results that are consistent with the 
hypothesis of impaired cortical learning in this group.  During the early learning phase, several regions 
involved in cognitive control demonstrated reduced overall choice-related activation in patients as 
compared to controls, which is consistent with a reduction in explicit learning during the early learning 
phase.  Further, within the AB pair, B choices were associated with reduced activation in error- and 
conflict-processing regions including dorsal ACC, anterior prefrontal cortex, and thalamus, as well as 
OFC, medial temporal lobe, and cerebellar regions associated with executive control such as crus I and II 
(Habas et al 2009) among patients. In some of these regions, including bilateral anterior prefrontal cortex 
and left superior parietal lobule, this reduction in activation for B choices was associated with worse 
performance on the AB pair (and, for SPL, reduced win-stay behavior).  Reduced error responses among 
individuals with schizophrenia are well established, and may reflect a failure to engage evaluative 
processes that contributes to impaired learning (Polli et al 2008). However, it is important to keep in mind 
that this relationship may simply represent larger error responses among those participants who are 
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doing well enough to know that “B” choices are less likely to yield reward, and may not be causally related 
to learning performance. 
 At the time of feedback, however, whole-brain activity was remarkably similar between patients 
and controls.  Analyses of both positive versus negative feedback and prediction error analyses revealed 
patterns where reward regions responded to positive feedback or prediction errors and cognitive control 
regions responded to negative feedback or prediction error, a pattern that was intact in patients.  There 
were few group differences at the time of feedback, and those we did see were small effects in regions 
not typically associated with any of the learning systems discussed here.  One exception is VMPFC, 
which demonstrated effects of both choice type and feedback type that were absent in the patient group; 
however, these effects did not resemble a prediction error in controls and did not correlate with behavior 
or clinical symptoms.  However, despite the intact activation at a group level, activation in response to 
positive feedback correlated with anhedonia/avolition in the patient group in both striatal and cortical 
regions.  This finding is consistent with the hypothesis that deficits in responses to positive feedback 
contribute to these symptoms, although evidence for this interpretation is weakened by the fact that 
neither activation in these regions nor anhedonia/avolition severity correlated with gain learning rate. 
 While there is some evidence here that is suggestive that deficits in cortical learning mechanisms 
may have contributed to impaired performance in patients, the analyses of learning phase here were not 
individualized to each subject’s performance and may therefore have obscured important differences in 
these mechanisms, which may be active only at the earliest stages of learning.  While the reinforcement 
learning model data was fit to individual subject behavior, these analyses may have been influenced by 
the fact that they examined brain activity during the full acquisition phase, which for many subjects 
included a long period after learning had plateaued.  This design was chosen with gradual striatal learning 
in mind, and while it allows a preliminary look at cortical learning, additional analyses that give a more 
nuanced picture of cortical learning in this task are possible.  In future work, we plan to examine pre-
plateau learning as defined on a subject-by-subject basis in order to more accurately assess the 
contributions of cortical learning systems during early trials.  We also plan to examine choice- and 
feedback-related activity associated with win-stay/lose-shift behavior to determine whether there are 
abnormalities in cortical activation associated with the alterations in strategy use in the patient group. 
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 In addition to the limitations discussed above, the conclusions that can be drawn from this study 
about individuals with schizophrenia are limited by the fact that patients examined here were taking 
antipsychotic medications.  Correlations with dose equivalents revealed increased NoGo learning in 
patients with higher medication doses, but no significant relationships between dose and brain activity.  
Interestingly, increased NoGo learning is what the Frank model predicts for greater levels of D2R 
antagonism, meaning that this relationship actually provides support for the model (Frank and O'Reilly R 
2006; Waltz et al 2007).  Perhaps surprisingly, studies examining striatal activation in schizophrenia tend 
to find reduced striatal activation for unmedicated patients, with intact activation for patients taking 
atypical antipsychotics, including some direct evidence of a normalizing effect of starting these 
medications (Nielsen et al 2012).  The present study lends further support to these findings by 
demonstrating intact striatal activation in a population of patients primarily taking atypical antipsychotic 
medications. 
 In conclusion, this study demonstrated behavioral evidence of impaired learning from positive 
versus negative feedback, as well as impaired learning of stimuli with high versus low reinforcement 
ratios, among medicated patients with schizophrenia.  Striatal activation was intact in the patient group at 
the time of choice and feedback, including intact prediction error activity.  Cortical responses to feedback 
and prediction errors were also similar between groups.  At the time of choice, patients failed to recruit 
cognitive control regions to the same extent as controls during early learning, and showed reduced 
responses in cognitive control and error-related regions when making low-probability choices, which 
correlated with performance.  These findings are suggestive of alterations in cortical, but not basal 
ganglia, reinforcement learning mechanisms in the patient group.  Severity of anhedonia and avolition in 
patients were not related to behavioral learning impairments or to prediction error activity, but were 
associated with reduced responses to positive feedback in caudate and bilateral DLPFC, suggesting a 
relationship between these symptoms and altered processing of positive feedback in patients.  Future 
directions will further explore cortical activation during early learning and explicit strategy use to gain 
further insight into the contributions of explicit mechanisms to reinforcement learning in this population.  
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Supplementary Materials 
 
Movement Data: 
 
Table S1: Incremental (frame-by-frame) and absolute movement (root-mean-square values in mm), as 
well as mean voxelwise standard devation values for bolds 1-10 
GROUP BOLD INCREMENTAL ABSOLUTE SD 
CON 1 0.13  (0.07) 0.37  (0.27) 11.34  (2.83) 
 2 0.18  (0.19) 0.38  (0.29) 11.83  (3.6) 
 3 0.15  (0.09) 0.37  (0.26) 11.76  (2.74) 
 4 0.17  (0.14) 0.43  (0.31) 12.5  (3.38) 
 5 0.19  (0.15) 0.42  (0.28) 12.64  (3.42) 
 6 0.19  (0.12) 0.57  (0.56) 13.69  (4.27) 
 7 0.26  (0.29) 0.62  (0.59) 14.15  (5.21) 
 8 0.23  (0.2) 0.54  (0.45) 13.77  (4.48) 
 9 0.22  (0.23) 0.58  (0.41) 14.28  (4.45) 
 10 0.24  (0.21) 0.58  (0.43) 14.14  (4.38) 
SCZ 1 0.17  (0.16) 0.4  (0.46) 11.97  (4.16) 
 2 0.18  (0.12) 0.38  (0.35) 12.03  (3.8) 
 3 0.2  (0.22) 0.4  (0.36) 12.49  (4.83) 
 4 0.18  (0.11) 0.47  (0.38) 13.08  (3.99) 
 5 0.19  (0.12) 0.38  (0.31) 12.09  (3.16) 
 6 0.21  (0.16) 0.5  (0.54) 13.64  (4.07) 
 7 0.21  (0.2) 0.52  (0.63) 13.47  (4.37) 
 8 0.24  (0.28) 0.49  (0.6) 13.44  (5.61) 
 9 0.24  (0.3) 0.47  (0.45) 13.57  (4.97) 
 10 0.2  (0.12) 0.4  (0.21) 12.91  (3.25) 
 
 
Feedback ANOVA: Effects of Choice 
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Table S2. Feedback ANOVA: Effects of choice 
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Table S3.  Feedback ANOVA: Interactions between learning phase and choice 
Region BA Talairach Voxels Z Pattern 
Early Late 
Inferior Parietal Lobule 40 -47_-42_+46 51 4.36 NS ACE > BDF 
Insula 13 +33_-22_+25 169 4.83 NS ACE > BDF 
Medial Frontal Gyrus 6 +3_-14_+48 21 3.92 NS ACE > BDF 
Middle Frontal Gyrus 8 -45_+8_+42 105 5.15 NS ACE > BDF 
Parietal White Matter - -45_-15_+24 72 4.84 NS ACE > BDF 
Postcentral Gyrus 43 +53_-12_+18 119 4.99 NS ACE > BDF 
Postcentral Gyrus 4 +42_-17_+45 115 4.19 NS ACE > BDF 
Precuneus 19 +16_-79_+38 113 4.24 NS ACE > BDF 
Superior Temporal Gyrus 22 -40_-53_+11 78 4.47 NS ACE > BDF 
Superior Temporal Gyrus 41 -50_-36_+15 39 4.86 NS ACE > BDF 
Cerebellar Tonsil - -32_-51_-46 72 4.81 BDF > ACE ACE > BDF 
Cerebellar Tonsil - +35_-62_-38 169 4.85 BDF > ACE ACE > BDF 
Claustrum - +38_+00_+07 113 4.51 BDF > ACE ACE > BDF 
Cuneus 18 +07_-77_+26 171 4.18 BDF > ACE ACE > BDF 
Cuneus 18 +25_-77_+21 171 4.32 BDF > ACE ACE > BDF 
Cuneus 18 -15_-80_+23 136 4.10 BDF > ACE ACE > BDF 
Inferior Frontal Gyrus 13 +33_+22_+09 26 3.85 BDF > ACE ACE > BDF 
Inferior Temporal Gyrus 20 -50_-56_-11 95 5.45 BDF > ACE ACE > BDF 
Lingual Gyrus 18 +09_-81_+02 211 4.42 BDF > ACE ACE > BDF 
Lingual Gyrus 19 +15_-51_-01 41 4.42 BDF > ACE ACE > BDF 
Lingual Gyrus 19 +23_-71_-01 39 3.83 BDF > ACE ACE > BDF 
Lingual Gyrus 19 -15_-46_-01 35 4.13 BDF > ACE ACE > BDF 
Middle Frontal Gyrus 6 +40_+06_+47 91 4.62 BDF > ACE ACE > BDF 
Middle Occipital Gyrus 19 +44_-78_+05 56 4.32 BDF > ACE ACE > BDF 
Posterior Cingulate 30 -19_-59_+05 93 4.60 BDF > ACE ACE > BDF 
Precentral Gyrus 9 +36_+24_+36 167 4.80 BDF > ACE ACE > BDF 
Sub-Gyral 37 -52_-40_-03 72 4.92 BDF > ACE ACE > BDF 
Superior Temporal Gyrus 41 +48_-38_+08 52 4.75 BDF > ACE ACE > BDF 
Tuber - -31_-61_-30 58 4.57 BDF > ACE ACE > BDF 
Inferior Frontal Gyrus 9 +49_+04_+23 61 4.24 NS (+) ACE, (-) BDF 
Medial Frontal Gyrus 6 +0_-22_+70 19 4.12 NS (+) ACE, (-) BDF 
Posterior Cingulate 31 -09_-65_+14 148 4.60 NS (+) ACE, (-) BDF 
Precentral Gyrus 6 +52_-05_+39 88 4.78 NS (+) ACE, (-) BDF 
Superior Frontal Gyrus 6 +25_+06_+57 133 4.95 NS (+) ACE, (-) BDF 
Superior Frontal Gyrus 6 -13_+14_+48 302 4.82 NS (+) ACE, (-) BDF 
Superior Temporal Gyrus 39 +56_-62_+19 95 5.02 (+) BDF Early, (-) ACE Early (+) ACE, (-) BDF 
Inferior Frontal Gyrus 46 -42_+34_+10 21 4.32 BDF > ACE (+) ACE, (-) BDF 
Medial Frontal Gyrus 10 +20_+51_+8 101 5.66 BDF > ACE (+) ACE, (-) BDF 
Precuneus 19 +34_-67_+39 234 4.44 BDF > ACE (+) ACE, (-) BDF 
Superior Frontal Gyrus 6 +11_+10_+66 14 4.01 BDF > ACE (+) ACE, (-) BDF 
Transverse Temporal Gyrus 42 -58_-15_+15 23 4.54 NS BDF Shifted Later 
Parahippocampal Gyrus 28 -23_-26_-8 49 4.49 BDF > ACE NS 
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The preceding chapters examined the potential relationships between impairments in three candidate 
processes involved in translating reward information into goal-directed behavior and symptoms of 
anhedonia and avolition in schizophrenia: hedonics, reward prediction, and reinforcement learning.  We 
chose to examine these processes because they are not only necessary for the generation of goal-
directed behavior, but they are likely candidates for alteration in schizophrenia given their dependence on 
dopaminergic systems thought to be disrupted in this illness.  However, a number of higher-level cognitive 
processes also contribute to forming goal-directed action plans, which may also be disrupted in patients 
experiencing these symptoms (Figure 5.1).  Here, we discuss how our results speak to the relative 
contributions of these different mechanisms to motivational impairments in schizophrenia, as well as their 
implications for future work in this field. 
 
 
Figure 5.1. Components of reward-to-outcome translation. Figure adapted from (Barch and Dowd 
2010). This figure outlines a conceptual overview of several processes thought to be involved in 
translating reward information into goal-directed behaviors, which may be compromised in schizophrenia. 
 
Hedonics, reward prediction, and reinforcement learning: Summary and implications. 
 In Chapter 2, we examined hedonics (Figure 5.1a) in schizophrenia using self-reports and brain 
responses to emotionally evocative stimuli.  We found that as a group, individuals with schizophrenia 
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demonstrated reduced valence, but not arousal, experiences of both positive and negative stimuli.  
However, we also found that individuals with more severe anhedonia reported experiencing less emotion 
in response to both positive and negative stimuli, a relationship that held among both patients and 
controls and fully mediated the differences between groups. These behavioral findings suggest that the 
relationship between reduced emotional experience and greater anhedonia are not specific to 
schizophrenia, but may reflect a relationship with the clinical dimension of anhedonia that crosses 
diagnostic boundaries.  Further, they suggest that this relationship is not specific to a disruption in 
hedonic processes, because negative experiences were affected as well.   This pattern of blunting for 
both positive and negative experiences has been reported in past studies in both patients with 
schizophrenia and controls, (Burbridge and Barch 2007; Herbener et al 2007) as well as in patients with 
major depressive disorder (Treadway and Zald 2011). Further studies of anhedonia in healthy adults as 
well as other psychiatric and neurological disorders may shed light on the extent to which this relationship 
is generalizable. In terms of fMRI results, this study demonstrated patterns of activation across emotional 
conditions that did not differ between groups at a whole-brain level, though ROI analysis revealed regions 
in left putamen and right ventral striatum with altered activation for positive stimuli in patients.  In addition, 
increased anhedonia was associated with reduced activation for positive vs. negative stimuli in bilateral 
amygdala and right ventral striatum in patients, and in bilateral caudate in controls.  These results are 
consistent with the possibility that hedonic deficits are associated with impairments in striatal and 
amygdala processing of pleasant stimuli, but due to nonspecificity in the anhedonia rating scales, may 
reflect motivational deficits as well. 
 In Chapter 3, we examined reward prediction in schizophrenia using a Pavlovian paradigm with 
monetary reward.  We found intact striatal responses to reward receipt in the patient group that were not 
sensitive to anhedonia/avolition severity. These findings are somewhat at odds with the results of Chapter 
2, which show abnormal responses to pleasant experiences among patients, particularly those higher in 
anhedonia.  However, they do agree with several studies in the literature in showing intact activation in 
response to receipt of monetary reward (Kirsch et al 2007; Schlagenhauf et al 2009; Simon et al 2010; 
Walter et al 2009). One potential explanation for this is that well-predicted rewards are expected to elicit a 
minimal dopaminergic response, and tasks examining pleasant events that are not preceded by predictive 
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cues, or that deliberately elicit prediction errors, may be more sensitive to alterations in feedback 
responses among individuals with schizophrenia, at least those with higher self-reported anhedonia.  It is 
also possible that anhedonic individuals are able to respond normally to simple monetary rewards, but 
have more difficulty responding to the complex scenes and faces used in emotion studies. This study also 
found that during reward anticipation, greater anhedonia/avolition was associated with smaller responses 
in ventral striatum in patients, consistent with the hypothesis that reductions in striatal reward prediction 
contribute to anhedonia in schizophrenia.  In addition, the same relationship was seen in VMPFC among 
both patients and controls, again suggesting that there may be aspects of the relationship between 
anhedonia and reward processing that cross diagnostic boundaries. 
 Chapter 4 examined probabilistic reinforcement learning in schizophrenia and found behavioral 
evidence for impairments in learning from positive feedback in patients as compared to controls.  We 
found no evidence of altered striatal responses to choice, feedback, or prediction error, but did find 
evidence suggestive of impairments in cortical learning systems relying on cognitive control regions 
including DLPFC.  Reduced responses to positive feedback in caudate and posterior DLPFC were 
associated with greater anhedonia/avolition severity among patients, but not controls. The finding of a 
relationship between activation for positive feedback and motivational deficits in the reinforcement 
learning study, but not in the reward-prediction study (or others in the literature), suggests that deficits in 
feedback responses among amotivated individuals may be related to using feedback information to 
update reward representations and guide future choices.  The fact that we found this relationship in 
bilateral DLPFC lends further support to this hypothesis, as maintaining a dynamic representation of the 
state of the organism and the environment is a function thought to be supported by this region.  
Specifically, posterior DLPFC has been implicated in decision-making, and has high connectivity with 
posterior parietal cortex (Cieslik et al 2012).  Posterior parietal cortex has been proposed to act as a 
salience-specific behavioral integrator, incorporating information about expected rewards and goal 
context with visuospatial, motor, and memory information under top-down influence from DLPFC (Gottlieb 
2007).  The reduced activation in response to positive feedback in posterior DLPFC regions among 
patients high in avolition may therefore represent disruption in a network responsible for integrating 
reward information with other contextual information required to guide appropriate behavior.  
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 Taken together, a few commonalities stand out across these studies.  First, all three studies 
examined populations of controls and patients who differed significantly in their levels of self-reported 
anhedonia/avolition.  Second, all three studies identified activation patterns in reward processing systems 
that were surprisingly intact among the patient group.  While there were some group differences that 
could be meaningful, in general these differences were either of small effect sizes, or were not found in 
regions associated with reward processing.  Third, despite the relative lack of group differences, all three 
studies identified relationships between altered activation and severity of self-reported 
anhedonia/avolition among patients.  This pattern of findings suggests that the processes examined here 
vary with individual differences in anhedonia/avolition in a meaningful way, but that there is additional 
variance in these symptoms that is unaccounted for by any of the three processes studied.  One 
possibility, consistent with the cortical learning impairments and association of altered posterior DLPFC 
activity with anhedonia/avolition shown in Chapter 4, is that impairments in cortically mediated processes 
involved in the generation of goal-directed behavior also contribute to these symptoms.   
 
From reward prediction to goal-directed behavior: cortical contributions 
 In the studies described here, we examined the hypothesis that reductions in goal-directed 
behavior result from disruptions in dopamine-mediated striatal reward valuation and prediction systems, 
which would reduce the ability of appetitive cues to drive behavior.  However, these disruptions may be 
exacerbated by impairments in higher-level cognitive processes required to translate information about 
reward values and predictions into goal-directed behavior.  These processes are illustrated in Figure 5.1 
((Barch and Dowd 2010), adapted from (Wallis 2007)).  First, information from the hedonic, reward 
prediction, and reinforcement learning processes studied here must be integrated into representations of 
value.  A prominent hypothesis posits that this computation is supported by OFC, which integrates the 
reinforcing properties of the stimulus with the internal state of the organism, as well as updating changes 
in reward contingencies (Wallis 2007).  In addition, action plans must be generated using current 
information about values and goals, a process that may be supported by DLPFC (Miller and Cohen 
2001).  Further, candidate action plans must undergo cost-benefit analysis in which the effort associated 
with the plan is computed, purportedly by dorsal ACC (Croxson et al 2009; Salamone et al 2007), and 
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weighed against the expected value of potential rewards. Interaction between these processes allows 
selection of the action plan most likely to yield the desired outcome, which is then translated into a 
behavioral response. Below, we discuss the existing evidence and need for future work to determine 
whether disruptions in these processes also contribute to motivational deficits in schizophrenia.  
 Value computation and OFC function in schizophrenia:  The hypothesis that motivational deficits 
in schizophrenia may reflect deficits in OFC-based value representation has been raised by Gold and 
colleagues, who have found behavioral evidence that individuals with schizophrenia have difficulty 
integrating and updating information about rewards and punishments (Gold et al 2008).  Experimental 
paradigms probing OFC function, including probabilistic reversal learning and the Iowa Gambling Task, 
have both yielded fairly consistent evidence of impairment in schizophrenia (Ceaser et al 2008. Shurman, 
2005 #158; Elliott et al 1995; Kester et al 2006; Kim et al 2009; Lee and Seo 2007; Martino et al 2007; 
Oades 1997; Pantelis et al 1999; Premkumar et al 2008; Sevy et al 2007; Turnbull et al 2006; Tyson et al 
2004; Waltz and Gold 2007; Yip et al 2009). There is also evidence for an association between reduced 
OFC volume and negative symptoms in schizophrenia (Baare et al 1999; Gur et al 2000). Further, a study 
using a computational reinforcement learning model was able to reproduce the behavior of patients with 
high negative symptoms when deficits in putatively OFC-based functions were simulated (Gold et al 
2012).  However, as of yet, there is no neuroimaging data on OFC function in relationship to value 
representation in schizophrenia using tasks such as probabilistic reversal learning, making this a 
promising focus for future studies.  
 Effort computation and ACC function in schizophrenia:  To our knowledge, there is no work 
addressing effort computations in schizophrenia. ACC dysfunction has been reported in schizophrenia in 
studies showing reduced error-related responses (Polli et al 2008) and reduced conflict-related activation 
(Kerns et al 2005).  It is possible that these functions share common mechanisms with effort computation, 
as greater conflict and error are likely associated with a requirement for greater effort, but more work is 
needed to address this possibility. 
 Goal-directed action and DLPFC function in schizophrenia:  There is a large body of evidence for 
impairments in cognitive functions thought to be mediated by DLPFC in schizophrenia (Barch 2005; 
Heinrichs and Zakzanis 1998; Lee and Park 2005), including working memory, context representation, 
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goal maintenance, and planning.  Furthermore, there is robust evidence for altered DLPFC function in 
schizophrenia during cognitive control tasks (Minzenberg et al 2009). Given these findings, one appealing 
possibility is that a core deficit in the ability to represent goal and context information in working memory 
may underlie both cognitive and motivational deficits in schizophrenia (Figure 5.1e). Specifically, we 
speculate that these deficits may reflect impairments in the ability to maintain and utilize internal 
representations of emotional experiences, previous rewards, and motivational goals in order to drive goal-
directed behavior. This hypothesis is consistent with the correlation between reduced feedback-related 
activation in posterior DLPFC and anhedonia/avolition severity in patients as discussed above. Further, 
the ability to use internal goal and context representations may be closely related to the prefrontal explicit 
learning mechanisms discussed in Chapter 4, which showed some evidence of impairment in 
schizophrenia.   
One important direction for future research is to examine whether individuals with schizophrenia 
can adjust their cognitive performance under different motivational conditions, a process that may occur 
via modulation of DLPFC activity (Locke and Braver 2008). Several studies suggest that patients are not 
able to improve their performance on cognitive control tasks when offered monetary incentives (Green et 
al 1992; Hellman et al 1998; Roiser et al 2009; Vollema and van den Bosch 1995), though no 
neuroimaging studies have yet been conducted to examine the neural correlates of this impairment.  In a 
different approach, recent work by Ursu and colleagues demonstrated reductions in DLPFC activation in 
patients during maintenance of affective information, which were correlated with negative symptom 
severity (Ursu et al 2011). While this relationship was shown for negative stimuli, the general pattern is 
consistent with the hypothesis that individuals with schizophrenia may have difficulty representing 
information about rewards and incentives that can be used to drive goal directed behavior, and provides a 
model for future work.  
 
Anhedonia vs. Avolition: self-report limitations and future possibilities 
Each of the studies conducted here relied on self-report measures to assess anhedonia and 
avolition severity. As discussed previously, this assessment strategy has two major limitations: first, that 
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such measures do not adequately separate the constructs of anhedonia and avolition, and second, that it 
is not clear whether patients are able to give veridical self-reports of remembered or anticipated pleasure, 
as opposed to pleasure experienced in-the-moment (Strauss and Gold 2012).  The problem of measuring 
hedonic and motivational deficits separately is complex, given that motivational deficits may result from 
anhedonia, and amotivated individuals are likely to experience fewer pleasant events, decreasing overall 
pleasure experience (which may be misinterpreted as anhedonia).  This close interrelation is likely why 
these two symptoms load onto a single factor in clinician-rated scales of negative symptoms such as the 
SANS and the BNSS (Messinger et al 2011). Further complicating this distinction is the fact that most 
scales assessing “anhedonia” predate the knowledge of dissociable hedonic and motivational neural 
systems, and tend to conflate these constructs.  While we have tended to discuss a single dimension of 
anhedonia/avolition here for these reasons, we did explore the possibility of separating these constructs 
in each of the studies above.  In Chapter 2, we found that the relationships with anhedonia were also 
present when using the SANS avolition scale.  In Chapter 4, we found that correlations between self-
report scales did not respect the boundaries of whether the scale was intended to assess anhedonia or 
avolition.  Further, the correlations between anhedonia/avolition summary score and DLPFC activation in 
this study were present among several scales separately, including some newer scales intended to 
assess hedonics (e.g. TEPS consummatory pleasure) and some intended to assess motivation (e.g. the 
Apathy Scale).  New scales such as the Clinical Assessment Interview for Negative Symptoms (CAINS) 
(Horan et al 2011) may help to disentangle to what extent these difficulties are due to scale nonspecificity, 
and to what extent they reflect clinical co-occurrence of anhedonia and avolition.  The CAINS is unique 
among symptom scales in that it was developed using an iterative, data-driven approach to item 
generation, selection, and retention, and has undergone comprehensive assessment of its psychometric 
properties and validity in a large, diverse sample of patients.  While anhedonia and avolition load onto a 
single factor in this scale as well, the items addressing these symptoms carefully distinguish between the 
frequency of pleasant or goal-directed events and the internal experience when these events occur, 
information that may potentially be used to tease apart effects of hedonic versus motivational deficits. 
The second problem with self-report measures is that scores on these measures may be 
influenced by cognitive deficits that make reporting remembered or anticipated pleasure difficult in 
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patients. This possibility is consistent with our findings of group differences in self-reported 
anhedonia/avolition, but few group differences in brain activation on tasks that probe the reward system in 
response to stimuli presented in-the-moment.  However, if anhedonia scores in patients are driven 
primarily by difficulties in reporting, rather than experiencing, pleasure, we would not expect them to be 
associated with in-the-moment emotional experience, as we found in Chapter 2.  Further, we would not 
expect them to show the same relationships with behavioral or neuroimaging variables that were present 
in controls, as we found in Chapters 2 and 3.  We feel that these results provide evidence that the self-
reports used here captured meaningful variation in anhedonia/avolition severity over and above any 
influence of cognitive deficits in patients, though it does not rule out some contribution of cognitive 
impairments. 
Given these concerns, future studies may benefit from obtaining anhedonia and avolition 
measures that do not rely on self-report, which will also provide independent estimates of hedonic versus 
motivational deficits.  Assessments of avolition can be obtained from informants such as family members 
who can provide accurate information about a patient’s day-to-day activities.  Accurate measurements of 
anhedonia may be best obtained using laboratory-based assessments of in-the-moment consummatory 
behaviors. 
 
Conclusions 
In conclusion, the studies included here provide evidence that impairments in reward processing 
functions including hedonics, reward prediction, and reinforcement learning are likely contributors, but are 
not sufficient to explain, anhedonia and avolition in medicated chronic outpatients with schizophrenia. We 
found evidence that reductions in both positive and negative emotional experience are related to 
increased anhedonia, and that anhedonia was associated with reduced ventral striatal activation for 
positive versus negative stimuli.  We also found that anhedonia/avolition was related to reduced 
anticipatory activity in ventral striatum and VMPFC during reward prediction, and to reduced positive 
feedback responses in caudate and DLPFC during reinforcement learning.  However, group differences in 
functional activation in these studies, particularly in striatal regions, were few, and do not seem likely to 
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fully explain the much larger group differences in anhedonia/avolition severity.  We therefore hypothesize 
that deficits in additional processes required to translate information about received or anticipated 
rewards into goal-directed behavior also contribute to motivational deficits in schizophrenia.  In particular, 
we speculate that deficits in reward prediction and learning may be exacerbated by the inability to 
integrate, maintain, and flexibly update information about rewards, goals, and context in order to form 
action plans. What is needed next is research that tests the ability to use and maintain internal 
representations of reward information to modulate behavior and brain function in schizophrenia, along 
with work that characterizes links between deficits in this ability and everyday function in this illness. 
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